data_2po8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2po8 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 mptt . . . . . 0 C--O 1.237 0.437 0 CA-C-O 120.883 0.373 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 26.7 p -149.88 144.69 26.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.688 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.22 14.09 12.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 0.0 109.741 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 16.9 ptp180 177.14 177.64 0.3 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.811 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.03 -46.76 86.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.884 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -53.91 -25.44 20.21 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.8 m-20 -69.09 -10.02 55.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.54 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t -140.17 141.47 26.65 Favored Pre-proline 0 C--N 1.32 -0.684 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.651 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 33.6 Cg_endo -63.35 162.87 25.45 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.947 2.431 . . . . 0.0 112.273 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.27 8.57 0.44 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -78.67 -22.35 46.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.523 0.678 . . . . 0.0 109.553 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 28' ' ' SER . 68.1 m -152.17 -176.94 5.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.737 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.456 HG12 ' HE ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -133.97 144.61 35.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.758 0.313 . . . . 0.0 110.73 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.5 t -69.76 116.71 10.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.333 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.456 ' HE ' HG12 ' A' ' 19' ' ' ILE . 24.5 mmt85 -83.02 176.37 9.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.445 . . . . 0.0 111.386 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.89 -22.48 70.34 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.65 -0.704 . . . . 0.0 114.026 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -77.94 2.21 18.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.888 0.344 . . . . 0.0 111.901 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.28 28.53 55.65 Favored Glycine 0 C--O 1.237 0.306 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.446 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.44 159.03 43.1 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.023 0.439 . . . . 0.0 109.994 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.95 135.76 49.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -127.47 126.75 5.64 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.471 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 20.0 m . . . . . 0 C--N 1.323 -0.572 0 C-N-CA 122.188 0.195 . . . . 0.0 110.805 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.339 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 3.6 p -151.37 153.19 34.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.821 0.343 . . . . 0.0 111.731 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.668 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -118.77 11.96 12.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.412 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 36.7 ptt180 -168.47 178.46 4.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.567 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -74.9 -42.29 58.08 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.561 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -55.56 -24.15 30.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.668 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 55.2 m-20 -70.64 -14.75 62.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.401 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.609 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 5.0 t -123.75 142.23 38.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.755 0.312 . . . . 0.0 110.303 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 26.7 Cg_endo -61.74 164.42 16.18 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.904 2.403 . . . . 0.0 111.943 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.25 21.98 0.29 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 114.184 0.434 . . . . 0.0 114.184 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.63 -26.98 24.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.25 0.548 . . . . 0.0 110.018 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 64.4 m -152.19 -177.23 6.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.51 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -124.11 146.34 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.645 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.0 t -72.57 120.37 18.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.265 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -81.9 173.94 11.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.175 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.81 -24.16 66.24 Favored Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 113.155 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -73.86 -10.11 59.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.557 0.218 . . . . 0.0 111.517 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.53 35.22 10.68 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.749 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -145.55 156.53 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.434 . . . . 0.0 109.942 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -65.19 136.03 56.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.301 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -137.7 127.52 3.95 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 111.856 -178.645 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.783 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 5.2 p -142.77 142.35 31.89 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.365 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.59 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -108.62 14.68 24.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.125 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -179.08 174.57 1.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.646 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.13 -53.65 50.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.592 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.91 -13.64 17.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.988 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.59 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 9.1 t0 -64.14 -25.83 68.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.631 0.729 . . . . 0.0 109.935 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.595 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t -122.47 144.38 42.0 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.836 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 29.5 Cg_endo -61.75 160.3 29.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.796 2.331 . . . . 0.0 112.45 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.41 -9.02 4.14 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.466 -0.788 . . . . 0.0 114.308 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.74 -21.54 66.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.063 0.459 . . . . 0.0 110.511 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.1 m -150.63 -176.04 5.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.942 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.7 pt -130.69 152.0 36.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.113 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 t -80.49 125.74 30.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.18 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -76.67 169.31 18.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.894 0.378 . . . . 0.0 110.359 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.17 -23.06 71.28 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.053 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -80.48 -1.92 43.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.33 40.88 9.65 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.248 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -145.79 150.53 36.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.082 0.441 . . . . 0.0 110.181 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 76.5 m -66.69 134.59 52.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.081 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.68 137.65 6.88 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.3 m . . . . . 0 C--N 1.322 -0.587 0 CA-C-N 116.855 0.327 . . . . 0.0 111.114 -179.368 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.358 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 p -150.87 143.75 24.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.348 0.595 . . . . 0.0 112.065 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.56 ' HG2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -110.77 -0.7 16.92 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.56 ' HG2' ' HG2' ' A' ' 9' ' ' ARG . 13.5 ptm180 -167.4 154.35 8.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.053 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -55.69 -33.9 64.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.453 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 m -55.61 -26.6 44.84 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.478 ' CG ' ' HE ' ' A' ' 9' ' ' ARG . 50.7 m-20 -69.05 -14.36 62.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.33 . . . . 0.0 111.406 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.729 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -125.11 150.54 67.13 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.729 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 23.9 Cg_endo -59.58 157.88 30.17 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.735 2.29 . . . . 0.0 112.984 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.82 -24.21 48.14 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.13 -0.941 . . . . 0.0 114.109 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.44 18.3 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.138 0.469 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.9 m -154.18 174.6 14.54 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.65 154.99 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.0 t -82.35 128.41 34.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.983 0.42 . . . . 0.0 110.331 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -80.13 170.04 16.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.065 0.46 . . . . 0.0 110.687 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.56 -25.83 73.8 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.658 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -81.32 -0.39 40.85 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.73 38.81 13.05 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.397 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -140.69 157.92 44.73 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 59.4 m -65.34 140.38 58.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.621 0.724 . . . . 0.0 112.647 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.38 136.04 9.08 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 116.804 0.302 . . . . 0.0 111.161 -178.831 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.551 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 5.8 p -152.7 146.77 25.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.047 0.451 . . . . 0.0 111.984 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.464 ' HE ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -110.27 11.75 23.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 12.8 ptp180 -179.79 160.92 0.95 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.486 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.48 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 8.0 t0 -60.09 -26.81 66.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.307 0.575 . . . . 0.0 111.246 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -58.96 -26.97 64.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.701 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 8' ' ' CYS . 20.9 m-20 -84.97 15.65 3.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.48 0.181 . . . . 0.0 110.9 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.589 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -126.46 141.95 41.56 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-O 121.004 0.43 . . . . 0.0 111.196 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 60.4 Cg_endo -70.86 156.08 61.14 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.929 2.419 . . . . 0.0 111.824 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.02 -29.41 43.53 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.207 -0.451 . . . . 0.0 113.996 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.43 8.32 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 111.91 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.4 ' C ' HG22 ' A' ' 19' ' ' ILE . 60.4 m -152.29 179.74 8.27 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.4 HG22 ' C ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -143.54 149.17 18.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.48 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 41.0 t -78.88 120.34 23.36 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.087 0.47 . . . . 0.0 110.219 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -81.53 169.54 16.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.719 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.43 -26.57 68.24 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 113.767 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -81.83 7.39 12.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.928 0.364 . . . . 0.0 111.83 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.08 31.34 55.58 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.299 -0.477 . . . . 0.0 114.276 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -134.18 154.17 51.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 109.979 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.7 m -79.26 135.79 36.86 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.555 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.27 139.19 12.07 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.724 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.749 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.871 0.367 . . . . 0.0 111.546 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 p -146.92 143.43 28.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.174 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.66 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -105.58 13.82 29.4 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.799 0.809 . . . . 0.0 109.464 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -171.79 158.59 4.96 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.775 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.569 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 35.8 t70 -65.2 -39.91 93.48 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.643 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -57.71 -17.84 17.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.66 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 79.7 m-20 -70.4 -20.96 62.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.996 0.427 . . . . 0.0 110.537 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -106.63 141.58 23.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.319 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 50.5 Cg_endo -67.85 158.59 56.6 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.618 2.212 . . . . 0.0 111.408 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.89 -16.47 2.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.76 -24.17 66.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.909 0.354 . . . . 0.0 111.39 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.9 m -143.99 -177.17 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.7 pt -132.76 150.9 33.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.505 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.569 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 38.8 t -82.45 122.87 28.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -80.26 164.78 22.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.023 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.77 -23.93 63.84 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.305 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -76.96 -3.17 37.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.84 36.29 13.91 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.459 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -145.71 153.09 40.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -68.09 145.81 54.06 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.298 0.57 . . . . 0.0 111.269 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.9 143.12 11.52 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.193 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 C--N 1.323 -0.581 0 O-C-N 123.875 0.397 . . . . 0.0 111.345 -179.424 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.498 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.41 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.3 p -142.98 150.57 39.83 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.081 0.467 . . . . 0.0 111.735 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.646 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -113.68 8.03 17.42 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.181 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -169.51 164.88 10.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.024 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -66.84 -36.28 81.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -54.96 -24.55 24.47 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.646 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 52.8 m-20 -71.8 -13.08 61.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.758 0.313 . . . . 0.0 111.098 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -127.54 148.46 66.7 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.664 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 31.6 Cg_endo -62.12 159.03 36.36 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.301 2.001 . . . . 0.0 111.84 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.1 17.64 0.27 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 114.503 0.561 . . . . 0.0 114.503 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.23 -21.14 27.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.27 0.557 . . . . 0.0 109.942 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.62 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 56.8 m -149.93 -179.37 7.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.4 HD11 ' H ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -129.18 157.75 41.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.473 179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.0 t -77.41 117.35 18.81 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.656 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 17.4 mtp85 -80.77 169.59 17.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.57 -24.98 49.29 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.615 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -74.79 -8.46 56.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.704 0.252 . . . . 0.0 111.456 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.83 35.64 15.54 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.693 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -144.95 158.59 43.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.4 . . . . 0.0 109.997 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.7 m -65.0 138.01 58.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.754 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.656 ' HA3' ' HD2' ' A' ' 21' ' ' ARG . . . -147.51 150.92 23.22 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.157 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.238 0.484 0 C-N-CA 123.505 0.722 . . . . 0.0 112.052 -179.386 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.841 0.353 . . . . 0.0 110.876 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 p -146.06 147.86 32.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.6 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.5 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -113.16 19.9 16.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.261 0.553 . . . . 0.0 109.767 178.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -178.6 179.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.325 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -71.77 -50.45 29.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.166 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -54.87 -26.17 33.68 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.5 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 73.5 m-20 -63.48 -19.34 64.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.305 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.9 t -115.43 141.28 27.01 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.976 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 47.9 Cg_endo -67.67 159.96 50.28 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.995 2.463 . . . . 0.0 112.005 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.85 -16.31 7.56 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.958 -0.565 . . . . 0.0 114.356 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.86 -16.5 64.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.31 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 64.3 m -151.57 -175.58 5.25 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -137.2 152.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.6 t -77.26 120.65 22.6 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.47 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 58.7 mtp180 -80.6 169.85 17.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.758 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.76 -24.69 66.72 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.61 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -82.09 13.64 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.04 0.42 . . . . 0.0 111.834 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.65 31.42 70.6 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 121.415 -0.421 . . . . 0.0 113.779 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -140.78 155.26 46.44 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.423 0.63 . . . . 0.0 110.332 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -68.18 142.08 55.81 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.197 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' HA3' ' HD2' ' A' ' 21' ' ' ARG . . . -151.6 131.16 3.36 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 117.208 0.504 . . . . 0.0 110.014 -179.249 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.734 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.227 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 p -133.52 147.19 51.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.972 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.657 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -104.05 1.07 30.54 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -167.0 159.95 13.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.04 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.447 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 23.1 t0 -60.67 -37.78 82.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.293 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -57.22 -21.22 32.24 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.657 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 64.3 m-20 -67.82 -19.16 65.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 111.12 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.428 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 t -113.66 145.77 34.09 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.573 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 74.0 Cg_exo -53.83 149.89 31.8 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.367 2.711 . . . . 0.0 112.75 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.03 -22.67 13.41 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.022 -0.99 . . . . 0.0 114.871 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.79 81.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.242 0.521 . . . . 0.0 110.856 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.8 m -104.39 179.64 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.625 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.66 147.63 23.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.815 0.34 . . . . 0.0 110.616 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.447 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 43.3 t -77.62 120.55 22.73 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -80.22 170.29 16.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.16 0.505 . . . . 0.0 111.649 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.44 -26.2 61.64 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.704 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -74.08 -7.18 51.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.72 0.26 . . . . 0.0 111.344 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.49 35.24 14.45 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.554 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -141.94 154.44 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 0.0 110.337 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.6 m -63.22 137.73 58.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.674 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.64 126.78 3.54 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 120.682 0.277 . . . . 0.0 111.041 -179.48 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.7 tptt . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 25.9 p -154.21 150.14 27.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.571 0.7 . . . . 0.0 112.124 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.549 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -132.01 18.41 4.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.164 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.92 173.78 1.83 Allowed 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.22 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.86 -54.34 43.45 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m -58.9 -20.43 51.42 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.549 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 64.5 m-20 -61.52 -23.55 66.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.162 0.506 . . . . 0.0 111.326 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.554 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 t -124.81 142.27 40.43 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 35.8 Cg_endo -64.92 163.89 26.67 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.776 2.317 . . . . 0.0 112.366 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.21 -17.67 11.55 Favored Glycine 0 CA--C 1.521 0.411 0 O-C-N 123.583 0.552 . . . . 0.0 113.713 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.52 -10.2 57.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 110.946 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.7 m -149.99 -178.45 6.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.657 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.9 pt -140.88 148.27 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.748 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.5 t -75.22 122.1 23.14 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.357 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -81.44 171.25 14.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.774 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.09 -25.73 75.2 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.795 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -84.94 14.12 5.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.0 32.03 63.78 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 114.726 0.651 . . . . 0.0 114.726 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -135.98 158.53 44.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.949 0.404 . . . . 0.0 110.273 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.6 m -71.75 136.62 47.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.07 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.81 136.06 11.5 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.087 0.47 . . . . 0.0 111.999 -178.696 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 p -120.96 148.41 44.13 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.115 0.483 . . . . 0.0 111.067 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.552 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -101.3 -17.12 16.7 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.64 ' HG2' ' OD1' ' A' ' 13' ' ' ASP . 4.0 ptp85 -165.6 177.18 7.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.14 -1.845 . . . . 0.0 107.045 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 6.2 t0 -61.2 -37.64 83.7 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.074 0.464 . . . . 0.0 111.109 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -59.49 -29.03 67.55 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.64 ' OD1' ' HG2' ' A' ' 10' ' ' ARG . 1.0 OUTLIER -69.15 -13.32 62.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 111.02 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 4.2 t -103.34 143.14 26.02 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.408 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.664 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 37.9 Cg_endo -63.91 154.0 72.5 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.793 2.328 . . . . 0.0 111.961 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.62 -30.3 34.51 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.585 -0.734 . . . . 0.0 114.527 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.11 2.3 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.312 0.556 . . . . 0.0 112.193 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 62.3 m -148.79 -176.77 5.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -140.12 156.72 24.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.903 179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 44.2 t -77.01 121.08 23.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.476 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -81.11 169.73 17.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.33 -27.58 72.61 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.529 -0.759 . . . . 0.0 113.353 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -84.18 19.31 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.888 0.344 . . . . 0.0 111.875 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.41 32.08 82.39 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 114.111 0.404 . . . . 0.0 114.111 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 15.3 m-85 -135.98 158.88 43.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.211 0.529 . . . . 0.0 110.352 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m -70.06 142.03 52.74 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.213 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -138.86 132.81 5.9 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 120.843 0.354 . . . . 0.0 110.957 -179.53 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.629 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.321 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 11.6 p -119.24 177.92 4.71 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.161 0.505 . . . . 0.0 111.489 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.656 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -131.13 9.66 4.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.132 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -175.04 172.71 2.78 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.676 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.51 -43.52 69.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.722 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -59.76 -13.97 12.54 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.656 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 69.3 m-20 -68.01 -21.04 65.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.008 0.432 . . . . 0.0 110.992 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.548 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -111.47 141.57 24.79 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.006 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.548 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 24.6 Cg_endo -61.82 165.66 13.59 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.893 2.396 . . . . 0.0 112.177 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.37 21.31 0.23 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 114.48 0.552 . . . . 0.0 114.48 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.57 -28.77 23.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.233 0.539 . . . . 0.0 109.749 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 82.8 m -156.19 -175.24 5.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.17 148.83 33.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.46 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 t -76.21 123.01 25.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.589 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 46.4 mtp85 -80.31 172.98 13.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.229 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.25 -23.72 48.76 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.08 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.589 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 15.7 p-10 -76.59 -1.08 25.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.028 0.414 . . . . 0.0 111.449 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 79.67 33.24 34.81 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.331 -0.461 . . . . 0.0 113.733 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -144.11 155.18 43.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 110.164 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.1 m -63.87 138.05 58.31 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.352 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -153.83 143.42 10.11 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.962 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.6 p . . . . . 0 C--N 1.323 -0.562 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.977 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.681 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.58 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 4.7 p -119.06 145.09 46.19 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.3 0.572 . . . . 0.0 112.423 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.12 -1.57 28.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.057 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.712 ' NH1' ' HB3' ' A' ' 12' ' ' SER . 26.1 ptt85 -171.75 179.64 2.73 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.806 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -62.84 -56.96 12.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.494 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.712 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 28.8 t -69.79 3.0 2.82 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.58 ' OD2' ' HA ' ' A' ' 8' ' ' CYS . 7.7 t70 -73.24 -12.22 60.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.442 0.639 . . . . 0.0 109.808 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -126.57 145.54 53.54 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.231 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 30.9 Cg_endo -61.92 158.53 37.94 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.753 2.302 . . . . 0.0 112.443 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.0 -24.29 8.32 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.591 -0.731 . . . . 0.0 114.562 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.57 -23.35 67.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 110.913 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.7 m -134.5 -178.96 5.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.471 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 19' ' ' ILE . 17.5 pt -143.19 150.82 17.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.873 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.2 t -73.73 120.32 19.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.044 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.637 ' HD3' ' HA3' ' A' ' 27' ' ' GLY . 21.8 mmm180 -81.62 168.73 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.724 0.297 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.64 -25.13 62.96 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 116.044 -0.525 . . . . 0.0 113.375 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.88 -7.24 56.43 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.92 31.7 19.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.666 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -138.3 156.45 47.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 0.0 110.03 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.4 m -66.07 135.76 55.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.178 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.637 ' HA3' ' HD3' ' A' ' 21' ' ' ARG . . . -134.36 138.84 10.36 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 117.067 0.433 . . . . 0.0 111.846 -178.351 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.757 0.313 . . . . 0.0 110.941 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 3.9 p -149.3 144.22 26.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.894 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.481 ' HD2' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -105.63 11.35 32.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.674 -179.07 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -171.75 172.46 4.89 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.965 0.412 . . . . 0.0 110.653 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -60.57 -55.32 34.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.769 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.8 m -80.23 21.6 0.59 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.895 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 6.7 t0 -86.63 -29.56 22.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.636 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.8 t -108.78 146.33 33.54 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.557 -1.202 . . . . 0.0 109.408 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.636 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.0 Cg_endo -60.47 159.79 26.24 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.738 2.292 . . . . 0.0 112.434 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.36 -8.25 3.47 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 115.684 -0.689 . . . . 0.0 114.552 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.0 -20.81 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.166 0.508 . . . . 0.0 110.704 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 55.8 m -152.11 178.12 9.79 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.4 ' N ' HD11 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -128.46 143.69 40.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.532 178.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.9 t -75.24 121.47 22.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.56 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -82.13 171.17 14.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.68 -24.2 63.97 Favored Glycine 0 C--O 1.227 -0.293 0 CA-C-N 115.817 -0.628 . . . . 0.0 113.062 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -74.41 -11.3 60.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.473 0.178 . . . . 0.0 111.299 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.44 32.86 9.85 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.684 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -142.16 147.21 36.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.443 0.64 . . . . 0.0 110.625 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.6 m -65.62 136.3 56.15 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.97 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -124.44 125.71 5.85 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 C--N 1.327 -0.375 0 C-N-CA 122.701 0.4 . . . . 0.0 111.909 -178.56 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.589 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.231 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 18.6 p -148.91 143.18 26.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.027 0.441 . . . . 0.0 111.483 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -105.39 6.36 32.53 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 172.9 171.79 0.12 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.727 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.06 -30.37 68.0 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.4 0.438 . . . . 0.0 111.677 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -56.92 -26.74 59.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.557 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 1.7 m-20 -78.98 5.13 12.4 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.409 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 t -149.89 147.3 22.12 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.042 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 70.5 Cg_exo -55.13 150.41 39.59 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.125 2.55 . . . . 0.0 113.113 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.55 -24.03 16.11 Favored Glycine 0 N--CA 1.462 0.425 0 CA-C-N 114.951 -1.022 . . . . 0.0 114.197 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.89 -21.56 66.52 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.219 0.533 . . . . 0.0 110.963 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.9 m -128.7 -179.6 5.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.297 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.3 pt -142.11 159.51 20.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.607 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.6 t -79.61 120.35 23.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.942 0.401 . . . . 0.0 110.012 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.856 ' HD3' ' HA3' ' A' ' 27' ' ' GLY . 12.2 mmm180 -81.4 166.55 20.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.774 0.321 . . . . 0.0 110.466 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.41 58.96 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.362 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -77.6 -5.33 49.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.79 30.39 32.42 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.673 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -135.84 161.72 34.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.034 0.445 . . . . 0.0 110.125 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 99.3 m -68.62 136.15 52.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.968 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.856 ' HA3' ' HD3' ' A' ' 21' ' ' ARG . . . -140.06 137.64 8.55 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.325 -0.5 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.63 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.688 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.132 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 13' ' ' ASP . 1.8 p -135.56 144.83 46.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.819 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.512 HH11 ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -104.13 13.19 32.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.471 0.653 . . . . 0.0 110.311 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -170.27 165.56 8.92 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.566 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 26.6 t70 -65.78 -52.22 52.65 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.405 0.441 . . . . 0.0 111.009 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.6 t -74.66 29.22 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.104 0.478 . . . . 0.0 111.609 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 11' ' ' ASP . 1.4 t70 -96.26 -27.05 15.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.785 0.802 . . . . 0.0 109.244 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.724 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -108.44 151.8 41.73 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.172 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.724 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.6 Cg_endo -60.43 156.55 40.71 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.472 2.115 . . . . 0.0 112.024 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.28 -19.25 5.64 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.446 -0.797 . . . . 0.0 115.054 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.33 69.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 0.0 111.169 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 39.7 m -134.49 179.03 6.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.38 149.13 33.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.191 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.566 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 11.0 t -76.86 113.17 14.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' NE ' ' HA3' ' A' ' 27' ' ' GLY . 98.7 mtt180 -81.92 173.3 12.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.167 0.508 . . . . 0.0 111.717 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.28 -25.94 55.39 Favored Glycine 0 C--O 1.229 -0.212 0 CA-C-N 115.228 -0.896 . . . . 0.0 114.509 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.424 ' ND2' ' HB2' ' A' ' 25' ' ' TYR . 16.2 p-10 -78.3 4.04 13.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.168 0.484 . . . . 0.0 111.754 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.18 31.2 59.77 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.281 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.424 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 27.5 m-85 -139.68 158.39 44.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.348 0.594 . . . . 0.0 110.327 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.8 m -68.15 133.06 48.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.65 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -129.85 132.26 6.97 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 C--N 1.324 -0.537 0 O-C-N 123.94 0.436 . . . . 0.0 111.825 -179.371 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.574 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 121.055 0.455 . . . . 0.0 111.72 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.7 p -143.74 146.29 33.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.963 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.657 ' N ' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -104.88 -16.99 14.71 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.53 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 17.4 ptt180 -156.81 167.3 30.88 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.762 -2.017 . . . . 0.0 107.253 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.46 -24.0 67.06 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.065 0.459 . . . . 0.0 110.184 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.437 ' HB2' ' HG3' ' A' ' 10' ' ' ARG . 4.1 m -63.27 -27.11 69.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.528 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 10' ' ' ARG . 13.4 m-20 -81.13 15.65 1.82 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.065 0.459 . . . . 0.0 110.706 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.661 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -150.35 147.97 23.08 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.661 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 33.4 Cg_endo -62.73 156.18 54.8 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.448 2.099 . . . . 0.0 112.254 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.94 -8.47 5.91 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.582 -0.735 . . . . 0.0 114.223 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.21 -18.67 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.053 0.454 . . . . 0.0 110.545 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.2 m -143.84 179.83 6.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.119 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -131.35 167.53 25.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.563 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.0 t -87.82 123.47 32.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.987 0.422 . . . . 0.0 110.856 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -81.9 170.49 15.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.981 0.419 . . . . 0.0 110.86 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 -29.33 73.42 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.565 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -76.1 -4.6 42.38 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 37.05 11.16 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.925 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -142.88 153.73 43.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m -63.92 142.7 58.31 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.726 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -150.64 139.83 7.53 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 121.027 0.442 . . . . 0.0 111.375 -178.952 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.627 ' H ' ' HD2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -132.4 143.83 50.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.397 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.725 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -105.05 15.01 28.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.285 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 13' ' ' ASP . 29.0 ptt85 -170.86 169.07 6.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.552 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -66.76 -56.5 10.21 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.249 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m -78.73 22.91 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.834 0.349 . . . . 0.0 111.808 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.725 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 7.9 t0 -79.79 -36.35 37.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -93.61 144.84 28.86 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.891 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.606 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.1 Cg_endo -61.27 161.51 23.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.886 2.391 . . . . 0.0 112.109 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.29 -19.21 2.68 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 114.849 0.7 . . . . 0.0 114.849 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.72 -20.3 66.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.063 0.432 . . . . 0.0 111.408 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.0 m -151.25 -179.25 7.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.049 0.452 . . . . 0.0 110.118 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.02 148.52 22.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -69.7 120.63 15.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -81.01 -175.07 5.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.15 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.96 -24.89 76.2 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.257 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 25' ' ' TYR . 16.2 p-10 -83.97 17.74 2.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.42 28.91 73.76 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.389 -0.434 . . . . 0.0 113.792 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 13.4 m-85 -136.81 157.35 46.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.415 0.626 . . . . 0.0 110.385 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.6 m -64.8 134.89 55.08 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.275 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.46 132.75 6.9 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.32 -0.684 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -179.535 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.704 ' H ' ' HD2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.586 0.231 . . . . 0.0 110.501 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 2.1 p -146.09 145.31 30.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.363 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.681 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -105.69 4.12 29.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -168.32 159.4 10.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.618 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.546 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 21.0 t0 -58.89 -40.53 84.72 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.914 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -59.26 -17.87 32.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.681 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 62.5 m-20 -67.78 -22.32 65.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.829 0.347 . . . . 0.0 111.045 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -113.01 143.73 29.71 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.241 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 73.8 Cg_exo -52.94 148.71 28.66 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.239 2.626 . . . . 0.0 112.853 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.31 -22.06 6.78 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 114.937 -1.029 . . . . 0.0 114.614 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.48 94.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.068 0.434 . . . . 0.0 110.752 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 29.1 m -112.14 -179.89 3.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.037 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.4 147.33 28.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.68 0.276 . . . . 0.0 110.705 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 49.6 t -76.04 123.9 26.51 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.101 0.477 . . . . 0.0 110.268 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.97 173.26 12.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.327 0.585 . . . . 0.0 111.512 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.07 -25.59 73.36 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.951 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -81.15 7.94 9.93 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 35.65 58.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.653 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -139.31 158.31 44.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.037 0.446 . . . . 0.0 110.131 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 86.4 m -67.23 137.24 56.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.403 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -126.97 137.37 9.89 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.797 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.327 -0.39 0 O-C-N 124.081 0.518 . . . . 0.0 111.309 -179.554 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.76 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.044 0.449 . . . . 0.0 111.046 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -112.86 159.99 18.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.629 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.49 ' HD2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -117.02 17.33 14.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.253 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.646 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 2.3 ptm180 -177.53 153.49 0.9 Allowed 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.302 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -57.49 -50.74 72.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.718 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -78.39 24.07 0.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.972 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.646 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 1.1 t0 -81.56 -32.28 32.25 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.662 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -89.6 149.09 41.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.032 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.662 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 20.4 Cg_endo -59.05 155.28 40.08 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.487 2.125 . . . . 0.0 112.324 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.92 -26.53 2.91 Favored Glycine 0 N--CA 1.466 0.647 0 O-C-N 123.97 0.794 . . . . 0.0 115.076 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.86 -20.39 65.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.972 0.386 . . . . 0.0 111.535 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.9 m -143.93 -178.81 6.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.775 0.321 . . . . 0.0 110.293 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.11 156.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 8.1 t -80.82 128.39 33.61 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.061 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.45 175.11 10.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.947 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.56 -28.02 69.02 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.54 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -76.43 -4.55 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.86 33.01 22.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.13 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -137.41 154.54 49.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 50.8 m -61.38 142.03 57.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.531 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.63 128.18 3.15 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 111.168 -179.289 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.1 m . . . . . 0 C--O 1.238 0.493 0 CA-C-O 120.665 0.269 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.93 138.4 85.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.199 2.6 . . . . 0.0 112.131 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -97.45 -37.87 9.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.631 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 tp -98.24 129.64 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.266 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 26' ' ' CYS . 2.6 pt? -163.68 144.88 9.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.02 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 17.0 pttp -150.08 166.87 28.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -59.47 135.14 57.57 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.575 0.547 . . . . 0.0 111.61 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 26.7 p -149.88 144.69 26.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.688 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.22 14.09 12.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 0.0 109.741 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 16.9 ptp180 177.14 177.64 0.3 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.811 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.03 -46.76 86.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.884 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -53.91 -25.44 20.21 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.8 m-20 -69.09 -10.02 55.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.54 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t -140.17 141.47 26.65 Favored Pre-proline 0 C--N 1.32 -0.684 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.651 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 33.6 Cg_endo -63.35 162.87 25.45 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.947 2.431 . . . . 0.0 112.273 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.27 8.57 0.44 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -78.67 -22.35 46.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.523 0.678 . . . . 0.0 109.553 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 28' ' ' SER . 68.1 m -152.17 -176.94 5.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.737 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.456 HG12 ' HE ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -133.97 144.61 35.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.758 0.313 . . . . 0.0 110.73 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.5 t -69.76 116.71 10.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.333 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.456 ' HE ' HG12 ' A' ' 19' ' ' ILE . 24.5 mmt85 -83.02 176.37 9.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.445 . . . . 0.0 111.386 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.89 -22.48 70.34 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.65 -0.704 . . . . 0.0 114.026 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -77.94 2.21 18.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.888 0.344 . . . . 0.0 111.901 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.28 28.53 55.65 Favored Glycine 0 C--O 1.237 0.306 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.446 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 26.8 m-85 -138.44 159.03 43.1 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.023 0.439 . . . . 0.0 109.994 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 5' ' ' LEU . 77.0 m -69.95 135.76 49.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -127.47 126.75 5.64 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.471 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 20.0 m -65.78 147.0 54.08 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 122.188 0.195 . . . . 0.0 110.805 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.56 -36.23 88.66 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.845 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.5 m -93.09 37.16 1.03 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -69.59 -32.12 70.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.928 0.394 . . . . 0.0 109.997 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.29 50.08 2.35 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.833 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.18 -45.25 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.482 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.65 68.13 1.15 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.91 2.407 . . . . 0.0 112.097 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -138.94 -44.61 0.47 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.915 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -150.56 134.97 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.24 0.543 . . . . 0.0 110.403 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.602 HD11 ' HB3' ' A' ' 25' ' ' TYR . 66.8 tp -157.69 122.3 4.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.728 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -150.85 152.84 34.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.724 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 143.14 49.37 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 3.6 p -151.37 153.19 34.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.821 0.343 . . . . 0.0 111.731 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.668 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -118.77 11.96 12.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.412 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 36.7 ptt180 -168.47 178.46 4.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.567 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -74.9 -42.29 58.08 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.561 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -55.56 -24.15 30.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.668 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 55.2 m-20 -70.64 -14.75 62.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.401 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.609 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 5.0 t -123.75 142.23 38.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.755 0.312 . . . . 0.0 110.303 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 26.7 Cg_endo -61.74 164.42 16.18 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.904 2.403 . . . . 0.0 111.943 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.25 21.98 0.29 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 114.184 0.434 . . . . 0.0 114.184 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.63 -26.98 24.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.25 0.548 . . . . 0.0 110.018 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 64.4 m -152.19 -177.23 6.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.51 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -124.11 146.34 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.645 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.0 t -72.57 120.37 18.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.265 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -81.9 173.94 11.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.175 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.81 -24.16 66.24 Favored Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 113.155 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -73.86 -10.11 59.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.557 0.218 . . . . 0.0 111.517 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.53 35.22 10.68 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.749 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.602 ' HB3' HD11 ' A' ' 5' ' ' LEU . 90.9 m-85 -145.55 156.53 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.434 . . . . 0.0 109.942 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -65.19 136.03 56.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.301 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -137.7 127.52 3.95 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 7.2 m -67.29 126.07 28.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 111.856 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.44 -51.69 25.27 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.122 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.1 m -80.23 51.39 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.031 0.443 . . . . 0.0 110.315 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 4.0 t70 -161.42 -49.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.549 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.39 -45.0 1.37 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.97 -118.17 4.14 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.641 ' HB2' HG12 ' A' ' 4' ' ' ILE . 68.8 Cg_endo -73.76 133.81 19.12 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.709 2.273 . . . . 0.0 112.203 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -78.24 56.3 1.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.119 0.485 . . . . 0.0 110.422 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.641 HG12 ' HB2' ' A' ' 2' ' ' PRO . 48.3 mm -88.97 113.91 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.998 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.86 63.51 5.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.32 0.581 . . . . 0.0 110.992 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -139.85 119.42 13.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.288 0.566 . . . . 0.0 112.444 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.783 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -86.97 149.33 24.85 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 5.2 p -142.77 142.35 31.89 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.365 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.59 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -108.62 14.68 24.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.125 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -179.08 174.57 1.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.646 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.13 -53.65 50.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.592 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.91 -13.64 17.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.988 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.59 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 9.1 t0 -64.14 -25.83 68.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.631 0.729 . . . . 0.0 109.935 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.595 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t -122.47 144.38 42.0 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.836 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 29.5 Cg_endo -61.75 160.3 29.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.796 2.331 . . . . 0.0 112.45 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.41 -9.02 4.14 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.466 -0.788 . . . . 0.0 114.308 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.74 -21.54 66.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.063 0.459 . . . . 0.0 110.511 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.1 m -150.63 -176.04 5.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.942 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.7 pt -130.69 152.0 36.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.113 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 t -80.49 125.74 30.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.18 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -76.67 169.31 18.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.894 0.378 . . . . 0.0 110.359 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.17 -23.06 71.28 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.053 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -80.48 -1.92 43.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.33 40.88 9.65 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.248 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -145.79 150.53 36.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.082 0.441 . . . . 0.0 110.181 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 76.5 m -66.69 134.59 52.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.081 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.68 137.65 6.88 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 28.3 m -71.77 165.49 23.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.855 0.327 . . . . 0.0 111.114 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.52 -43.35 85.57 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.275 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -93.62 41.71 1.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.904 0.383 . . . . 0.0 110.005 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 28' ' ' SER . 37.9 t70 -58.85 -39.74 82.2 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.204 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.21 -36.43 88.72 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.185 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.49 -47.56 6.77 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.643 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--N 1.329 -0.312 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.358 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 56.1 m . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.591 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 42.3 Cg_endo -68.31 79.79 0.58 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.067 2.511 . . . . 0.0 112.482 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -60.63 -31.52 70.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.672 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.489 HD13 ' O ' ' A' ' 4' ' ' ILE . 1.4 pp -89.88 138.13 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.703 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.4 tp -143.65 54.25 1.32 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.589 0.709 . . . . 0.0 110.274 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 35.5 mmtp -89.49 137.68 32.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.561 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 144.85 56.71 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 p -150.87 143.75 24.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.348 0.595 . . . . 0.0 112.065 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.56 ' HG2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -110.77 -0.7 16.92 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.56 ' HG2' ' HG2' ' A' ' 9' ' ' ARG . 13.5 ptm180 -167.4 154.35 8.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.053 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -55.69 -33.9 64.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.453 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 m -55.61 -26.6 44.84 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.478 ' CG ' ' HE ' ' A' ' 9' ' ' ARG . 50.7 m-20 -69.05 -14.36 62.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.33 . . . . 0.0 111.406 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.729 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -125.11 150.54 67.13 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.729 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 23.9 Cg_endo -59.58 157.88 30.17 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.735 2.29 . . . . 0.0 112.984 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.82 -24.21 48.14 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.13 -0.941 . . . . 0.0 114.109 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.44 18.3 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.138 0.469 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.9 m -154.18 174.6 14.54 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.65 154.99 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.0 t -82.35 128.41 34.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.983 0.42 . . . . 0.0 110.331 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -80.13 170.04 16.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.065 0.46 . . . . 0.0 110.687 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.56 -25.83 73.8 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.658 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -81.32 -0.39 40.85 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.73 38.81 13.05 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.397 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -140.69 157.92 44.73 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 6' ' ' LYS . 59.4 m -65.34 140.38 58.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.621 0.724 . . . . 0.0 112.647 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.38 136.04 9.08 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 2' ' ' PRO . 28.6 t -57.86 133.84 55.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.804 0.302 . . . . 0.0 111.161 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.3 -35.79 91.48 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.7 m -85.14 58.3 4.95 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -69.15 56.1 0.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.831 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.89 37.59 0.34 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.645 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.25 -48.94 0.58 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.15 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.217 0.532 . . . . 0.0 110.372 179.886 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.04 125.16 15.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.875 2.383 . . . . 0.0 112.76 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -78.28 57.42 1.88 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.887 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.7 tt -150.23 147.58 15.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.658 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -60.46 130.16 45.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.086 0.469 . . . . 0.0 109.984 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 15.6 pttp -139.52 130.63 26.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.712 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.551 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -146.66 151.23 36.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.857 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 5.8 p -152.7 146.77 25.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.047 0.451 . . . . 0.0 111.984 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.464 ' HE ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -110.27 11.75 23.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 12.8 ptp180 -179.79 160.92 0.95 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.486 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.48 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 8.0 t0 -60.09 -26.81 66.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.307 0.575 . . . . 0.0 111.246 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -58.96 -26.97 64.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.701 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 8' ' ' CYS . 20.9 m-20 -84.97 15.65 3.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.48 0.181 . . . . 0.0 110.9 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.589 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -126.46 141.95 41.56 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-O 121.004 0.43 . . . . 0.0 111.196 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 60.4 Cg_endo -70.86 156.08 61.14 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.929 2.419 . . . . 0.0 111.824 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.02 -29.41 43.53 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.207 -0.451 . . . . 0.0 113.996 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 30' ' ' SER . . . -78.43 8.32 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 111.91 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.4 ' C ' HG22 ' A' ' 19' ' ' ILE . 60.4 m -152.29 179.74 8.27 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.4 HG22 ' C ' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -143.54 149.17 18.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.48 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 41.0 t -78.88 120.34 23.36 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.087 0.47 . . . . 0.0 110.219 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -81.53 169.54 16.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.719 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.43 -26.57 68.24 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 113.767 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -81.83 7.39 12.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.928 0.364 . . . . 0.0 111.83 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.08 31.34 55.58 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.299 -0.477 . . . . 0.0 114.276 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -134.18 154.17 51.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 109.979 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 10.7 m -79.26 135.79 36.86 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.555 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.27 139.19 12.07 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 46.7 m -70.69 63.29 0.28 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.85 -49.24 50.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.705 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.477 ' HB2' ' HA ' ' A' ' 17' ' ' ALA . 3.1 m -85.83 46.79 1.35 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.973 0.416 . . . . 0.0 109.898 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 2.6 t70 -160.46 -62.64 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.119 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.66 33.87 88.38 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.666 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.64 -120.58 1.84 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.189 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 121.05 0.452 . . . . 0.0 110.882 -179.82 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.13 131.78 31.76 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.826 2.351 . . . . 0.0 111.496 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 3' ' ' LYS . 12.3 mptt -81.44 -43.3 19.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.361 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.2 mm -88.93 66.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.409 0.623 . . . . 0.0 110.129 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.6 tp -65.71 133.39 50.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.933 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -150.94 140.13 21.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.182 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.749 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.52 147.77 26.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.546 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 p -146.92 143.43 28.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.174 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.66 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -105.58 13.82 29.4 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.799 0.809 . . . . 0.0 109.464 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -171.79 158.59 4.96 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.775 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.569 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 35.8 t70 -65.2 -39.91 93.48 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.643 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -57.71 -17.84 17.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.66 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 79.7 m-20 -70.4 -20.96 62.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.996 0.427 . . . . 0.0 110.537 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -106.63 141.58 23.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.319 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 50.5 Cg_endo -67.85 158.59 56.6 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.618 2.212 . . . . 0.0 111.408 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.89 -16.47 2.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.76 -24.17 66.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.909 0.354 . . . . 0.0 111.39 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.9 m -143.99 -177.17 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.7 pt -132.76 150.9 33.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.505 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.569 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 38.8 t -82.45 122.87 28.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -80.26 164.78 22.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.023 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.77 -23.93 63.84 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.305 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -76.96 -3.17 37.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.84 36.29 13.91 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.459 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -145.71 153.09 40.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -68.09 145.81 54.06 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.298 0.57 . . . . 0.0 111.269 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.9 143.12 11.52 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.193 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.7 m -60.87 139.12 58.07 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.875 0.397 . . . . 0.0 111.345 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.48 -110.53 1.1 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.0 m -88.16 28.41 1.07 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.281 0.562 . . . . 0.0 109.928 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.04 -37.46 84.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.283 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.09 38.23 16.05 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.973 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.37 135.41 4.61 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.016 -0.612 . . . . 0.0 111.691 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 C--N 1.323 -0.577 0 CA-C-O 120.966 0.412 . . . . 0.0 111.191 -179.593 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 55.5 m . . . . . 0 C--O 1.234 0.258 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.416 ' HG3' ' H ' ' A' ' 28' ' ' SER . 32.5 Cg_exo -57.43 118.14 4.96 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.471 2.114 . . . . 0.0 111.987 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -75.22 -30.1 60.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.673 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 tp -112.28 130.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.922 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.654 HD12 ' HB3' ' A' ' 25' ' ' TYR . 40.1 tp -131.87 119.08 20.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.975 0.417 . . . . 0.0 110.225 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 41.1 mtmt -149.75 145.76 26.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.422 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.498 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -71.39 136.78 47.91 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.022 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.3 p -142.98 150.57 39.83 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.081 0.467 . . . . 0.0 111.735 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.646 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -113.68 8.03 17.42 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.181 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -169.51 164.88 10.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.024 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -66.84 -36.28 81.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -54.96 -24.55 24.47 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.646 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 52.8 m-20 -71.8 -13.08 61.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.758 0.313 . . . . 0.0 111.098 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -127.54 148.46 66.7 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.664 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 31.6 Cg_endo -62.12 159.03 36.36 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.301 2.001 . . . . 0.0 111.84 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.1 17.64 0.27 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 114.503 0.561 . . . . 0.0 114.503 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.23 -21.14 27.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.27 0.557 . . . . 0.0 109.942 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.62 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 56.8 m -149.93 -179.37 7.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.4 HD11 ' H ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -129.18 157.75 41.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.473 179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.0 t -77.41 117.35 18.81 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.656 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 17.4 mtp85 -80.77 169.59 17.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.57 -24.98 49.29 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.615 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -74.79 -8.46 56.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.704 0.252 . . . . 0.0 111.456 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.83 35.64 15.54 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.693 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.654 ' HB3' HD12 ' A' ' 5' ' ' LEU . 89.2 m-85 -144.95 158.59 43.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.4 . . . . 0.0 109.997 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.7 m -65.0 138.01 58.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.754 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.656 ' HA3' ' HD2' ' A' ' 21' ' ' ARG . . . -147.51 150.92 23.22 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.157 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.416 ' H ' ' HG3' ' A' ' 2' ' ' PRO . 3.3 m -48.26 139.98 8.0 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.505 0.722 . . . . 0.0 112.052 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.82 -111.74 1.19 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.661 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -86.45 28.74 0.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.155 0.502 . . . . 0.0 110.587 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' HB3' HG23 ' A' ' 34' ' ' VAL . 32.0 m-20 -75.84 -54.28 7.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.291 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.53 39.43 93.13 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.55 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.62 -55.27 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.846 -1.169 . . . . 0.0 113.321 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 31' ' ' ASP . 31.3 m . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.72 0.771 . . . . 0.0 111.132 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 65.5 m . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 120.74 0.305 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -62.7 135.98 55.46 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.676 2.251 . . . . 0.0 111.838 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -83.94 45.96 1.14 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.962 0.41 . . . . 0.0 111.068 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.3 tp -151.22 136.01 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.845 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.58 41.86 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.452 0.644 . . . . 0.0 111.627 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -89.5 119.5 29.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.482 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -73.35 143.45 46.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.841 0.353 . . . . 0.0 110.876 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 p -146.06 147.86 32.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.6 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.5 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -113.16 19.9 16.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.261 0.553 . . . . 0.0 109.767 178.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -178.6 179.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.325 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -71.77 -50.45 29.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.166 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -54.87 -26.17 33.68 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.5 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 73.5 m-20 -63.48 -19.34 64.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.305 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.9 t -115.43 141.28 27.01 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.976 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 47.9 Cg_endo -67.67 159.96 50.28 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.995 2.463 . . . . 0.0 112.005 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.85 -16.31 7.56 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.958 -0.565 . . . . 0.0 114.356 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.86 -16.5 64.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.31 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 64.3 m -151.57 -175.58 5.25 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -137.2 152.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.6 t -77.26 120.65 22.6 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.47 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 58.7 mtp180 -80.6 169.85 17.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.758 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.76 -24.69 66.72 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.61 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -82.09 13.64 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.04 0.42 . . . . 0.0 111.834 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.65 31.42 70.6 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 121.415 -0.421 . . . . 0.0 113.779 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -140.78 155.26 46.44 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.423 0.63 . . . . 0.0 110.332 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -68.18 142.08 55.81 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.197 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' HA3' ' HD2' ' A' ' 21' ' ' ARG . . . -151.6 131.16 3.36 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.5 t -72.79 -178.28 2.66 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 117.208 0.504 . . . . 0.0 110.014 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -50.71 -40.03 40.03 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.059 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 m -94.48 56.46 2.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HB2' ' NE ' ' A' ' 21' ' ' ARG . 1.5 p-10 -58.58 -37.15 75.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.332 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.37 20.03 2.81 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.997 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 31' ' ' ASP . . . -77.77 145.53 30.14 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 120.74 0.305 . . . . 0.0 110.574 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 42.2 t . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.934 0.397 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 1' ' ' CYS . 17.1 Cg_exo -67.33 134.39 33.37 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.997 2.465 . . . . 0.0 111.891 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -68.04 -27.98 66.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.519 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.5 tp -150.12 134.26 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.988 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.437 ' HA ' HD13 ' A' ' 5' ' ' LEU . 3.0 mm? -89.97 151.39 21.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.158 0.504 . . . . 0.0 111.02 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.04 127.01 35.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.053 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.734 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -76.94 137.1 38.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.148 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 p -133.52 147.19 51.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.972 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.657 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -104.05 1.07 30.54 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -167.0 159.95 13.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.04 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.447 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 23.1 t0 -60.67 -37.78 82.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.293 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -57.22 -21.22 32.24 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.657 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 64.3 m-20 -67.82 -19.16 65.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 111.12 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.428 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 t -113.66 145.77 34.09 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.573 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 74.0 Cg_exo -53.83 149.89 31.8 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.367 2.711 . . . . 0.0 112.75 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.03 -22.67 13.41 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.022 -0.99 . . . . 0.0 114.871 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.79 81.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.242 0.521 . . . . 0.0 110.856 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.8 m -104.39 179.64 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.625 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.66 147.63 23.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.815 0.34 . . . . 0.0 110.616 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.447 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 43.3 t -77.62 120.55 22.73 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -80.22 170.29 16.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.16 0.505 . . . . 0.0 111.649 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.44 -26.2 61.64 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.704 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -74.08 -7.18 51.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.72 0.26 . . . . 0.0 111.344 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.49 35.24 14.45 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.554 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -141.94 154.44 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 0.0 110.337 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.6 m -63.22 137.73 58.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.674 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.64 126.78 3.54 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 m -63.64 138.37 58.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.682 0.277 . . . . 0.0 111.041 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.76 -55.89 2.2 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.6 p -147.68 21.93 1.15 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -125.4 43.9 2.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.151 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.41 -56.57 23.7 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.854 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.39 -122.92 30.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.169 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.445 -0.707 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.539 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 30' ' ' SER . 73.7 m . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.724 0.297 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.64 132.13 26.21 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.779 2.319 . . . . 0.0 112.561 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -89.4 66.88 7.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.38 0.61 . . . . 0.0 110.224 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.3 tp -87.11 126.28 40.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.99 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 25' ' ' TYR . 43.8 tp -90.36 130.23 36.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.713 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 36.2 mtmt -148.37 168.72 21.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.978 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -83.96 140.28 32.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 25.9 p -154.21 150.14 27.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.571 0.7 . . . . 0.0 112.124 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.549 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -132.01 18.41 4.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.164 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.92 173.78 1.83 Allowed 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.22 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.86 -54.34 43.45 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m -58.9 -20.43 51.42 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.549 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 64.5 m-20 -61.52 -23.55 66.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.162 0.506 . . . . 0.0 111.326 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.554 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 t -124.81 142.27 40.43 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 35.8 Cg_endo -64.92 163.89 26.67 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.776 2.317 . . . . 0.0 112.366 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.21 -17.67 11.55 Favored Glycine 0 CA--C 1.521 0.411 0 O-C-N 123.583 0.552 . . . . 0.0 113.713 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.52 -10.2 57.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 110.946 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.7 m -149.99 -178.45 6.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.657 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.9 pt -140.88 148.27 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.748 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.5 t -75.22 122.1 23.14 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.357 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -81.44 171.25 14.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.774 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.09 -25.73 75.2 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.795 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -84.94 14.12 5.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.0 32.03 63.78 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 114.726 0.651 . . . . 0.0 114.726 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.709 ' HB3' HD11 ' A' ' 5' ' ' LEU . 16.0 m-85 -135.98 158.53 44.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.949 0.404 . . . . 0.0 110.273 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 6' ' ' LYS . 61.6 m -71.75 136.62 47.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.07 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.81 136.06 11.5 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -50.6 129.44 22.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.087 0.47 . . . . 0.0 111.999 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.24 63.25 0.55 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.5 ' HA ' ' HB2' ' A' ' 1' ' ' CYS . 12.5 m -73.47 48.78 0.26 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.858 0.463 . . . . 0.0 111.774 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -67.87 -50.88 53.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.552 0.691 . . . . 0.0 109.553 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.27 46.77 3.06 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.662 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.31 -125.44 8.76 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.352 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 121.593 0.711 . . . . 0.0 110.523 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.36 111.45 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.453 2.102 . . . . 0.0 111.833 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -83.57 40.07 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.35 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.9 tp -151.94 133.6 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.084 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mp -62.79 135.93 57.6 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.081 0.467 . . . . 0.0 111.295 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 6' ' ' LYS . 33.1 mmtm -146.16 123.87 11.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.163 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -101.04 144.62 29.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.993 179.226 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 p -120.96 148.41 44.13 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.115 0.483 . . . . 0.0 111.067 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.552 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -101.3 -17.12 16.7 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.64 ' HG2' ' OD1' ' A' ' 13' ' ' ASP . 4.0 ptp85 -165.6 177.18 7.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.14 -1.845 . . . . 0.0 107.045 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 6.2 t0 -61.2 -37.64 83.7 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.074 0.464 . . . . 0.0 111.109 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -59.49 -29.03 67.55 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.64 ' OD1' ' HG2' ' A' ' 10' ' ' ARG . 1.0 OUTLIER -69.15 -13.32 62.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 111.02 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 4.2 t -103.34 143.14 26.02 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.408 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.664 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 37.9 Cg_endo -63.91 154.0 72.5 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.793 2.328 . . . . 0.0 111.961 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.62 -30.3 34.51 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.585 -0.734 . . . . 0.0 114.527 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.11 2.3 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.312 0.556 . . . . 0.0 112.193 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 62.3 m -148.79 -176.77 5.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -140.12 156.72 24.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.903 179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 44.2 t -77.01 121.08 23.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.476 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -81.11 169.73 17.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.33 -27.58 72.61 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.529 -0.759 . . . . 0.0 113.353 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -84.18 19.31 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.888 0.344 . . . . 0.0 111.875 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.41 32.08 82.39 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 114.111 0.404 . . . . 0.0 114.111 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 15.3 m-85 -135.98 158.88 43.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.211 0.529 . . . . 0.0 110.352 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m -70.06 142.03 52.74 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.213 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -138.86 132.81 5.9 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 m -64.69 139.55 58.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.843 0.354 . . . . 0.0 110.957 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.32 -51.49 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.546 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -81.8 46.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.996 0.427 . . . . 0.0 110.484 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -172.68 -105.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.375 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.56 -25.23 11.27 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.68 -46.66 60.46 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.619 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.627 0.727 . . . . 0.0 111.634 -179.801 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.54 119.2 6.08 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.618 2.212 . . . . 0.0 111.992 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -79.92 43.32 0.59 Allowed 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.289 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.526 HG21 ' HG3' ' A' ' 6' ' ' LYS . 7.4 tp -152.32 144.12 15.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.91 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.401 HD12 ' HE2' ' A' ' 25' ' ' TYR . 17.2 tp -69.81 74.16 0.43 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.041 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.526 ' HG3' HG21 ' A' ' 4' ' ' ILE . 44.5 mttm -88.65 62.18 6.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.629 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -74.04 130.82 40.58 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 11.6 p -119.24 177.92 4.71 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.161 0.505 . . . . 0.0 111.489 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.656 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -131.13 9.66 4.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.132 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -175.04 172.71 2.78 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.676 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.51 -43.52 69.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.722 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -59.76 -13.97 12.54 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.656 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 69.3 m-20 -68.01 -21.04 65.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.008 0.432 . . . . 0.0 110.992 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.548 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -111.47 141.57 24.79 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.006 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.548 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 24.6 Cg_endo -61.82 165.66 13.59 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.893 2.396 . . . . 0.0 112.177 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.37 21.31 0.23 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 114.48 0.552 . . . . 0.0 114.48 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.57 -28.77 23.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.233 0.539 . . . . 0.0 109.749 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 82.8 m -156.19 -175.24 5.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.17 148.83 33.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.46 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 t -76.21 123.01 25.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.589 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 46.4 mtp85 -80.31 172.98 13.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.229 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.25 -23.72 48.76 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.08 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.589 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 15.7 p-10 -76.59 -1.08 25.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.028 0.414 . . . . 0.0 111.449 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 79.67 33.24 34.81 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.331 -0.461 . . . . 0.0 113.733 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.401 ' HE2' HD12 ' A' ' 5' ' ' LEU . 71.1 m-85 -144.11 155.18 43.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 110.164 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.467 ' SG ' ' HD3' ' A' ' 6' ' ' LYS . 72.1 m -63.87 138.05 58.31 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.352 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -153.83 143.42 10.11 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.962 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.561 ' HB3' HG13 ' A' ' 34' ' ' VAL . 27.6 p -69.64 147.02 51.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.87 -58.27 5.85 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -155.82 23.76 0.39 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.49 51.99 1.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.99 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.96 -51.84 3.21 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.381 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 134.56 43.84 0.12 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.029 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 28' ' ' SER . 4.4 p . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 121.764 0.792 . . . . 0.0 110.696 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 44.7 t . . . . . 0 C--O 1.236 0.352 0 CA-C-O 120.908 0.385 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.883 ' HB2' HD12 ' A' ' 5' ' ' LEU . 15.9 Cg_exo -67.02 132.33 27.81 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.463 2.108 . . . . 0.0 111.095 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -79.19 -35.66 41.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.88 0.371 . . . . 0.0 110.944 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.435 ' O ' HD11 ' A' ' 4' ' ' ILE . 1.6 pp -139.7 136.07 39.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.841 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.883 HD12 ' HB2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -163.02 165.18 25.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.336 0.589 . . . . 0.0 111.34 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.611 ' HZ3' ' HB3' ' A' ' 6' ' ' LYS . 0.4 OUTLIER -96.06 136.19 36.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.247 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.681 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -73.48 137.83 44.74 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 176.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.58 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 4.7 p -119.06 145.09 46.19 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.3 0.572 . . . . 0.0 112.423 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.12 -1.57 28.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.057 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.712 ' NH1' ' HB3' ' A' ' 12' ' ' SER . 26.1 ptt85 -171.75 179.64 2.73 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.806 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -62.84 -56.96 12.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.494 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.712 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 28.8 t -69.79 3.0 2.82 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.58 ' OD2' ' HA ' ' A' ' 8' ' ' CYS . 7.7 t70 -73.24 -12.22 60.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.442 0.639 . . . . 0.0 109.808 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -126.57 145.54 53.54 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.231 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 30.9 Cg_endo -61.92 158.53 37.94 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.753 2.302 . . . . 0.0 112.443 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.0 -24.29 8.32 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.591 -0.731 . . . . 0.0 114.562 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.57 -23.35 67.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 110.913 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HA ' ' N ' ' A' ' 29' ' ' GLY . 57.7 m -134.5 -178.96 5.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.471 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 19' ' ' ILE . 17.5 pt -143.19 150.82 17.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.873 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.2 t -73.73 120.32 19.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.044 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.637 ' HD3' ' HA3' ' A' ' 27' ' ' GLY . 21.8 mmm180 -81.62 168.73 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.724 0.297 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.64 -25.13 62.96 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 116.044 -0.525 . . . . 0.0 113.375 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.88 -7.24 56.43 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.92 31.7 19.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.666 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.466 ' HB3' HD22 ' A' ' 5' ' ' LEU . 84.2 m-85 -138.3 156.45 47.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 0.0 110.03 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.4 m -66.07 135.76 55.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.178 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.637 ' HA3' ' HD3' ' A' ' 21' ' ' ARG . . . -134.36 138.84 10.36 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.858 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 1.2 m -45.78 126.16 6.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.067 0.433 . . . . 0.0 111.846 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.02 -53.98 9.98 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.178 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.7 m -84.99 45.37 1.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.123 0.487 . . . . 0.0 110.071 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.858 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 21.7 t70 -164.96 -120.25 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' H ' ' CG ' ' A' ' 31' ' ' ASP . . . -178.79 21.75 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.601 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.92 52.78 10.69 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.316 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.345 0.593 . . . . 0.0 112.422 -179.623 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.0 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.55 132.77 50.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.679 2.253 . . . . 0.0 112.093 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HG3' HG23 ' A' ' 4' ' ' ILE . 53.3 pttt -157.89 -49.07 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.659 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.441 HG23 ' HG3' ' A' ' 3' ' ' LYS . 9.4 tp -151.15 52.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 122.678 1.227 . . . . 0.0 109.549 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.821 HD22 ' H ' ' A' ' 5' ' ' LEU . 1.9 pt? -72.73 128.82 36.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.35 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.694 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 12.5 mmmm -118.56 128.8 54.91 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -67.97 139.17 56.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.757 0.313 . . . . 0.0 110.941 -179.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 3.9 p -149.3 144.22 26.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.894 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.481 ' HD2' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -105.63 11.35 32.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.674 -179.07 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -171.75 172.46 4.89 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.965 0.412 . . . . 0.0 110.653 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -60.57 -55.32 34.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.769 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.8 m -80.23 21.6 0.59 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.895 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 6.7 t0 -86.63 -29.56 22.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.636 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.8 t -108.78 146.33 33.54 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.557 -1.202 . . . . 0.0 109.408 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.636 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.0 Cg_endo -60.47 159.79 26.24 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.738 2.292 . . . . 0.0 112.434 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.36 -8.25 3.47 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 115.684 -0.689 . . . . 0.0 114.552 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.0 -20.81 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.166 0.508 . . . . 0.0 110.704 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 55.8 m -152.11 178.12 9.79 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.4 ' N ' HD11 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -128.46 143.69 40.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.532 178.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.9 t -75.24 121.47 22.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.56 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -82.13 171.17 14.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.68 -24.2 63.97 Favored Glycine 0 C--O 1.227 -0.293 0 CA-C-N 115.817 -0.628 . . . . 0.0 113.062 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -74.41 -11.3 60.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.473 0.178 . . . . 0.0 111.299 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.44 32.86 9.85 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.684 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 66.4 m-85 -142.16 147.21 36.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.443 0.64 . . . . 0.0 110.625 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 6' ' ' LYS . 37.6 m -65.62 136.3 56.15 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.97 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -124.44 125.71 5.85 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -75.2 69.96 2.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.701 0.4 . . . . 0.0 111.909 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.34 26.02 63.49 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.085 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.51 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 4.7 m -99.88 61.73 1.13 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.231 0.538 . . . . 0.0 109.679 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.61 59.88 1.19 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.065 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.97 -47.09 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.587 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.44 147.08 8.63 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.51 ' HB ' ' CB ' ' A' ' 30' ' ' SER . 8.1 p . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.169 0.509 . . . . 0.0 111.096 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 86.3 m . . . . . 0 C--O 1.239 0.501 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.417 ' O ' ' HE3' ' A' ' 3' ' ' LYS . 78.5 Cg_exo -49.97 137.75 35.84 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.117 2.544 . . . . 0.0 111.749 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -132.74 55.12 1.91 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.902 0.382 . . . . 0.0 111.255 -177.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.7 mm -89.11 121.56 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -76.21 65.85 2.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.302 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -148.18 123.25 10.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.539 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.589 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.05 150.1 25.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.536 179.211 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 18.6 p -148.91 143.18 26.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.027 0.441 . . . . 0.0 111.483 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -105.39 6.36 32.53 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 172.9 171.79 0.12 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.727 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.06 -30.37 68.0 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.4 0.438 . . . . 0.0 111.677 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -56.92 -26.74 59.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.557 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 1.7 m-20 -78.98 5.13 12.4 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.409 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 t -149.89 147.3 22.12 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.042 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 70.5 Cg_exo -55.13 150.41 39.59 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.125 2.55 . . . . 0.0 113.113 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.55 -24.03 16.11 Favored Glycine 0 N--CA 1.462 0.425 0 CA-C-N 114.951 -1.022 . . . . 0.0 114.197 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.89 -21.56 66.52 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.219 0.533 . . . . 0.0 110.963 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HA ' ' N ' ' A' ' 29' ' ' GLY . 51.9 m -128.7 -179.6 5.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.297 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.3 pt -142.11 159.51 20.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.607 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.6 t -79.61 120.35 23.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.942 0.401 . . . . 0.0 110.012 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.856 ' HD3' ' HA3' ' A' ' 27' ' ' GLY . 12.2 mmm180 -81.4 166.55 20.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.774 0.321 . . . . 0.0 110.466 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.41 58.96 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.362 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -77.6 -5.33 49.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.79 30.39 32.42 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.673 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -135.84 161.72 34.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.034 0.445 . . . . 0.0 110.125 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 99.3 m -68.62 136.15 52.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.968 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.856 ' HA3' ' HD3' ' A' ' 21' ' ' ARG . . . -140.06 137.64 8.55 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 17.6 m -45.9 129.33 9.46 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -106.19 -56.01 0.67 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.8 m -93.53 45.61 1.17 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 1.9 t70 -171.28 121.51 0.53 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.19 44.08 3.23 Favored Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.096 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.79 127.93 41.99 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.333 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.679 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.684 0.278 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.409 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.0 Cg_endo -65.4 158.11 54.42 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.707 2.272 . . . . 0.0 112.247 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -76.06 49.84 0.57 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.377 0.608 . . . . 0.0 110.624 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 5' ' ' LEU . 48.9 mm -112.09 146.35 17.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.436 ' N ' HG22 ' A' ' 4' ' ' ILE . 16.7 tp -66.45 87.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.136 0.493 . . . . 0.0 109.755 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.843 ' HD2' ' HB2' ' A' ' 26' ' ' CYS . 16.8 pttm -88.58 73.53 8.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.96 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.688 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -92.44 143.95 25.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.311 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 13' ' ' ASP . 1.8 p -135.56 144.83 46.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.819 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.512 HH11 ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -104.13 13.19 32.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.471 0.653 . . . . 0.0 110.311 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -170.27 165.56 8.92 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.566 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 26.6 t70 -65.78 -52.22 52.65 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.405 0.441 . . . . 0.0 111.009 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.6 t -74.66 29.22 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.104 0.478 . . . . 0.0 111.609 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 11' ' ' ASP . 1.4 t70 -96.26 -27.05 15.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.785 0.802 . . . . 0.0 109.244 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.724 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -108.44 151.8 41.73 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.172 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.724 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.6 Cg_endo -60.43 156.55 40.71 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.472 2.115 . . . . 0.0 112.024 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.28 -19.25 5.64 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.446 -0.797 . . . . 0.0 115.054 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.33 69.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 0.0 111.169 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 39.7 m -134.49 179.03 6.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.38 149.13 33.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.191 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.566 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 11.0 t -76.86 113.17 14.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' NE ' ' HA3' ' A' ' 27' ' ' GLY . 98.7 mtt180 -81.92 173.3 12.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.167 0.508 . . . . 0.0 111.717 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.28 -25.94 55.39 Favored Glycine 0 C--O 1.229 -0.212 0 CA-C-N 115.228 -0.896 . . . . 0.0 114.509 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.424 ' ND2' ' HB2' ' A' ' 25' ' ' TYR . 16.2 p-10 -78.3 4.04 13.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.168 0.484 . . . . 0.0 111.754 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.18 31.2 59.77 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.281 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.424 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 27.5 m-85 -139.68 158.39 44.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.348 0.594 . . . . 0.0 110.327 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.843 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 63.8 m -68.15 133.06 48.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.65 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -129.85 132.26 6.97 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -55.96 146.71 21.52 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.94 0.436 . . . . 0.0 111.825 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.93 -52.6 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.421 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 m -97.98 33.7 2.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.443 0.64 . . . . 0.0 109.303 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -148.31 -42.04 0.16 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.072 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.86 -47.49 1.03 Allowed Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.15 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.12 49.3 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.287 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.351 0.596 . . . . 0.0 110.684 179.771 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 55.9 m . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.769 0.319 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.619 ' HB2' HG21 ' A' ' 4' ' ' ILE . 17.3 Cg_exo -66.68 158.04 57.97 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.054 2.503 . . . . 0.0 111.936 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.755 ' HB3' ' HZ2' ' A' ' 3' ' ' LYS . 5.1 mmmp? -74.12 51.09 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.811 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.619 HG21 ' HB2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -145.17 146.43 19.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.594 HD13 ' HE2' ' A' ' 25' ' ' TYR . 31.1 tp -67.95 64.64 0.09 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.578 ' HG3' HG23 ' A' ' 4' ' ' ILE . 53.1 mttm -90.45 56.15 3.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.013 0.435 . . . . 0.0 110.039 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.574 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -64.77 135.75 56.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.72 -179.109 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.7 p -143.74 146.29 33.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.963 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.657 ' N ' ' HD2' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -104.88 -16.99 14.71 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.53 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 17.4 ptt180 -156.81 167.3 30.88 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.762 -2.017 . . . . 0.0 107.253 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.46 -24.0 67.06 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.065 0.459 . . . . 0.0 110.184 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.437 ' HB2' ' HG3' ' A' ' 10' ' ' ARG . 4.1 m -63.27 -27.11 69.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.528 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 10' ' ' ARG . 13.4 m-20 -81.13 15.65 1.82 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.065 0.459 . . . . 0.0 110.706 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.661 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -150.35 147.97 23.08 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.661 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 33.4 Cg_endo -62.73 156.18 54.8 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.448 2.099 . . . . 0.0 112.254 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.94 -8.47 5.91 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.582 -0.735 . . . . 0.0 114.223 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.21 -18.67 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.053 0.454 . . . . 0.0 110.545 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.2 m -143.84 179.83 6.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.119 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -131.35 167.53 25.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.563 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.0 t -87.82 123.47 32.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.987 0.422 . . . . 0.0 110.856 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -81.9 170.49 15.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.981 0.419 . . . . 0.0 110.86 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 -29.33 73.42 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.565 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -76.1 -4.6 42.38 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 37.05 11.16 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.925 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.594 ' HE2' HD13 ' A' ' 5' ' ' LEU . 77.7 m-85 -142.88 153.73 43.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 6' ' ' LYS . 61.3 m -63.92 142.7 58.31 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.726 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -150.64 139.83 7.53 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.535 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 15.9 m -60.24 137.8 58.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.027 0.442 . . . . 0.0 111.375 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.95 -96.81 0.18 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.162 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.3 m -78.68 50.63 1.0 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 110.593 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 1.1 t70 -148.48 -52.08 0.17 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.368 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' SER . . . 175.91 108.18 0.22 Allowed Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.61 49.08 1.03 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.528 -0.368 . . . . 0.0 113.625 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.4 t . . . . . 0 C--N 1.324 -0.525 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.161 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 C--O 1.233 0.211 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.16 129.8 26.81 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.643 2.228 . . . . 0.0 111.639 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.559 ' HA ' ' HB3' ' A' ' 28' ' ' SER . 53.3 tttm -86.38 63.36 7.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.108 0.48 . . . . 0.0 111.212 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 tt -87.49 138.61 18.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.282 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.1 tp -103.59 124.33 48.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.008 0.432 . . . . 0.0 111.629 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 33.2 mmtp -150.94 143.22 24.18 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.627 ' H ' ' HD2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -82.32 137.83 34.69 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.308 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -132.4 143.83 50.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.397 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.725 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -105.05 15.01 28.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.285 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 13' ' ' ASP . 29.0 ptt85 -170.86 169.07 6.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.552 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -66.76 -56.5 10.21 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.249 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m -78.73 22.91 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.834 0.349 . . . . 0.0 111.808 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.725 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 7.9 t0 -79.79 -36.35 37.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -93.61 144.84 28.86 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.891 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.606 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.1 Cg_endo -61.27 161.51 23.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.886 2.391 . . . . 0.0 112.109 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.29 -19.21 2.68 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 114.849 0.7 . . . . 0.0 114.849 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.72 -20.3 66.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.063 0.432 . . . . 0.0 111.408 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.0 m -151.25 -179.25 7.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.049 0.452 . . . . 0.0 110.118 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.02 148.52 22.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -69.7 120.63 15.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -81.01 -175.07 5.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.15 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.96 -24.89 76.2 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.257 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 25' ' ' TYR . 16.2 p-10 -83.97 17.74 2.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.42 28.91 73.76 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.389 -0.434 . . . . 0.0 113.792 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 13.4 m-85 -136.81 157.35 46.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.415 0.626 . . . . 0.0 110.385 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 6' ' ' LYS . 84.6 m -64.8 134.89 55.08 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.275 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.46 132.75 6.9 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.559 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 11.9 p -61.76 146.07 50.55 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.13 45.99 1.19 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.029 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 28' ' ' SER . 7.4 m -82.03 16.79 1.78 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.251 0.548 . . . . 0.0 110.72 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -72.36 -27.75 62.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.64 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.97 41.55 0.17 Allowed Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.573 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.82 175.57 45.98 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.313 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 121.147 0.498 . . . . 0.0 110.487 179.604 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 C--O 1.24 0.586 0 CA-C-O 120.614 0.245 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -80.74 147.71 17.38 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.641 2.894 . . . . 0.0 112.481 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' O ' HG22 ' A' ' 4' ' ' ILE . 37.3 ttmt -178.75 -54.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.38 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 3' ' ' LYS . 32.3 pt -147.7 161.65 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.157 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' A' ' 5' ' ' LEU . 1.1 mm? -71.82 130.7 41.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.221 0.534 . . . . 0.0 110.689 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -103.71 113.97 27.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.288 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.704 ' H ' ' HD2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -108.64 153.04 23.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.501 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 2.1 p -146.09 145.31 30.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.363 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.681 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -105.69 4.12 29.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -168.32 159.4 10.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.618 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.546 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 21.0 t0 -58.89 -40.53 84.72 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.914 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -59.26 -17.87 32.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.681 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 62.5 m-20 -67.78 -22.32 65.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.829 0.347 . . . . 0.0 111.045 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -113.01 143.73 29.71 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.241 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 73.8 Cg_exo -52.94 148.71 28.66 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.239 2.626 . . . . 0.0 112.853 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.31 -22.06 6.78 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 114.937 -1.029 . . . . 0.0 114.614 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . . . -63.17 -39.48 94.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.068 0.434 . . . . 0.0 110.752 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 29.1 m -112.14 -179.89 3.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.037 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.4 147.33 28.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.68 0.276 . . . . 0.0 110.705 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 49.6 t -76.04 123.9 26.51 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.101 0.477 . . . . 0.0 110.268 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.97 173.26 12.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.327 0.585 . . . . 0.0 111.512 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.07 -25.59 73.36 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.951 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -81.15 7.94 9.93 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 35.65 58.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.653 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -139.31 158.31 44.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.037 0.446 . . . . 0.0 110.131 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 86.4 m -67.23 137.24 56.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.403 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -126.97 137.37 9.89 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.797 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m -57.85 139.77 53.38 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 124.081 0.518 . . . . 0.0 111.309 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.79 -109.99 0.48 Allowed Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -78.46 47.49 0.71 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.14 0.495 . . . . 0.0 111.02 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.594 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 8.0 p-10 -144.45 -50.87 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.256 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.65 33.66 83.15 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.654 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.56 51.5 0.17 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.848 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG23 ' SG ' ' A' ' 18' ' ' CYS . 44.1 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.946 0.403 . . . . 0.0 110.207 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.91 151.1 86.98 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.562 2.175 . . . . 0.0 112.182 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -57.21 -31.98 66.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.145 0.498 . . . . 0.0 110.6 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.75 119.32 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.321 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.485 HD11 ' N ' ' A' ' 5' ' ' LEU . 8.2 mp -80.56 118.76 22.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -102.82 130.58 49.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.952 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.76 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -71.83 130.76 41.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.046 -179.542 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -112.86 159.99 18.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.629 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.49 ' HD2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -117.02 17.33 14.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.253 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.646 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 2.3 ptm180 -177.53 153.49 0.9 Allowed 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.302 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -57.49 -50.74 72.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.718 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -78.39 24.07 0.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.972 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.646 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 1.1 t0 -81.56 -32.28 32.25 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.662 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -89.6 149.09 41.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.032 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.662 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 20.4 Cg_endo -59.05 155.28 40.08 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.487 2.125 . . . . 0.0 112.324 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.92 -26.53 2.91 Favored Glycine 0 N--CA 1.466 0.647 0 O-C-N 123.97 0.794 . . . . 0.0 115.076 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.86 -20.39 65.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.972 0.386 . . . . 0.0 111.535 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.9 m -143.93 -178.81 6.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.775 0.321 . . . . 0.0 110.293 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.491 HD11 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -142.11 156.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 8.1 t -80.82 128.39 33.61 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.061 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.45 175.11 10.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.947 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.56 -28.02 69.02 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.54 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -76.43 -4.55 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.86 33.01 22.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.13 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -137.41 154.54 49.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 50.8 m -61.38 142.03 57.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.531 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.63 128.18 3.15 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 15.6 m -76.41 58.87 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 111.168 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 19' ' ' ILE . . . -60.38 -41.52 98.53 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.56 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -82.03 34.0 0.4 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.934 0.397 . . . . 0.0 110.411 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 33.9 t70 -162.85 57.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.858 0.837 . . . . 0.0 109.373 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.16 -33.98 1.51 Allowed Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.59 -0.732 . . . . 0.0 113.443 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.77 23.05 6.99 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.445 -0.716 0 CA-C-O 121.591 0.71 . . . . 0.0 110.902 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 mptt . . . . . 0 C--O 1.237 0.437 0 CA-C-O 120.883 0.373 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 26.7 p -149.88 144.69 26.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.688 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.22 14.09 12.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 0.0 109.741 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.425 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 16.9 ptp180 177.14 177.64 0.3 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.811 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.03 -46.76 86.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.884 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -53.91 -25.44 20.21 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.8 m-20 -69.09 -10.02 55.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.54 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t -140.17 141.47 26.65 Favored Pre-proline 0 C--N 1.32 -0.684 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.651 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 33.6 Cg_endo -63.35 162.87 25.45 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.947 2.431 . . . . 0.0 112.273 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.27 8.57 0.44 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.67 -22.35 46.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.523 0.678 . . . . 0.0 109.553 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 28' ' ' SER . 68.1 m -152.17 -176.94 5.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.737 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.494 HG12 ' HE ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -133.97 144.61 35.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.758 0.313 . . . . 0.0 110.73 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.5 t -69.76 116.71 10.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.333 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HE ' HG12 ' A' ' 19' ' ' ILE . 24.5 mmt85 -83.02 176.37 9.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.445 . . . . 0.0 111.386 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.89 -22.48 70.34 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.65 -0.704 . . . . 0.0 114.026 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 17.4 p-10 -77.94 2.21 18.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.888 0.344 . . . . 0.0 111.901 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.28 28.53 55.65 Favored Glycine 0 C--O 1.237 0.306 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.446 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.44 159.03 43.1 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.023 0.439 . . . . 0.0 109.994 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.95 135.76 49.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -127.47 126.75 5.64 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.468 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 20.0 m . . . . . 0 C--N 1.323 -0.572 0 C-N-CA 122.188 0.195 . . . . 0.0 110.805 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.339 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.483 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 3.6 p -151.37 153.19 34.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.821 0.343 . . . . 0.0 111.731 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.686 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -118.77 11.96 12.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 36.7 ptt180 -168.47 178.46 4.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.567 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -74.9 -42.29 58.08 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.561 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -55.56 -24.15 30.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.686 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 55.2 m-20 -70.64 -14.75 62.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.401 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 5.0 t -123.75 142.23 38.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.755 0.312 . . . . 0.0 110.303 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.606 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 26.7 Cg_endo -61.74 164.42 16.18 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.904 2.403 . . . . 0.0 111.943 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.25 21.98 0.29 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 114.184 0.434 . . . . 0.0 114.184 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.63 -26.98 24.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.25 0.548 . . . . 0.0 110.018 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 64.4 m -152.19 -177.23 6.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.51 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -124.11 146.34 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.645 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.0 t -72.57 120.37 18.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.265 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -81.9 173.94 11.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.175 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.81 -24.16 66.24 Favored Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 113.155 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -73.86 -10.11 59.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.557 0.218 . . . . 0.0 111.517 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.53 35.22 10.68 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.749 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -145.55 156.53 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.434 . . . . 0.0 109.942 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -65.19 136.03 56.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.301 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -137.7 127.52 3.95 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 111.856 -178.645 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 5.2 p -142.77 142.35 31.89 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.365 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.611 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -108.62 14.68 24.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.125 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -179.08 174.57 1.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.646 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.13 -53.65 50.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.592 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.91 -13.64 17.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.988 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.611 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 9.1 t0 -64.14 -25.83 68.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.631 0.729 . . . . 0.0 109.935 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t -122.47 144.38 42.0 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.836 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 29.5 Cg_endo -61.75 160.3 29.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.796 2.331 . . . . 0.0 112.45 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.41 -9.02 4.14 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.466 -0.788 . . . . 0.0 114.308 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.74 -21.54 66.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.063 0.459 . . . . 0.0 110.511 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.1 m -150.63 -176.04 5.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.942 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.7 pt -130.69 152.0 36.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.113 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 t -80.49 125.74 30.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.18 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -76.67 169.31 18.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.894 0.378 . . . . 0.0 110.359 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.17 -23.06 71.28 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.053 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -80.48 -1.92 43.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.33 40.88 9.65 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.248 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -145.79 150.53 36.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.082 0.441 . . . . 0.0 110.181 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 76.5 m -66.69 134.59 52.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.081 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.68 137.65 6.88 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.3 m . . . . . 0 C--N 1.322 -0.587 0 CA-C-N 116.855 0.327 . . . . 0.0 111.114 -179.368 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.358 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 p -150.87 143.75 24.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.348 0.595 . . . . 0.0 112.065 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.561 ' HG2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -110.77 -0.7 16.92 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.561 ' HG2' ' HG2' ' A' ' 9' ' ' ARG . 13.5 ptm180 -167.4 154.35 8.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.053 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -55.69 -33.9 64.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.453 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 m -55.61 -26.6 44.84 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.491 ' CG ' ' HE ' ' A' ' 9' ' ' ARG . 50.7 m-20 -69.05 -14.36 62.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.33 . . . . 0.0 111.406 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.731 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -125.11 150.54 67.13 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.731 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 23.9 Cg_endo -59.58 157.88 30.17 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.735 2.29 . . . . 0.0 112.984 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.82 -24.21 48.14 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.13 -0.941 . . . . 0.0 114.109 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.44 18.3 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.138 0.469 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.9 m -154.18 174.6 14.54 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.65 154.99 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.0 t -82.35 128.41 34.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.983 0.42 . . . . 0.0 110.331 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -80.13 170.04 16.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.065 0.46 . . . . 0.0 110.687 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.56 -25.83 73.8 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.658 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -81.32 -0.39 40.85 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.73 38.81 13.05 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.397 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -140.69 157.92 44.73 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 59.4 m -65.34 140.38 58.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.621 0.724 . . . . 0.0 112.647 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.38 136.04 9.08 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 116.804 0.302 . . . . 0.0 111.161 -178.831 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 5.8 p -152.7 146.77 25.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.047 0.451 . . . . 0.0 111.984 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.474 ' HE ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -110.27 11.75 23.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.749 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 12.8 ptp180 -179.79 160.92 0.95 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.486 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 8.0 t0 -60.09 -26.81 66.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.307 0.575 . . . . 0.0 111.246 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -58.96 -26.97 64.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.701 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 8' ' ' CYS . 20.9 m-20 -84.97 15.65 3.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.48 0.181 . . . . 0.0 110.9 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -126.46 141.95 41.56 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-O 121.004 0.43 . . . . 0.0 111.196 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 60.4 Cg_endo -70.86 156.08 61.14 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.929 2.419 . . . . 0.0 111.824 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.02 -29.41 43.53 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.207 -0.451 . . . . 0.0 113.996 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.43 8.32 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 111.91 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.4 m -152.29 179.74 8.27 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -143.54 149.17 18.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 41.0 t -78.88 120.34 23.36 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.087 0.47 . . . . 0.0 110.219 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -81.53 169.54 16.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.719 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.43 -26.57 68.24 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 113.767 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -81.83 7.39 12.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.928 0.364 . . . . 0.0 111.83 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.08 31.34 55.58 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.299 -0.477 . . . . 0.0 114.276 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -134.18 154.17 51.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 109.979 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.7 m -79.26 135.79 36.86 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.555 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.454 ' O ' HD13 ' A' ' 19' ' ' ILE . . . -123.27 139.19 12.07 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.724 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.871 0.367 . . . . 0.0 111.546 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 2.5 p -146.92 143.43 28.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.174 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.678 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -105.58 13.82 29.4 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.799 0.809 . . . . 0.0 109.464 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -171.79 158.59 4.96 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.775 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.577 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 35.8 t70 -65.2 -39.91 93.48 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.643 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -57.71 -17.84 17.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.678 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 79.7 m-20 -70.4 -20.96 62.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.996 0.427 . . . . 0.0 110.537 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -106.63 141.58 23.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.319 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 50.5 Cg_endo -67.85 158.59 56.6 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.618 2.212 . . . . 0.0 111.408 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.89 -16.47 2.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.76 -24.17 66.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.909 0.354 . . . . 0.0 111.39 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.9 m -143.99 -177.17 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.7 pt -132.76 150.9 33.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.505 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.577 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 38.8 t -82.45 122.87 28.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -80.26 164.78 22.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.023 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.77 -23.93 63.84 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.305 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -76.96 -3.17 37.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.84 36.29 13.91 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.459 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -145.71 153.09 40.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -68.09 145.81 54.06 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.298 0.57 . . . . 0.0 111.269 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.9 143.12 11.52 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.193 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 C--N 1.323 -0.581 0 O-C-N 123.875 0.397 . . . . 0.0 111.345 -179.424 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.41 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.3 p -142.98 150.57 39.83 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.081 0.467 . . . . 0.0 111.735 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.663 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -113.68 8.03 17.42 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.181 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -169.51 164.88 10.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.024 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -66.84 -36.28 81.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -54.96 -24.55 24.47 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.663 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 52.8 m-20 -71.8 -13.08 61.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.758 0.313 . . . . 0.0 111.098 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -127.54 148.46 66.7 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.668 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 31.6 Cg_endo -62.12 159.03 36.36 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.301 2.001 . . . . 0.0 111.84 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.1 17.64 0.27 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 114.503 0.561 . . . . 0.0 114.503 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.432 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.23 -21.14 27.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.27 0.557 . . . . 0.0 109.942 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 56.8 m -149.93 -179.37 7.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.457 ' H ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -129.18 157.75 41.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.473 179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.0 t -77.41 117.35 18.81 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.668 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 17.4 mtp85 -80.77 169.59 17.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.57 -24.98 49.29 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.615 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -74.79 -8.46 56.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.704 0.252 . . . . 0.0 111.456 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.83 35.64 15.54 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.693 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -144.95 158.59 43.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.4 . . . . 0.0 109.997 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.7 m -65.0 138.01 58.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.754 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.668 ' HA3' ' HD2' ' A' ' 21' ' ' ARG . . . -147.51 150.92 23.22 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.157 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.238 0.484 0 C-N-CA 123.505 0.722 . . . . 0.0 112.052 -179.386 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.841 0.353 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 p -146.06 147.86 32.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.6 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.511 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -113.16 19.9 16.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.261 0.553 . . . . 0.0 109.767 178.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -178.6 179.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.325 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -71.77 -50.45 29.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.166 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -54.87 -26.17 33.68 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 73.5 m-20 -63.48 -19.34 64.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.305 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.597 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.9 t -115.43 141.28 27.01 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.976 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.597 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 47.9 Cg_endo -67.67 159.96 50.28 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.995 2.463 . . . . 0.0 112.005 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.85 -16.31 7.56 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.958 -0.565 . . . . 0.0 114.356 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.86 -16.5 64.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.31 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 64.3 m -151.57 -175.58 5.25 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -137.2 152.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.6 t -77.26 120.65 22.6 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.481 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 58.7 mtp180 -80.6 169.85 17.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.758 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.76 -24.69 66.72 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.61 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 13.8 p-10 -82.09 13.64 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.04 0.42 . . . . 0.0 111.834 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.65 31.42 70.6 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 121.415 -0.421 . . . . 0.0 113.779 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -140.78 155.26 46.44 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.423 0.63 . . . . 0.0 110.332 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -68.18 142.08 55.81 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.197 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.481 ' HA3' ' HD2' ' A' ' 21' ' ' ARG . . . -151.6 131.16 3.36 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 117.208 0.504 . . . . 0.0 110.014 -179.249 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.227 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . 1.1 p -133.52 147.19 51.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.972 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.677 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -104.05 1.07 30.54 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -167.0 159.95 13.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.04 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 23.1 t0 -60.67 -37.78 82.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.293 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -57.22 -21.22 32.24 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.677 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 64.3 m-20 -67.82 -19.16 65.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 111.12 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.451 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 t -113.66 145.77 34.09 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.573 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 74.0 Cg_exo -53.83 149.89 31.8 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.367 2.711 . . . . 0.0 112.75 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.03 -22.67 13.41 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.022 -0.99 . . . . 0.0 114.871 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.79 81.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.242 0.521 . . . . 0.0 110.856 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.8 m -104.39 179.64 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.625 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.66 147.63 23.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.815 0.34 . . . . 0.0 110.616 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 43.3 t -77.62 120.55 22.73 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -80.22 170.29 16.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.16 0.505 . . . . 0.0 111.649 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.44 -26.2 61.64 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.704 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -74.08 -7.18 51.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.72 0.26 . . . . 0.0 111.344 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.49 35.24 14.45 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.554 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -141.94 154.44 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 0.0 110.337 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.6 m -63.22 137.73 58.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.674 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.64 126.78 3.54 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 120.682 0.277 . . . . 0.0 111.041 -179.48 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.7 tptt . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 25.9 p -154.21 150.14 27.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.571 0.7 . . . . 0.0 112.124 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.563 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -132.01 18.41 4.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.164 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.92 173.78 1.83 Allowed 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.22 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.86 -54.34 43.45 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m -58.9 -20.43 51.42 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.563 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 64.5 m-20 -61.52 -23.55 66.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.162 0.506 . . . . 0.0 111.326 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 t -124.81 142.27 40.43 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 35.8 Cg_endo -64.92 163.89 26.67 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.776 2.317 . . . . 0.0 112.366 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.21 -17.67 11.55 Favored Glycine 0 CA--C 1.521 0.411 0 O-C-N 123.583 0.552 . . . . 0.0 113.713 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.52 -10.2 57.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 110.946 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.7 m -149.99 -178.45 6.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.657 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.9 pt -140.88 148.27 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.748 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.5 t -75.22 122.1 23.14 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.357 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -81.44 171.25 14.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.774 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.09 -25.73 75.2 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.795 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -84.94 14.12 5.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.0 32.03 63.78 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 114.726 0.651 . . . . 0.0 114.726 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -135.98 158.53 44.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.949 0.404 . . . . 0.0 110.273 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.6 m -71.75 136.62 47.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.07 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.81 136.06 11.5 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.087 0.47 . . . . 0.0 111.999 -178.696 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 p -120.96 148.41 44.13 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.115 0.483 . . . . 0.0 111.067 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -101.3 -17.12 16.7 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.657 ' HG2' ' OD1' ' A' ' 13' ' ' ASP . 4.0 ptp85 -165.6 177.18 7.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.14 -1.845 . . . . 0.0 107.045 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 6.2 t0 -61.2 -37.64 83.7 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.074 0.464 . . . . 0.0 111.109 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -59.49 -29.03 67.55 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.657 ' OD1' ' HG2' ' A' ' 10' ' ' ARG . 1.0 OUTLIER -69.15 -13.32 62.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 111.02 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.657 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 4.2 t -103.34 143.14 26.02 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.408 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.657 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 37.9 Cg_endo -63.91 154.0 72.5 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.793 2.328 . . . . 0.0 111.961 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.62 -30.3 34.51 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.585 -0.734 . . . . 0.0 114.527 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.11 2.3 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.312 0.556 . . . . 0.0 112.193 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 62.3 m -148.79 -176.77 5.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.12 156.72 24.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.903 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 44.2 t -77.01 121.08 23.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.476 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -81.11 169.73 17.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.33 -27.58 72.61 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.529 -0.759 . . . . 0.0 113.353 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -84.18 19.31 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.888 0.344 . . . . 0.0 111.875 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.41 32.08 82.39 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 114.111 0.404 . . . . 0.0 114.111 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 15.3 m-85 -135.98 158.88 43.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.211 0.529 . . . . 0.0 110.352 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.463 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m -70.06 142.03 52.74 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.213 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -138.86 132.81 5.9 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 120.843 0.354 . . . . 0.0 110.957 -179.53 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.321 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 11.6 p -119.24 177.92 4.71 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.161 0.505 . . . . 0.0 111.489 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.674 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -131.13 9.66 4.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.132 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -175.04 172.71 2.78 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.676 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.51 -43.52 69.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.722 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -59.76 -13.97 12.54 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.674 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 69.3 m-20 -68.01 -21.04 65.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.008 0.432 . . . . 0.0 110.992 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -111.47 141.57 24.79 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.006 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 24.6 Cg_endo -61.82 165.66 13.59 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.893 2.396 . . . . 0.0 112.177 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.37 21.31 0.23 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 114.48 0.552 . . . . 0.0 114.48 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.57 -28.77 23.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.233 0.539 . . . . 0.0 109.749 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 82.8 m -156.19 -175.24 5.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.42 ' H ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -129.17 148.83 33.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.46 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 t -76.21 123.01 25.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.606 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 46.4 mtp85 -80.31 172.98 13.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.229 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.25 -23.72 48.76 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.08 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.606 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 15.7 p-10 -76.59 -1.08 25.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.028 0.414 . . . . 0.0 111.449 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 79.67 33.24 34.81 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.331 -0.461 . . . . 0.0 113.733 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -144.11 155.18 43.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 110.164 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.1 m -63.87 138.05 58.31 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.352 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -153.83 143.42 10.11 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.962 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.6 p . . . . . 0 C--N 1.323 -0.562 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.977 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.583 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 4.7 p -119.06 145.09 46.19 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.3 0.572 . . . . 0.0 112.423 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.12 -1.57 28.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.057 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.717 ' NH1' ' HB3' ' A' ' 12' ' ' SER . 26.1 ptt85 -171.75 179.64 2.73 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.806 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -62.84 -56.96 12.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.494 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.717 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 28.8 t -69.79 3.0 2.82 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 8' ' ' CYS . 7.7 t70 -73.24 -12.22 60.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.442 0.639 . . . . 0.0 109.808 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -126.57 145.54 53.54 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.231 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 30.9 Cg_endo -61.92 158.53 37.94 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.753 2.302 . . . . 0.0 112.443 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.0 -24.29 8.32 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.591 -0.731 . . . . 0.0 114.562 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.57 -23.35 67.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 110.913 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.7 m -134.5 -178.96 5.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.471 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 pt -143.19 150.82 17.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.873 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.2 t -73.73 120.32 19.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.044 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' HD3' ' HA3' ' A' ' 27' ' ' GLY . 21.8 mmm180 -81.62 168.73 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.724 0.297 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.64 -25.13 62.96 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 116.044 -0.525 . . . . 0.0 113.375 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.88 -7.24 56.43 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.92 31.7 19.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.666 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -138.3 156.45 47.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 0.0 110.03 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.4 m -66.07 135.76 55.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.178 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.612 ' HA3' ' HD3' ' A' ' 21' ' ' ARG . . . -134.36 138.84 10.36 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 117.067 0.433 . . . . 0.0 111.846 -178.351 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.757 0.313 . . . . 0.0 110.941 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.631 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 3.9 p -149.3 144.22 26.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.894 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.498 ' HD2' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -105.63 11.35 32.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.674 -179.07 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 13' ' ' ASP . 20.0 ptt-85 -171.75 172.46 4.89 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.965 0.412 . . . . 0.0 110.653 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -60.57 -55.32 34.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.769 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.8 m -80.23 21.6 0.59 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.895 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.631 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 6.7 t0 -86.63 -29.56 22.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.636 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.8 t -108.78 146.33 33.54 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.557 -1.202 . . . . 0.0 109.408 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.636 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.0 Cg_endo -60.47 159.79 26.24 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.738 2.292 . . . . 0.0 112.434 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.36 -8.25 3.47 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 115.684 -0.689 . . . . 0.0 114.552 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.0 -20.81 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.166 0.508 . . . . 0.0 110.704 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 55.8 m -152.11 178.12 9.79 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.46 143.69 40.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.532 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.9 t -75.24 121.47 22.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.56 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -82.13 171.17 14.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.68 -24.2 63.97 Favored Glycine 0 C--O 1.227 -0.293 0 CA-C-N 115.817 -0.628 . . . . 0.0 113.062 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -74.41 -11.3 60.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.473 0.178 . . . . 0.0 111.299 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.44 32.86 9.85 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.684 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -142.16 147.21 36.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.443 0.64 . . . . 0.0 110.625 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.6 m -65.62 136.3 56.15 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.97 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -124.44 125.71 5.85 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 C--N 1.327 -0.375 0 C-N-CA 122.701 0.4 . . . . 0.0 111.909 -178.56 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.231 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 18.6 p -148.91 143.18 26.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.027 0.441 . . . . 0.0 111.483 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.553 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -105.39 6.36 32.53 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.449 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 172.9 171.79 0.12 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.727 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.06 -30.37 68.0 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.4 0.438 . . . . 0.0 111.677 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -56.92 -26.74 59.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.553 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 1.7 m-20 -78.98 5.13 12.4 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.428 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 t -149.89 147.3 22.12 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.042 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 70.5 Cg_exo -55.13 150.41 39.59 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.125 2.55 . . . . 0.0 113.113 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.55 -24.03 16.11 Favored Glycine 0 N--CA 1.462 0.425 0 CA-C-N 114.951 -1.022 . . . . 0.0 114.197 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.89 -21.56 66.52 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.219 0.533 . . . . 0.0 110.963 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.9 m -128.7 -179.6 5.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.297 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.3 pt -142.11 159.51 20.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.607 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.6 t -79.61 120.35 23.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.942 0.401 . . . . 0.0 110.012 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.853 ' HD3' ' HA3' ' A' ' 27' ' ' GLY . 12.2 mmm180 -81.4 166.55 20.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.774 0.321 . . . . 0.0 110.466 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.41 58.96 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.362 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -77.6 -5.33 49.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.79 30.39 32.42 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.673 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -135.84 161.72 34.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.034 0.445 . . . . 0.0 110.125 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 99.3 m -68.62 136.15 52.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.968 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.853 ' HA3' ' HD3' ' A' ' 21' ' ' ARG . . . -140.06 137.64 8.55 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.325 -0.5 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.63 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.132 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 13' ' ' ASP . 1.8 p -135.56 144.83 46.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.819 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.526 ' HG3' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -104.13 13.19 32.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.471 0.653 . . . . 0.0 110.311 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 35.6 ptt180 -170.27 165.56 8.92 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.602 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 26.6 t70 -65.78 -52.22 52.65 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.405 0.441 . . . . 0.0 111.009 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.6 t -74.66 29.22 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.104 0.478 . . . . 0.0 111.609 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 11' ' ' ASP . 1.4 t70 -96.26 -27.05 15.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.785 0.802 . . . . 0.0 109.244 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.73 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -108.44 151.8 41.73 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.172 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.73 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.6 Cg_endo -60.43 156.55 40.71 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.472 2.115 . . . . 0.0 112.024 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.28 -19.25 5.64 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.446 -0.797 . . . . 0.0 115.054 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.33 69.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 0.0 111.169 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 39.7 m -134.49 179.03 6.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.38 149.13 33.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.191 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.602 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 11.0 t -76.86 113.17 14.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.502 ' NE ' ' HA3' ' A' ' 27' ' ' GLY . 98.7 mtt180 -81.92 173.3 12.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.167 0.508 . . . . 0.0 111.717 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.28 -25.94 55.39 Favored Glycine 0 C--O 1.229 -0.212 0 CA-C-N 115.228 -0.896 . . . . 0.0 114.509 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.442 HD21 ' HB2' ' A' ' 25' ' ' TYR . 16.2 p-10 -78.3 4.04 13.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.168 0.484 . . . . 0.0 111.754 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.18 31.2 59.77 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.281 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.442 ' HB2' HD21 ' A' ' 23' ' ' ASN . 27.5 m-85 -139.68 158.39 44.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.348 0.594 . . . . 0.0 110.327 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.8 m -68.15 133.06 48.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.65 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -129.85 132.26 6.97 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 C--N 1.324 -0.537 0 O-C-N 123.94 0.436 . . . . 0.0 111.825 -179.371 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.548 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 121.055 0.455 . . . . 0.0 111.72 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.7 p -143.74 146.29 33.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.963 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.652 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -104.88 -16.99 14.71 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 17.4 ptt180 -156.81 167.3 30.88 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.762 -2.017 . . . . 0.0 107.253 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.46 -24.0 67.06 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.065 0.459 . . . . 0.0 110.184 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 10' ' ' ARG . 4.1 m -63.27 -27.11 69.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.528 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.547 ' OD2' ' HG2' ' A' ' 10' ' ' ARG . 13.4 m-20 -81.13 15.65 1.82 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.065 0.459 . . . . 0.0 110.706 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.663 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -150.35 147.97 23.08 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.663 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 33.4 Cg_endo -62.73 156.18 54.8 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.448 2.099 . . . . 0.0 112.254 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.94 -8.47 5.91 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.582 -0.735 . . . . 0.0 114.223 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.21 -18.67 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.053 0.454 . . . . 0.0 110.545 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.2 m -143.84 179.83 6.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.119 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -131.35 167.53 25.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.563 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.0 t -87.82 123.47 32.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.987 0.422 . . . . 0.0 110.856 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -81.9 170.49 15.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.981 0.419 . . . . 0.0 110.86 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 -29.33 73.42 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.565 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -76.1 -4.6 42.38 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 37.05 11.16 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.925 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -142.88 153.73 43.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m -63.92 142.7 58.31 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.726 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -150.64 139.83 7.53 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 121.027 0.442 . . . . 0.0 111.375 -178.952 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -132.4 143.83 50.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.397 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.738 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -105.05 15.01 28.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.285 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.614 ' HG2' ' HB2' ' A' ' 13' ' ' ASP . 29.0 ptt85 -170.86 169.07 6.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.552 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -66.76 -56.5 10.21 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.249 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m -78.73 22.91 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.834 0.349 . . . . 0.0 111.808 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.738 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 7.9 t0 -79.79 -36.35 37.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.604 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -93.61 144.84 28.86 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.891 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.1 Cg_endo -61.27 161.51 23.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.886 2.391 . . . . 0.0 112.109 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.29 -19.21 2.68 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 114.849 0.7 . . . . 0.0 114.849 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.72 -20.3 66.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.063 0.432 . . . . 0.0 111.408 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.0 m -151.25 -179.25 7.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.049 0.452 . . . . 0.0 110.118 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.02 148.52 22.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -69.7 120.63 15.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -81.01 -175.07 5.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.15 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.96 -24.89 76.2 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.257 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 25' ' ' TYR . 16.2 p-10 -83.97 17.74 2.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.42 28.91 73.76 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.389 -0.434 . . . . 0.0 113.792 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.436 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 13.4 m-85 -136.81 157.35 46.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.415 0.626 . . . . 0.0 110.385 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.6 m -64.8 134.89 55.08 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.275 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.46 132.75 6.9 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.32 -0.684 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -179.535 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.586 0.231 . . . . 0.0 110.501 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 2.1 p -146.09 145.31 30.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.363 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.694 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -105.69 4.12 29.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.137 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -168.32 159.4 10.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.618 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.556 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 21.0 t0 -58.89 -40.53 84.72 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.914 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -59.26 -17.87 32.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.694 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 62.5 m-20 -67.78 -22.32 65.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.829 0.347 . . . . 0.0 111.045 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -113.01 143.73 29.71 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.241 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 73.8 Cg_exo -52.94 148.71 28.66 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.239 2.626 . . . . 0.0 112.853 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.31 -22.06 6.78 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 114.937 -1.029 . . . . 0.0 114.614 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.48 94.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.068 0.434 . . . . 0.0 110.752 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 29.1 m -112.14 -179.89 3.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.037 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.4 147.33 28.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.68 0.276 . . . . 0.0 110.705 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.556 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 49.6 t -76.04 123.9 26.51 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.101 0.477 . . . . 0.0 110.268 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.97 173.26 12.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.327 0.585 . . . . 0.0 111.512 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.07 -25.59 73.36 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.951 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -81.15 7.94 9.93 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 35.65 58.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.653 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 46.7 m-85 -139.31 158.31 44.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.037 0.446 . . . . 0.0 110.131 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 86.4 m -67.23 137.24 56.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.403 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -126.97 137.37 9.89 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.797 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.327 -0.39 0 O-C-N 124.081 0.518 . . . . 0.0 111.309 -179.554 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.044 0.449 . . . . 0.0 111.046 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -112.86 159.99 18.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.629 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.526 ' HD2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -117.02 17.33 14.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.253 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.667 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 2.3 ptm180 -177.53 153.49 0.9 Allowed 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.302 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.515 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -57.49 -50.74 72.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.718 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -78.39 24.07 0.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.972 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.667 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 1.1 t0 -81.56 -32.28 32.25 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -89.6 149.09 41.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.032 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.664 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 20.4 Cg_endo -59.05 155.28 40.08 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.487 2.125 . . . . 0.0 112.324 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.92 -26.53 2.91 Favored Glycine 0 N--CA 1.466 0.647 0 O-C-N 123.97 0.794 . . . . 0.0 115.076 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.86 -20.39 65.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.972 0.386 . . . . 0.0 111.535 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.9 m -143.93 -178.81 6.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.775 0.321 . . . . 0.0 110.293 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.403 ' N ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -142.11 156.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.039 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 8.1 t -80.82 128.39 33.61 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.061 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.45 175.11 10.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.947 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.56 -28.02 69.02 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.54 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -76.43 -4.55 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.86 33.01 22.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.13 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -137.41 154.54 49.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 50.8 m -61.38 142.03 57.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.531 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.63 128.18 3.15 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 111.168 -179.289 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 29.1 m . . . . . 0 C--O 1.238 0.493 0 CA-C-O 120.665 0.269 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 1' ' ' CYS . 31.9 Cg_exo -58.93 138.4 85.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.199 2.6 . . . . 0.0 112.131 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -97.45 -37.87 9.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.631 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 tp -98.24 129.64 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.266 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 26' ' ' CYS . 2.6 pt? -163.68 144.88 9.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.02 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 17.0 pttp -150.08 166.87 28.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -59.47 135.14 57.57 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.575 0.547 . . . . 0.0 111.61 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 26.7 p -149.88 144.69 26.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.688 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.22 14.09 12.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 0.0 109.741 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.425 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 16.9 ptp180 177.14 177.64 0.3 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.811 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.03 -46.76 86.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.884 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -53.91 -25.44 20.21 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.8 m-20 -69.09 -10.02 55.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.54 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t -140.17 141.47 26.65 Favored Pre-proline 0 C--N 1.32 -0.684 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.651 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 33.6 Cg_endo -63.35 162.87 25.45 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.947 2.431 . . . . 0.0 112.273 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.27 8.57 0.44 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.67 -22.35 46.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.523 0.678 . . . . 0.0 109.553 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 28' ' ' SER . 68.1 m -152.17 -176.94 5.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.737 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.494 HG12 ' HE ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -133.97 144.61 35.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.758 0.313 . . . . 0.0 110.73 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.5 t -69.76 116.71 10.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.333 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HE ' HG12 ' A' ' 19' ' ' ILE . 24.5 mmt85 -83.02 176.37 9.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.445 . . . . 0.0 111.386 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.89 -22.48 70.34 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.65 -0.704 . . . . 0.0 114.026 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 17.4 p-10 -77.94 2.21 18.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.888 0.344 . . . . 0.0 111.901 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.28 28.53 55.65 Favored Glycine 0 C--O 1.237 0.306 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.446 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 26.8 m-85 -138.44 159.03 43.1 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.023 0.439 . . . . 0.0 109.994 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 5' ' ' LEU . 77.0 m -69.95 135.76 49.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -127.47 126.75 5.64 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.468 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 20.0 m -65.78 147.0 54.08 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 122.188 0.195 . . . . 0.0 110.805 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.56 -36.23 88.66 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.845 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.5 m -93.09 37.16 1.03 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -69.59 -32.12 70.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.928 0.394 . . . . 0.0 109.997 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.29 50.08 2.35 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.833 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.18 -45.25 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.482 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.65 68.13 1.15 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.91 2.407 . . . . 0.0 112.097 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -138.94 -44.61 0.47 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.915 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -150.56 134.97 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.24 0.543 . . . . 0.0 110.403 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.436 HD13 HG11 ' A' ' 34' ' ' VAL . 66.8 tp -157.69 122.3 4.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.728 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -150.85 152.84 34.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.724 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 143.14 49.37 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.483 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 3.6 p -151.37 153.19 34.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.821 0.343 . . . . 0.0 111.731 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.686 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -118.77 11.96 12.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 36.7 ptt180 -168.47 178.46 4.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.567 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -74.9 -42.29 58.08 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.561 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -55.56 -24.15 30.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.686 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 55.2 m-20 -70.64 -14.75 62.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.401 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 5.0 t -123.75 142.23 38.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.755 0.312 . . . . 0.0 110.303 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.606 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 26.7 Cg_endo -61.74 164.42 16.18 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.904 2.403 . . . . 0.0 111.943 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.25 21.98 0.29 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 114.184 0.434 . . . . 0.0 114.184 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.63 -26.98 24.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.25 0.548 . . . . 0.0 110.018 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 64.4 m -152.19 -177.23 6.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.51 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -124.11 146.34 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.645 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.0 t -72.57 120.37 18.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.265 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -81.9 173.94 11.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.175 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.81 -24.16 66.24 Favored Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 113.155 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -73.86 -10.11 59.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.557 0.218 . . . . 0.0 111.517 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.53 35.22 10.68 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.749 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -145.55 156.53 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.434 . . . . 0.0 109.942 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -65.19 136.03 56.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.301 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.577 ' HA2' HG22 ' A' ' 34' ' ' VAL . . . -137.7 127.52 3.95 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 7.2 m -67.29 126.07 28.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 111.856 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.44 -51.69 25.27 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.122 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.1 m -80.23 51.39 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.031 0.443 . . . . 0.0 110.315 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 4.0 t70 -161.42 -49.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.549 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.39 -45.0 1.37 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.97 -118.17 4.14 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.577 HG22 ' HA2' ' A' ' 27' ' ' GLY . 43.4 t . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.654 ' HB2' HG12 ' A' ' 4' ' ' ILE . 68.8 Cg_endo -73.76 133.81 19.12 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.709 2.273 . . . . 0.0 112.203 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -78.24 56.3 1.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.119 0.485 . . . . 0.0 110.422 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 2' ' ' PRO . 48.3 mm -88.97 113.91 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.998 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.86 63.51 5.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.32 0.581 . . . . 0.0 110.992 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HB2' HG22 ' A' ' 4' ' ' ILE . 2.8 mtpm? -139.85 119.42 13.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.288 0.566 . . . . 0.0 112.444 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.889 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -86.97 149.33 24.85 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 5.2 p -142.77 142.35 31.89 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.365 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.611 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -108.62 14.68 24.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.125 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -179.08 174.57 1.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.646 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.13 -53.65 50.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.592 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.91 -13.64 17.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.988 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.611 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 9.1 t0 -64.14 -25.83 68.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.631 0.729 . . . . 0.0 109.935 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t -122.47 144.38 42.0 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.836 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 29.5 Cg_endo -61.75 160.3 29.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.796 2.331 . . . . 0.0 112.45 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.41 -9.02 4.14 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.466 -0.788 . . . . 0.0 114.308 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.74 -21.54 66.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.063 0.459 . . . . 0.0 110.511 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.1 m -150.63 -176.04 5.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.942 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.7 pt -130.69 152.0 36.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.113 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 t -80.49 125.74 30.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.18 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -76.67 169.31 18.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.894 0.378 . . . . 0.0 110.359 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.17 -23.06 71.28 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.053 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -80.48 -1.92 43.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.33 40.88 9.65 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.248 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -145.79 150.53 36.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.082 0.441 . . . . 0.0 110.181 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 76.5 m -66.69 134.59 52.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.081 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.68 137.65 6.88 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 28.3 m -71.77 165.49 23.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.855 0.327 . . . . 0.0 111.114 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.52 -43.35 85.57 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.275 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -93.62 41.71 1.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.904 0.383 . . . . 0.0 110.005 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 28' ' ' SER . 37.9 t70 -58.85 -39.74 82.2 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.204 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.21 -36.43 88.72 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.185 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.49 -47.56 6.77 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.643 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--N 1.329 -0.312 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.358 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 56.1 m . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.578 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 42.3 Cg_endo -68.31 79.79 0.58 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.067 2.511 . . . . 0.0 112.482 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -60.63 -31.52 70.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.672 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' A' ' 26' ' ' CYS . 1.4 pp -89.88 138.13 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.703 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.4 tp -143.65 54.25 1.32 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.589 0.709 . . . . 0.0 110.274 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 35.5 mmtp -89.49 137.68 32.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.561 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 144.85 56.71 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 p -150.87 143.75 24.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.348 0.595 . . . . 0.0 112.065 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.561 ' HG2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -110.77 -0.7 16.92 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.561 ' HG2' ' HG2' ' A' ' 9' ' ' ARG . 13.5 ptm180 -167.4 154.35 8.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.053 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -55.69 -33.9 64.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.453 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 m -55.61 -26.6 44.84 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.491 ' CG ' ' HE ' ' A' ' 9' ' ' ARG . 50.7 m-20 -69.05 -14.36 62.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.33 . . . . 0.0 111.406 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.731 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -125.11 150.54 67.13 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.731 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 23.9 Cg_endo -59.58 157.88 30.17 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.735 2.29 . . . . 0.0 112.984 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.82 -24.21 48.14 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.13 -0.941 . . . . 0.0 114.109 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.44 18.3 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.138 0.469 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.9 m -154.18 174.6 14.54 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.65 154.99 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.0 t -82.35 128.41 34.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.983 0.42 . . . . 0.0 110.331 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -80.13 170.04 16.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.065 0.46 . . . . 0.0 110.687 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.56 -25.83 73.8 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.658 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -81.32 -0.39 40.85 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.73 38.81 13.05 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.397 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -140.69 157.92 44.73 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.671 ' HB3' HD13 ' A' ' 4' ' ' ILE . 59.4 m -65.34 140.38 58.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.621 0.724 . . . . 0.0 112.647 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.38 136.04 9.08 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.578 ' HB2' ' HA ' ' A' ' 2' ' ' PRO . 28.6 t -57.86 133.84 55.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.804 0.302 . . . . 0.0 111.161 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.3 -35.79 91.48 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.409 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 15.7 m -85.14 58.3 4.95 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -69.15 56.1 0.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.831 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.89 37.59 0.34 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.645 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.25 -48.94 0.58 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.15 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 30' ' ' SER . 60.3 t . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.217 0.532 . . . . 0.0 110.372 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.04 125.16 15.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.875 2.383 . . . . 0.0 112.76 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -78.28 57.42 1.88 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.887 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.7 tt -150.23 147.58 15.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.658 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.636 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.0 pt? -60.46 130.16 45.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.086 0.469 . . . . 0.0 109.984 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 15.6 pttp -139.52 130.63 26.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.712 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -146.66 151.23 36.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.857 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 5.8 p -152.7 146.77 25.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.047 0.451 . . . . 0.0 111.984 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.474 ' HE ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -110.27 11.75 23.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 12.8 ptp180 -179.79 160.92 0.95 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.486 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 8.0 t0 -60.09 -26.81 66.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.307 0.575 . . . . 0.0 111.246 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -58.96 -26.97 64.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.701 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 8' ' ' CYS . 20.9 m-20 -84.97 15.65 3.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.48 0.181 . . . . 0.0 110.9 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -126.46 141.95 41.56 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-O 121.004 0.43 . . . . 0.0 111.196 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 60.4 Cg_endo -70.86 156.08 61.14 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.929 2.419 . . . . 0.0 111.824 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.02 -29.41 43.53 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.207 -0.451 . . . . 0.0 113.996 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 30' ' ' SER . . . -78.43 8.32 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 111.91 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.4 m -152.29 179.74 8.27 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.61 HD12 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -143.54 149.17 18.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 41.0 t -78.88 120.34 23.36 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.087 0.47 . . . . 0.0 110.219 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -81.53 169.54 16.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.719 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.43 -26.57 68.24 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 113.767 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -81.83 7.39 12.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.928 0.364 . . . . 0.0 111.83 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.08 31.34 55.58 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.299 -0.477 . . . . 0.0 114.276 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -134.18 154.17 51.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 109.979 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 10.7 m -79.26 135.79 36.86 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.555 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.454 ' O ' HD13 ' A' ' 19' ' ' ILE . . . -123.27 139.19 12.07 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 46.7 m -70.69 63.29 0.28 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.61 ' HA3' HD12 ' A' ' 19' ' ' ILE . . . -67.85 -49.24 50.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.705 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.521 ' HB2' ' HA ' ' A' ' 17' ' ' ALA . 3.1 m -85.83 46.79 1.35 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.973 0.416 . . . . 0.0 109.898 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 2.6 t70 -160.46 -62.64 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.119 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.66 33.87 88.38 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.666 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.64 -120.58 1.84 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.189 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 121.05 0.452 . . . . 0.0 110.882 -179.82 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.13 131.78 31.76 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.826 2.351 . . . . 0.0 111.496 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 12.3 mptt -81.44 -43.3 19.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.361 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.2 mm -88.93 66.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.409 0.623 . . . . 0.0 110.129 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.6 tp -65.71 133.39 50.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.933 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -150.94 140.13 21.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.182 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.837 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.52 147.77 26.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.546 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 2.5 p -146.92 143.43 28.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.174 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.678 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -105.58 13.82 29.4 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.799 0.809 . . . . 0.0 109.464 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -171.79 158.59 4.96 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.775 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.577 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 35.8 t70 -65.2 -39.91 93.48 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.643 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -57.71 -17.84 17.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.678 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 79.7 m-20 -70.4 -20.96 62.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.996 0.427 . . . . 0.0 110.537 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -106.63 141.58 23.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.319 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 50.5 Cg_endo -67.85 158.59 56.6 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.618 2.212 . . . . 0.0 111.408 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.89 -16.47 2.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.76 -24.17 66.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.909 0.354 . . . . 0.0 111.39 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.9 m -143.99 -177.17 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.7 pt -132.76 150.9 33.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.505 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.577 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 38.8 t -82.45 122.87 28.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -80.26 164.78 22.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.023 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.77 -23.93 63.84 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.305 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -76.96 -3.17 37.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.84 36.29 13.91 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.459 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -145.71 153.09 40.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -68.09 145.81 54.06 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.298 0.57 . . . . 0.0 111.269 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.9 143.12 11.52 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.193 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.7 m -60.87 139.12 58.07 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.875 0.397 . . . . 0.0 111.345 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.48 -110.53 1.1 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.0 m -88.16 28.41 1.07 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.281 0.562 . . . . 0.0 109.928 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.04 -37.46 84.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.283 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.09 38.23 16.05 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.973 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.37 135.41 4.61 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.016 -0.612 . . . . 0.0 111.691 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 C--N 1.323 -0.577 0 CA-C-O 120.966 0.412 . . . . 0.0 111.191 -179.593 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 55.5 m . . . . . 0 C--O 1.234 0.258 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.444 ' HG3' ' H ' ' A' ' 28' ' ' SER . 32.5 Cg_exo -57.43 118.14 4.96 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.471 2.114 . . . . 0.0 111.987 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -75.22 -30.1 60.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.673 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 tp -112.28 130.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.922 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.1 tp -131.87 119.08 20.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.975 0.417 . . . . 0.0 110.225 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 6' ' ' LYS . 41.1 mtmt -149.75 145.76 26.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.422 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.57 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -71.39 136.78 47.91 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.022 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.3 p -142.98 150.57 39.83 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.081 0.467 . . . . 0.0 111.735 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.663 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -113.68 8.03 17.42 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.181 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -169.51 164.88 10.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.024 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -66.84 -36.28 81.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -54.96 -24.55 24.47 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.663 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 52.8 m-20 -71.8 -13.08 61.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.758 0.313 . . . . 0.0 111.098 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -127.54 148.46 66.7 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.668 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 31.6 Cg_endo -62.12 159.03 36.36 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.301 2.001 . . . . 0.0 111.84 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.1 17.64 0.27 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 114.503 0.561 . . . . 0.0 114.503 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.432 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.23 -21.14 27.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.27 0.557 . . . . 0.0 109.942 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 56.8 m -149.93 -179.37 7.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.457 ' H ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -129.18 157.75 41.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.473 179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.0 t -77.41 117.35 18.81 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.668 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 17.4 mtp85 -80.77 169.59 17.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.57 -24.98 49.29 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.615 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -74.79 -8.46 56.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.704 0.252 . . . . 0.0 111.456 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.83 35.64 15.54 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.693 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -144.95 158.59 43.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.4 . . . . 0.0 109.997 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.7 m -65.0 138.01 58.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.754 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.668 ' HA3' ' HD2' ' A' ' 21' ' ' ARG . . . -147.51 150.92 23.22 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.157 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.444 ' H ' ' HG3' ' A' ' 2' ' ' PRO . 3.3 m -48.26 139.98 8.0 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.505 0.722 . . . . 0.0 112.052 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.82 -111.74 1.19 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.661 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -86.45 28.74 0.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.155 0.502 . . . . 0.0 110.587 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.623 ' HB3' HG22 ' A' ' 34' ' ' VAL . 32.0 m-20 -75.84 -54.28 7.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.291 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.53 39.43 93.13 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.55 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.62 -55.27 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.846 -1.169 . . . . 0.0 113.321 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.623 HG22 ' HB3' ' A' ' 31' ' ' ASP . 31.3 m . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.72 0.771 . . . . 0.0 111.132 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 65.5 m . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 120.74 0.305 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -62.7 135.98 55.46 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.676 2.251 . . . . 0.0 111.838 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -83.94 45.96 1.14 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.962 0.41 . . . . 0.0 111.068 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.3 tp -151.22 136.01 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.845 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.58 41.86 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.452 0.644 . . . . 0.0 111.627 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -89.5 119.5 29.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.482 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.539 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -73.35 143.45 46.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.841 0.353 . . . . 0.0 110.876 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 p -146.06 147.86 32.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.6 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.511 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -113.16 19.9 16.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.261 0.553 . . . . 0.0 109.767 178.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -178.6 179.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.325 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -71.77 -50.45 29.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.166 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -54.87 -26.17 33.68 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 73.5 m-20 -63.48 -19.34 64.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.305 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.597 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.9 t -115.43 141.28 27.01 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.976 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.597 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 47.9 Cg_endo -67.67 159.96 50.28 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.995 2.463 . . . . 0.0 112.005 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.85 -16.31 7.56 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.958 -0.565 . . . . 0.0 114.356 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.86 -16.5 64.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.31 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 64.3 m -151.57 -175.58 5.25 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -137.2 152.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.6 t -77.26 120.65 22.6 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.481 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 58.7 mtp180 -80.6 169.85 17.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.758 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.76 -24.69 66.72 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.61 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 13.8 p-10 -82.09 13.64 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.04 0.42 . . . . 0.0 111.834 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.65 31.42 70.6 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 121.415 -0.421 . . . . 0.0 113.779 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -140.78 155.26 46.44 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.423 0.63 . . . . 0.0 110.332 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -68.18 142.08 55.81 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.197 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.481 ' HA3' ' HD2' ' A' ' 21' ' ' ARG . . . -151.6 131.16 3.36 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.5 t -72.79 -178.28 2.66 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 117.208 0.504 . . . . 0.0 110.014 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -50.71 -40.03 40.03 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.059 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 m -94.48 56.46 2.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HB2' ' NE ' ' A' ' 21' ' ' ARG . 1.5 p-10 -58.58 -37.15 75.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.332 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.37 20.03 2.81 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.997 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.77 145.53 30.14 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 120.74 0.305 . . . . 0.0 110.574 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 42.2 t . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.934 0.397 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 1' ' ' CYS . 17.1 Cg_exo -67.33 134.39 33.37 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.997 2.465 . . . . 0.0 111.891 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -68.04 -27.98 66.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.519 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.5 tp -150.12 134.26 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.988 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -89.97 151.39 21.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.158 0.504 . . . . 0.0 111.02 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.04 127.01 35.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.053 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.814 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -76.94 137.1 38.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.148 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . 1.1 p -133.52 147.19 51.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.972 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.677 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -104.05 1.07 30.54 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -167.0 159.95 13.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.04 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 23.1 t0 -60.67 -37.78 82.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.293 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -57.22 -21.22 32.24 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.677 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 64.3 m-20 -67.82 -19.16 65.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 111.12 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.451 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 t -113.66 145.77 34.09 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.573 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 74.0 Cg_exo -53.83 149.89 31.8 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.367 2.711 . . . . 0.0 112.75 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.03 -22.67 13.41 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.022 -0.99 . . . . 0.0 114.871 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.79 81.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.242 0.521 . . . . 0.0 110.856 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.8 m -104.39 179.64 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.625 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.66 147.63 23.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.815 0.34 . . . . 0.0 110.616 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 43.3 t -77.62 120.55 22.73 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -80.22 170.29 16.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.16 0.505 . . . . 0.0 111.649 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.44 -26.2 61.64 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.704 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -74.08 -7.18 51.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.72 0.26 . . . . 0.0 111.344 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.49 35.24 14.45 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.554 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -141.94 154.44 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 0.0 110.337 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.6 m -63.22 137.73 58.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.674 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.64 126.78 3.54 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 m -63.64 138.37 58.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.682 0.277 . . . . 0.0 111.041 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.76 -55.89 2.2 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.6 p -147.68 21.93 1.15 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -125.4 43.9 2.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.151 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.41 -56.57 23.7 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.854 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.39 -122.92 30.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.169 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.445 -0.707 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.539 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 30' ' ' SER . 73.7 m . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.724 0.297 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.64 132.13 26.21 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.779 2.319 . . . . 0.0 112.561 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -89.4 66.88 7.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.38 0.61 . . . . 0.0 110.224 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.3 tp -87.11 126.28 40.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.99 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.418 HD11 ' HB3' ' A' ' 25' ' ' TYR . 43.8 tp -90.36 130.23 36.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.713 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 36.2 mtmt -148.37 168.72 21.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.978 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -83.96 140.28 32.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 25.9 p -154.21 150.14 27.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.571 0.7 . . . . 0.0 112.124 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.563 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -132.01 18.41 4.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.164 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.92 173.78 1.83 Allowed 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.22 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.86 -54.34 43.45 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m -58.9 -20.43 51.42 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.563 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 64.5 m-20 -61.52 -23.55 66.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.162 0.506 . . . . 0.0 111.326 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 t -124.81 142.27 40.43 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 35.8 Cg_endo -64.92 163.89 26.67 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.776 2.317 . . . . 0.0 112.366 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.21 -17.67 11.55 Favored Glycine 0 CA--C 1.521 0.411 0 O-C-N 123.583 0.552 . . . . 0.0 113.713 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 1' ' ' CYS . . . -69.52 -10.2 57.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 110.946 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.7 m -149.99 -178.45 6.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.657 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.9 pt -140.88 148.27 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.748 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.5 t -75.22 122.1 23.14 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.357 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -81.44 171.25 14.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.774 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.09 -25.73 75.2 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.795 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -84.94 14.12 5.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.0 32.03 63.78 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 114.726 0.651 . . . . 0.0 114.726 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.418 ' HB3' HD11 ' A' ' 5' ' ' LEU . 16.0 m-85 -135.98 158.53 44.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.949 0.404 . . . . 0.0 110.273 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 6' ' ' LYS . 61.6 m -71.75 136.62 47.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.07 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.81 136.06 11.5 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -50.6 129.44 22.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.087 0.47 . . . . 0.0 111.999 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.24 63.25 0.55 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 1' ' ' CYS . 12.5 m -73.47 48.78 0.26 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.858 0.463 . . . . 0.0 111.774 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -67.87 -50.88 53.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.552 0.691 . . . . 0.0 109.553 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.27 46.77 3.06 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.662 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.31 -125.44 8.76 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.352 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 121.593 0.711 . . . . 0.0 110.523 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.36 111.45 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.453 2.102 . . . . 0.0 111.833 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -83.57 40.07 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.35 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.9 tp -151.94 133.6 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.084 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mp -62.79 135.93 57.6 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.081 0.467 . . . . 0.0 111.295 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -146.16 123.87 11.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.163 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -101.04 144.62 29.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.993 179.226 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 p -120.96 148.41 44.13 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.115 0.483 . . . . 0.0 111.067 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -101.3 -17.12 16.7 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.657 ' HG2' ' OD1' ' A' ' 13' ' ' ASP . 4.0 ptp85 -165.6 177.18 7.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.14 -1.845 . . . . 0.0 107.045 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 6.2 t0 -61.2 -37.64 83.7 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.074 0.464 . . . . 0.0 111.109 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -59.49 -29.03 67.55 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.657 ' OD1' ' HG2' ' A' ' 10' ' ' ARG . 1.0 OUTLIER -69.15 -13.32 62.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 111.02 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.657 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 4.2 t -103.34 143.14 26.02 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.408 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.657 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 37.9 Cg_endo -63.91 154.0 72.5 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.793 2.328 . . . . 0.0 111.961 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.62 -30.3 34.51 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.585 -0.734 . . . . 0.0 114.527 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.11 2.3 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.312 0.556 . . . . 0.0 112.193 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 62.3 m -148.79 -176.77 5.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.12 156.72 24.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.903 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 44.2 t -77.01 121.08 23.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.476 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -81.11 169.73 17.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.33 -27.58 72.61 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.529 -0.759 . . . . 0.0 113.353 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -84.18 19.31 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.888 0.344 . . . . 0.0 111.875 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.41 32.08 82.39 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 114.111 0.404 . . . . 0.0 114.111 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 15.3 m-85 -135.98 158.88 43.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.211 0.529 . . . . 0.0 110.352 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.463 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m -70.06 142.03 52.74 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.213 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -138.86 132.81 5.9 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 m -64.69 139.55 58.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.843 0.354 . . . . 0.0 110.957 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.32 -51.49 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.546 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -81.8 46.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.996 0.427 . . . . 0.0 110.484 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -172.68 -105.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.375 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.56 -25.23 11.27 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.68 -46.66 60.46 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.619 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.627 0.727 . . . . 0.0 111.634 -179.801 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 45.1 m . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 1' ' ' CYS . 10.4 Cg_exo -71.54 119.2 6.08 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.618 2.212 . . . . 0.0 111.992 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.92 43.32 0.59 Allowed 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.289 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.605 HG23 ' HG3' ' A' ' 6' ' ' LYS . 7.4 tp -152.32 144.12 15.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.91 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.417 ' HG ' ' HD2' ' A' ' 7' ' ' LYS . 17.2 tp -69.81 74.16 0.43 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.041 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.605 ' HG3' HG23 ' A' ' 4' ' ' ILE . 44.5 mttm -88.65 62.18 6.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.695 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -74.04 130.82 40.58 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 11.6 p -119.24 177.92 4.71 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.161 0.505 . . . . 0.0 111.489 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.674 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -131.13 9.66 4.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.132 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -175.04 172.71 2.78 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.676 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.51 -43.52 69.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.722 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -59.76 -13.97 12.54 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.674 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 69.3 m-20 -68.01 -21.04 65.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.008 0.432 . . . . 0.0 110.992 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -111.47 141.57 24.79 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.006 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 24.6 Cg_endo -61.82 165.66 13.59 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.893 2.396 . . . . 0.0 112.177 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.37 21.31 0.23 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 114.48 0.552 . . . . 0.0 114.48 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.57 -28.77 23.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.233 0.539 . . . . 0.0 109.749 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 82.8 m -156.19 -175.24 5.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.42 ' H ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -129.17 148.83 33.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.46 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 t -76.21 123.01 25.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.606 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 46.4 mtp85 -80.31 172.98 13.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.229 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.25 -23.72 48.76 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.08 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.606 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 15.7 p-10 -76.59 -1.08 25.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.028 0.414 . . . . 0.0 111.449 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 79.67 33.24 34.81 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.331 -0.461 . . . . 0.0 113.733 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -144.11 155.18 43.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 110.164 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.484 ' SG ' ' HD3' ' A' ' 6' ' ' LYS . 72.1 m -63.87 138.05 58.31 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.352 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -153.83 143.42 10.11 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.962 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.6 p -69.64 147.02 51.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.87 -58.27 5.85 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -155.82 23.76 0.39 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.49 51.99 1.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.99 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.96 -51.84 3.21 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.381 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 134.56 43.84 0.12 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.029 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 121.764 0.792 . . . . 0.0 110.696 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 44.7 t . . . . . 0 C--O 1.236 0.352 0 CA-C-O 120.908 0.385 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.871 ' HB2' HD12 ' A' ' 5' ' ' LEU . 15.9 Cg_exo -67.02 132.33 27.81 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.463 2.108 . . . . 0.0 111.095 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -79.19 -35.66 41.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.88 0.371 . . . . 0.0 110.944 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.493 ' O ' HD12 ' A' ' 4' ' ' ILE . 1.6 pp -139.7 136.07 39.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.841 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.871 HD12 ' HB2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -163.02 165.18 25.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.336 0.589 . . . . 0.0 111.34 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.06 136.19 36.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.247 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.749 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -73.48 137.83 44.74 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 176.544 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.583 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 4.7 p -119.06 145.09 46.19 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.3 0.572 . . . . 0.0 112.423 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.12 -1.57 28.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.057 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.717 ' NH1' ' HB3' ' A' ' 12' ' ' SER . 26.1 ptt85 -171.75 179.64 2.73 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.806 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -62.84 -56.96 12.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.494 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.717 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 28.8 t -69.79 3.0 2.82 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 8' ' ' CYS . 7.7 t70 -73.24 -12.22 60.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.442 0.639 . . . . 0.0 109.808 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -126.57 145.54 53.54 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.231 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 30.9 Cg_endo -61.92 158.53 37.94 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.753 2.302 . . . . 0.0 112.443 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.0 -24.29 8.32 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.591 -0.731 . . . . 0.0 114.562 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.57 -23.35 67.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 110.913 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.443 ' HA ' ' N ' ' A' ' 29' ' ' GLY . 57.7 m -134.5 -178.96 5.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.471 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 pt -143.19 150.82 17.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.873 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.2 t -73.73 120.32 19.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.044 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' HD3' ' HA3' ' A' ' 27' ' ' GLY . 21.8 mmm180 -81.62 168.73 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.724 0.297 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.64 -25.13 62.96 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 116.044 -0.525 . . . . 0.0 113.375 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.88 -7.24 56.43 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.92 31.7 19.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.666 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.523 ' HB3' HD23 ' A' ' 5' ' ' LEU . 84.2 m-85 -138.3 156.45 47.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 0.0 110.03 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 83.4 m -66.07 135.76 55.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.178 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.612 ' HA3' ' HD3' ' A' ' 21' ' ' ARG . . . -134.36 138.84 10.36 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.887 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 1.2 m -45.78 126.16 6.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.067 0.433 . . . . 0.0 111.846 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.02 -53.98 9.98 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.178 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.7 m -84.99 45.37 1.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.123 0.487 . . . . 0.0 110.071 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.887 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 21.7 t70 -164.96 -120.25 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' H ' ' CG ' ' A' ' 31' ' ' ASP . . . -178.79 21.75 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.601 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.92 52.78 10.69 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.316 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.345 0.593 . . . . 0.0 112.422 -179.623 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.0 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.55 132.77 50.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.679 2.253 . . . . 0.0 112.093 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HG3' HG22 ' A' ' 4' ' ' ILE . 53.3 pttt -157.89 -49.07 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.659 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.431 HG22 ' HG3' ' A' ' 3' ' ' LYS . 9.4 tp -151.15 52.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 122.678 1.227 . . . . 0.0 109.549 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.785 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.9 pt? -72.73 128.82 36.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.35 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.705 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 12.5 mmmm -118.56 128.8 54.91 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.616 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -67.97 139.17 56.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.757 0.313 . . . . 0.0 110.941 -179.38 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.631 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 3.9 p -149.3 144.22 26.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.894 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.498 ' HD2' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -105.63 11.35 32.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.674 -179.07 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 13' ' ' ASP . 20.0 ptt-85 -171.75 172.46 4.89 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.965 0.412 . . . . 0.0 110.653 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -60.57 -55.32 34.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.769 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.8 m -80.23 21.6 0.59 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.895 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.631 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 6.7 t0 -86.63 -29.56 22.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.636 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.8 t -108.78 146.33 33.54 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.557 -1.202 . . . . 0.0 109.408 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.636 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.0 Cg_endo -60.47 159.79 26.24 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.738 2.292 . . . . 0.0 112.434 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.36 -8.25 3.47 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 115.684 -0.689 . . . . 0.0 114.552 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.0 -20.81 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.166 0.508 . . . . 0.0 110.704 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 55.8 m -152.11 178.12 9.79 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.46 143.69 40.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.532 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.9 t -75.24 121.47 22.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.56 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -82.13 171.17 14.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.68 -24.2 63.97 Favored Glycine 0 C--O 1.227 -0.293 0 CA-C-N 115.817 -0.628 . . . . 0.0 113.062 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -74.41 -11.3 60.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.473 0.178 . . . . 0.0 111.299 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.44 32.86 9.85 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.684 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -142.16 147.21 36.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.443 0.64 . . . . 0.0 110.625 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' A' ' 6' ' ' LYS . 37.6 m -65.62 136.3 56.15 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.97 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -124.44 125.71 5.85 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -75.2 69.96 2.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.701 0.4 . . . . 0.0 111.909 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.34 26.02 63.49 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.085 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.517 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 4.7 m -99.88 61.73 1.13 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.231 0.538 . . . . 0.0 109.679 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.61 59.88 1.19 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.065 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.97 -47.09 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.587 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.44 147.08 8.63 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.517 ' HB ' ' CB ' ' A' ' 30' ' ' SER . 8.1 p . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.169 0.509 . . . . 0.0 111.096 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 86.3 m . . . . . 0 C--O 1.239 0.501 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' O ' ' HE3' ' A' ' 3' ' ' LYS . 78.5 Cg_exo -49.97 137.75 35.84 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.117 2.544 . . . . 0.0 111.749 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -132.74 55.12 1.91 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.902 0.382 . . . . 0.0 111.255 -177.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.7 mm -89.11 121.56 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -76.21 65.85 2.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.302 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -148.18 123.25 10.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.539 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.67 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.05 150.1 25.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.536 179.211 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 18.6 p -148.91 143.18 26.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.027 0.441 . . . . 0.0 111.483 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.553 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -105.39 6.36 32.53 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.449 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 172.9 171.79 0.12 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.727 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.06 -30.37 68.0 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.4 0.438 . . . . 0.0 111.677 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -56.92 -26.74 59.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.553 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 1.7 m-20 -78.98 5.13 12.4 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.428 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 t -149.89 147.3 22.12 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.042 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 70.5 Cg_exo -55.13 150.41 39.59 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.125 2.55 . . . . 0.0 113.113 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.55 -24.03 16.11 Favored Glycine 0 N--CA 1.462 0.425 0 CA-C-N 114.951 -1.022 . . . . 0.0 114.197 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.89 -21.56 66.52 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.219 0.533 . . . . 0.0 110.963 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.422 ' HA ' ' N ' ' A' ' 29' ' ' GLY . 51.9 m -128.7 -179.6 5.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.297 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.3 pt -142.11 159.51 20.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.607 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.6 t -79.61 120.35 23.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.942 0.401 . . . . 0.0 110.012 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.853 ' HD3' ' HA3' ' A' ' 27' ' ' GLY . 12.2 mmm180 -81.4 166.55 20.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.774 0.321 . . . . 0.0 110.466 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.41 58.96 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.362 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -77.6 -5.33 49.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.79 30.39 32.42 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.673 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -135.84 161.72 34.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.034 0.445 . . . . 0.0 110.125 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 99.3 m -68.62 136.15 52.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.968 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.853 ' HA3' ' HD3' ' A' ' 21' ' ' ARG . . . -140.06 137.64 8.55 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.44 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 17.6 m -45.9 129.33 9.46 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -106.19 -56.01 0.67 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.8 m -93.53 45.61 1.17 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 1.9 t70 -171.28 121.51 0.53 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.19 44.08 3.23 Favored Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.096 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.79 127.93 41.99 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.333 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.679 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.684 0.278 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.439 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.0 Cg_endo -65.4 158.11 54.42 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.707 2.272 . . . . 0.0 112.247 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -76.06 49.84 0.57 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.377 0.608 . . . . 0.0 110.624 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 2' ' ' PRO . 48.9 mm -112.09 146.35 17.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.45 87.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.136 0.493 . . . . 0.0 109.755 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.871 ' HD2' ' HB2' ' A' ' 26' ' ' CYS . 16.8 pttm -88.58 73.53 8.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.96 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.774 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -92.44 143.95 25.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.311 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 13' ' ' ASP . 1.8 p -135.56 144.83 46.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.819 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.526 ' HG3' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -104.13 13.19 32.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.471 0.653 . . . . 0.0 110.311 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 35.6 ptt180 -170.27 165.56 8.92 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.602 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 26.6 t70 -65.78 -52.22 52.65 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.405 0.441 . . . . 0.0 111.009 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.6 t -74.66 29.22 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.104 0.478 . . . . 0.0 111.609 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 11' ' ' ASP . 1.4 t70 -96.26 -27.05 15.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.785 0.802 . . . . 0.0 109.244 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.73 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -108.44 151.8 41.73 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.172 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.73 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.6 Cg_endo -60.43 156.55 40.71 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.472 2.115 . . . . 0.0 112.024 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.28 -19.25 5.64 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.446 -0.797 . . . . 0.0 115.054 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.33 69.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 0.0 111.169 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 39.7 m -134.49 179.03 6.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.38 149.13 33.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.191 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.602 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 11.0 t -76.86 113.17 14.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.502 ' NE ' ' HA3' ' A' ' 27' ' ' GLY . 98.7 mtt180 -81.92 173.3 12.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.167 0.508 . . . . 0.0 111.717 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.28 -25.94 55.39 Favored Glycine 0 C--O 1.229 -0.212 0 CA-C-N 115.228 -0.896 . . . . 0.0 114.509 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.442 HD21 ' HB2' ' A' ' 25' ' ' TYR . 16.2 p-10 -78.3 4.04 13.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.168 0.484 . . . . 0.0 111.754 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.18 31.2 59.77 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.281 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.442 ' HB2' HD21 ' A' ' 23' ' ' ASN . 27.5 m-85 -139.68 158.39 44.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.348 0.594 . . . . 0.0 110.327 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.871 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 63.8 m -68.15 133.06 48.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.65 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -129.85 132.26 6.97 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -55.96 146.71 21.52 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.94 0.436 . . . . 0.0 111.825 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.93 -52.6 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.421 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 m -97.98 33.7 2.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.443 0.64 . . . . 0.0 109.303 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -148.31 -42.04 0.16 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.072 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.86 -47.49 1.03 Allowed Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.15 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.12 49.3 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.287 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.351 0.596 . . . . 0.0 110.684 179.771 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 55.9 m . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.769 0.319 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.631 ' HB2' HG22 ' A' ' 4' ' ' ILE . 17.3 Cg_exo -66.68 158.04 57.97 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.054 2.503 . . . . 0.0 111.936 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 mmmp? -74.12 51.09 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.811 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -145.17 146.43 19.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.553 HD12 ' HE2' ' A' ' 25' ' ' TYR . 31.1 tp -67.95 64.64 0.09 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.602 ' HG3' HG23 ' A' ' 4' ' ' ILE . 53.1 mttm -90.45 56.15 3.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.013 0.435 . . . . 0.0 110.039 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.652 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -64.77 135.75 56.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.72 -179.109 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.7 p -143.74 146.29 33.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.963 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.652 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -104.88 -16.99 14.71 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 17.4 ptt180 -156.81 167.3 30.88 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.762 -2.017 . . . . 0.0 107.253 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.46 -24.0 67.06 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.065 0.459 . . . . 0.0 110.184 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 10' ' ' ARG . 4.1 m -63.27 -27.11 69.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.528 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.547 ' OD2' ' HG2' ' A' ' 10' ' ' ARG . 13.4 m-20 -81.13 15.65 1.82 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.065 0.459 . . . . 0.0 110.706 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.663 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -150.35 147.97 23.08 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.663 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 33.4 Cg_endo -62.73 156.18 54.8 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.448 2.099 . . . . 0.0 112.254 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.94 -8.47 5.91 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.582 -0.735 . . . . 0.0 114.223 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.21 -18.67 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.053 0.454 . . . . 0.0 110.545 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.2 m -143.84 179.83 6.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.119 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -131.35 167.53 25.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.563 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.0 t -87.82 123.47 32.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.987 0.422 . . . . 0.0 110.856 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -81.9 170.49 15.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.981 0.419 . . . . 0.0 110.86 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 -29.33 73.42 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.565 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -76.1 -4.6 42.38 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 37.05 11.16 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.925 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.553 ' HE2' HD12 ' A' ' 5' ' ' LEU . 77.7 m-85 -142.88 153.73 43.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 6' ' ' LYS . 61.3 m -63.92 142.7 58.31 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.726 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -150.64 139.83 7.53 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 15.9 m -60.24 137.8 58.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.027 0.442 . . . . 0.0 111.375 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.95 -96.81 0.18 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.162 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.3 m -78.68 50.63 1.0 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 110.593 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 1.1 t70 -148.48 -52.08 0.17 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.368 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.91 108.18 0.22 Allowed Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.61 49.08 1.03 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.528 -0.368 . . . . 0.0 113.625 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.4 t . . . . . 0 C--N 1.324 -0.525 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.161 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 C--O 1.233 0.211 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.16 129.8 26.81 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.643 2.228 . . . . 0.0 111.639 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.562 ' HA ' ' HB3' ' A' ' 28' ' ' SER . 53.3 tttm -86.38 63.36 7.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.108 0.48 . . . . 0.0 111.212 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 tt -87.49 138.61 18.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.282 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.1 tp -103.59 124.33 48.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.008 0.432 . . . . 0.0 111.629 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 33.2 mmtp -150.94 143.22 24.18 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.703 ' HD2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -82.32 137.83 34.69 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.308 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -132.4 143.83 50.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.397 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.738 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -105.05 15.01 28.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.285 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.614 ' HG2' ' HB2' ' A' ' 13' ' ' ASP . 29.0 ptt85 -170.86 169.07 6.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.552 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -66.76 -56.5 10.21 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.249 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m -78.73 22.91 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.834 0.349 . . . . 0.0 111.808 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.738 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 7.9 t0 -79.79 -36.35 37.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.604 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -93.61 144.84 28.86 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.891 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.1 Cg_endo -61.27 161.51 23.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.886 2.391 . . . . 0.0 112.109 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.29 -19.21 2.68 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 114.849 0.7 . . . . 0.0 114.849 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.72 -20.3 66.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.063 0.432 . . . . 0.0 111.408 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.0 m -151.25 -179.25 7.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.049 0.452 . . . . 0.0 110.118 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.02 148.52 22.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -69.7 120.63 15.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -81.01 -175.07 5.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.15 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.96 -24.89 76.2 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.257 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 25' ' ' TYR . 16.2 p-10 -83.97 17.74 2.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.42 28.91 73.76 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.389 -0.434 . . . . 0.0 113.792 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.436 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 13.4 m-85 -136.81 157.35 46.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.415 0.626 . . . . 0.0 110.385 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 6' ' ' LYS . 84.6 m -64.8 134.89 55.08 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.275 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.46 132.75 6.9 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.562 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 11.9 p -61.76 146.07 50.55 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.13 45.99 1.19 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.029 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 m -82.03 16.79 1.78 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.251 0.548 . . . . 0.0 110.72 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -72.36 -27.75 62.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.64 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.97 41.55 0.17 Allowed Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.573 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.82 175.57 45.98 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.313 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 121.147 0.498 . . . . 0.0 110.487 179.604 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 C--O 1.24 0.586 0 CA-C-O 120.614 0.245 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -80.74 147.71 17.38 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.641 2.894 . . . . 0.0 112.481 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 3' ' ' LYS . 37.3 ttmt -178.75 -54.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.38 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.3 pt -147.7 161.65 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.157 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 5' ' ' LEU . 1.1 mm? -71.82 130.7 41.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.221 0.534 . . . . 0.0 110.689 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -103.71 113.97 27.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.288 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.772 ' HD2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -108.64 153.04 23.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.501 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 2.1 p -146.09 145.31 30.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.363 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.694 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -105.69 4.12 29.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.137 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -168.32 159.4 10.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.618 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.556 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 21.0 t0 -58.89 -40.53 84.72 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.914 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -59.26 -17.87 32.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.694 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 62.5 m-20 -67.78 -22.32 65.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.829 0.347 . . . . 0.0 111.045 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -113.01 143.73 29.71 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.241 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 73.8 Cg_exo -52.94 148.71 28.66 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.239 2.626 . . . . 0.0 112.853 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.31 -22.06 6.78 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 114.937 -1.029 . . . . 0.0 114.614 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.621 ' HB1' ' HB3' ' A' ' 31' ' ' ASP . . . -63.17 -39.48 94.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.068 0.434 . . . . 0.0 110.752 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 29.1 m -112.14 -179.89 3.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.037 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.4 147.33 28.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.68 0.276 . . . . 0.0 110.705 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.556 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 49.6 t -76.04 123.9 26.51 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.101 0.477 . . . . 0.0 110.268 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.97 173.26 12.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.327 0.585 . . . . 0.0 111.512 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.07 -25.59 73.36 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.951 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -81.15 7.94 9.93 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 35.65 58.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.653 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 46.7 m-85 -139.31 158.31 44.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.037 0.446 . . . . 0.0 110.131 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 86.4 m -67.23 137.24 56.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.403 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -126.97 137.37 9.89 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.797 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m -57.85 139.77 53.38 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 124.081 0.518 . . . . 0.0 111.309 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.79 -109.99 0.48 Allowed Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -78.46 47.49 0.71 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.14 0.495 . . . . 0.0 111.02 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.621 ' HB3' ' HB1' ' A' ' 17' ' ' ALA . 8.0 p-10 -144.45 -50.87 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.256 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.65 33.66 83.15 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.654 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.56 51.5 0.17 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.848 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.946 0.403 . . . . 0.0 110.207 179.8 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.91 151.1 86.98 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.562 2.175 . . . . 0.0 112.182 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -57.21 -31.98 66.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.145 0.498 . . . . 0.0 110.6 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.75 119.32 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.321 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 8.2 mp -80.56 118.76 22.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -102.82 130.58 49.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.952 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.828 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -71.83 130.76 41.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.046 -179.542 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -112.86 159.99 18.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.629 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.526 ' HD2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -117.02 17.33 14.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.253 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.667 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 2.3 ptm180 -177.53 153.49 0.9 Allowed 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.302 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.515 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -57.49 -50.74 72.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.718 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -78.39 24.07 0.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.972 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.667 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 1.1 t0 -81.56 -32.28 32.25 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -89.6 149.09 41.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.032 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.664 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 20.4 Cg_endo -59.05 155.28 40.08 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.487 2.125 . . . . 0.0 112.324 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.92 -26.53 2.91 Favored Glycine 0 N--CA 1.466 0.647 0 O-C-N 123.97 0.794 . . . . 0.0 115.076 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.86 -20.39 65.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.972 0.386 . . . . 0.0 111.535 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.9 m -143.93 -178.81 6.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.775 0.321 . . . . 0.0 110.293 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.617 HD11 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -142.11 156.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.039 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 8.1 t -80.82 128.39 33.61 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.061 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.45 175.11 10.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.947 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.56 -28.02 69.02 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.54 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -76.43 -4.55 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.86 33.01 22.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.13 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.401 ' CD2' ' HB3' ' A' ' 5' ' ' LEU . 82.1 m-85 -137.41 154.54 49.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 50.8 m -61.38 142.03 57.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.531 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.63 128.18 3.15 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 15.6 m -76.41 58.87 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 111.168 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.617 ' HA3' HD11 ' A' ' 19' ' ' ILE . . . -60.38 -41.52 98.53 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.56 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -82.03 34.0 0.4 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.934 0.397 . . . . 0.0 110.411 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 33.9 t70 -162.85 57.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.858 0.837 . . . . 0.0 109.373 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.16 -33.98 1.51 Allowed Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.59 -0.732 . . . . 0.0 113.443 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.77 23.05 6.99 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.445 -0.716 0 CA-C-O 121.591 0.71 . . . . 0.0 110.902 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 mptt . . . . . 0 C--O 1.237 0.437 0 CA-C-O 120.883 0.373 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 26.7 p -149.88 144.69 26.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.688 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.22 14.09 12.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 0.0 109.741 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.425 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 16.9 ptp180 177.14 177.64 0.3 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.811 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.03 -46.76 86.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.884 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -53.91 -25.44 20.21 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.8 m-20 -69.09 -10.02 55.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.54 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t -140.17 141.47 26.65 Favored Pre-proline 0 C--N 1.32 -0.684 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.651 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 33.6 Cg_endo -63.35 162.87 25.45 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.947 2.431 . . . . 0.0 112.273 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.27 8.57 0.44 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.67 -22.35 46.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.523 0.678 . . . . 0.0 109.553 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 28' ' ' SER . 68.1 m -152.17 -176.94 5.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.737 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.494 HG12 ' HE ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -133.97 144.61 35.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.758 0.313 . . . . 0.0 110.73 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.5 t -69.76 116.71 10.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.333 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HE ' HG12 ' A' ' 19' ' ' ILE . 24.5 mmt85 -83.02 176.37 9.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.445 . . . . 0.0 111.386 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.89 -22.48 70.34 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.65 -0.704 . . . . 0.0 114.026 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 17.4 p-10 -77.94 2.21 18.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.888 0.344 . . . . 0.0 111.901 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.28 28.53 55.65 Favored Glycine 0 C--O 1.237 0.306 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.446 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.44 159.03 43.1 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.023 0.439 . . . . 0.0 109.994 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.95 135.76 49.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -127.47 126.75 5.64 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.468 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 20.0 m . . . . . 0 C--N 1.323 -0.572 0 C-N-CA 122.188 0.195 . . . . 0.0 110.805 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.339 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.483 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 3.6 p -151.37 153.19 34.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.821 0.343 . . . . 0.0 111.731 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.686 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -118.77 11.96 12.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 36.7 ptt180 -168.47 178.46 4.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.567 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -74.9 -42.29 58.08 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.561 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -55.56 -24.15 30.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.686 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 55.2 m-20 -70.64 -14.75 62.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.401 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 5.0 t -123.75 142.23 38.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.755 0.312 . . . . 0.0 110.303 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.606 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 26.7 Cg_endo -61.74 164.42 16.18 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.904 2.403 . . . . 0.0 111.943 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.25 21.98 0.29 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 114.184 0.434 . . . . 0.0 114.184 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.63 -26.98 24.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.25 0.548 . . . . 0.0 110.018 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 64.4 m -152.19 -177.23 6.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.51 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -124.11 146.34 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.645 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.0 t -72.57 120.37 18.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.265 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -81.9 173.94 11.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.175 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.81 -24.16 66.24 Favored Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 113.155 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -73.86 -10.11 59.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.557 0.218 . . . . 0.0 111.517 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.53 35.22 10.68 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.749 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -145.55 156.53 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.434 . . . . 0.0 109.942 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -65.19 136.03 56.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.301 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -137.7 127.52 3.95 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 111.856 -178.645 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 5.2 p -142.77 142.35 31.89 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.365 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.611 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -108.62 14.68 24.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.125 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -179.08 174.57 1.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.646 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.13 -53.65 50.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.592 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.91 -13.64 17.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.988 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.611 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 9.1 t0 -64.14 -25.83 68.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.631 0.729 . . . . 0.0 109.935 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t -122.47 144.38 42.0 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.836 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 29.5 Cg_endo -61.75 160.3 29.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.796 2.331 . . . . 0.0 112.45 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.41 -9.02 4.14 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.466 -0.788 . . . . 0.0 114.308 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.74 -21.54 66.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.063 0.459 . . . . 0.0 110.511 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.1 m -150.63 -176.04 5.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.942 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.7 pt -130.69 152.0 36.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.113 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 t -80.49 125.74 30.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.18 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -76.67 169.31 18.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.894 0.378 . . . . 0.0 110.359 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.17 -23.06 71.28 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.053 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -80.48 -1.92 43.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.33 40.88 9.65 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.248 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -145.79 150.53 36.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.082 0.441 . . . . 0.0 110.181 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 76.5 m -66.69 134.59 52.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.081 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.68 137.65 6.88 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.3 m . . . . . 0 C--N 1.322 -0.587 0 CA-C-N 116.855 0.327 . . . . 0.0 111.114 -179.368 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.358 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 p -150.87 143.75 24.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.348 0.595 . . . . 0.0 112.065 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.561 ' HG2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -110.77 -0.7 16.92 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.561 ' HG2' ' HG2' ' A' ' 9' ' ' ARG . 13.5 ptm180 -167.4 154.35 8.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.053 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -55.69 -33.9 64.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.453 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 m -55.61 -26.6 44.84 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.491 ' CG ' ' HE ' ' A' ' 9' ' ' ARG . 50.7 m-20 -69.05 -14.36 62.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.33 . . . . 0.0 111.406 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.731 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -125.11 150.54 67.13 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.731 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 23.9 Cg_endo -59.58 157.88 30.17 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.735 2.29 . . . . 0.0 112.984 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.82 -24.21 48.14 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.13 -0.941 . . . . 0.0 114.109 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.44 18.3 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.138 0.469 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.9 m -154.18 174.6 14.54 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.65 154.99 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.0 t -82.35 128.41 34.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.983 0.42 . . . . 0.0 110.331 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -80.13 170.04 16.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.065 0.46 . . . . 0.0 110.687 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.56 -25.83 73.8 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.658 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -81.32 -0.39 40.85 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.73 38.81 13.05 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.397 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -140.69 157.92 44.73 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 59.4 m -65.34 140.38 58.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.621 0.724 . . . . 0.0 112.647 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.38 136.04 9.08 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 116.804 0.302 . . . . 0.0 111.161 -178.831 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 5.8 p -152.7 146.77 25.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.047 0.451 . . . . 0.0 111.984 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.474 ' HE ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -110.27 11.75 23.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 12.8 ptp180 -179.79 160.92 0.95 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.486 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 8.0 t0 -60.09 -26.81 66.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.307 0.575 . . . . 0.0 111.246 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -58.96 -26.97 64.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.701 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 8' ' ' CYS . 20.9 m-20 -84.97 15.65 3.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.48 0.181 . . . . 0.0 110.9 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -126.46 141.95 41.56 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-O 121.004 0.43 . . . . 0.0 111.196 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 60.4 Cg_endo -70.86 156.08 61.14 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.929 2.419 . . . . 0.0 111.824 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.02 -29.41 43.53 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.207 -0.451 . . . . 0.0 113.996 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.43 8.32 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 111.91 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.4 m -152.29 179.74 8.27 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 27' ' ' GLY . 0.2 OUTLIER -143.54 149.17 18.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 41.0 t -78.88 120.34 23.36 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.087 0.47 . . . . 0.0 110.219 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -81.53 169.54 16.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.719 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.43 -26.57 68.24 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 113.767 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -81.83 7.39 12.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.928 0.364 . . . . 0.0 111.83 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.08 31.34 55.58 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.299 -0.477 . . . . 0.0 114.276 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -134.18 154.17 51.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 109.979 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.7 m -79.26 135.79 36.86 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.555 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.454 ' O ' HD13 ' A' ' 19' ' ' ILE . . . -123.27 139.19 12.07 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 m . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.724 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.871 0.367 . . . . 0.0 111.546 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 2.5 p -146.92 143.43 28.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.174 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.678 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -105.58 13.82 29.4 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.799 0.809 . . . . 0.0 109.464 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -171.79 158.59 4.96 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.775 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.577 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 35.8 t70 -65.2 -39.91 93.48 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.643 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -57.71 -17.84 17.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.678 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 79.7 m-20 -70.4 -20.96 62.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.996 0.427 . . . . 0.0 110.537 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -106.63 141.58 23.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.319 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 50.5 Cg_endo -67.85 158.59 56.6 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.618 2.212 . . . . 0.0 111.408 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.89 -16.47 2.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.76 -24.17 66.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.909 0.354 . . . . 0.0 111.39 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.9 m -143.99 -177.17 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.7 pt -132.76 150.9 33.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.505 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.577 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 38.8 t -82.45 122.87 28.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -80.26 164.78 22.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.023 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.77 -23.93 63.84 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.305 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -76.96 -3.17 37.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.84 36.29 13.91 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.459 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -145.71 153.09 40.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -68.09 145.81 54.06 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.298 0.57 . . . . 0.0 111.269 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.9 143.12 11.52 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.193 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 C--N 1.323 -0.581 0 O-C-N 123.875 0.397 . . . . 0.0 111.345 -179.424 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.41 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.3 p -142.98 150.57 39.83 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.081 0.467 . . . . 0.0 111.735 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.663 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -113.68 8.03 17.42 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.181 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -169.51 164.88 10.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.024 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -66.84 -36.28 81.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -54.96 -24.55 24.47 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.663 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 52.8 m-20 -71.8 -13.08 61.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.758 0.313 . . . . 0.0 111.098 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -127.54 148.46 66.7 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.668 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 31.6 Cg_endo -62.12 159.03 36.36 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.301 2.001 . . . . 0.0 111.84 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.1 17.64 0.27 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 114.503 0.561 . . . . 0.0 114.503 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.432 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.23 -21.14 27.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.27 0.557 . . . . 0.0 109.942 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 56.8 m -149.93 -179.37 7.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.457 ' H ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -129.18 157.75 41.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.473 179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.0 t -77.41 117.35 18.81 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.668 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 17.4 mtp85 -80.77 169.59 17.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.57 -24.98 49.29 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.615 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -74.79 -8.46 56.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.704 0.252 . . . . 0.0 111.456 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.83 35.64 15.54 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.693 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -144.95 158.59 43.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.4 . . . . 0.0 109.997 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.7 m -65.0 138.01 58.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.754 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.668 ' HA3' ' HD2' ' A' ' 21' ' ' ARG . . . -147.51 150.92 23.22 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.157 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.238 0.484 0 C-N-CA 123.505 0.722 . . . . 0.0 112.052 -179.386 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.841 0.353 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 p -146.06 147.86 32.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.6 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.511 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -113.16 19.9 16.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.261 0.553 . . . . 0.0 109.767 178.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -178.6 179.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.325 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -71.77 -50.45 29.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.166 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -54.87 -26.17 33.68 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.511 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 73.5 m-20 -63.48 -19.34 64.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.305 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.597 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.9 t -115.43 141.28 27.01 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.976 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.597 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 47.9 Cg_endo -67.67 159.96 50.28 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.995 2.463 . . . . 0.0 112.005 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.85 -16.31 7.56 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.958 -0.565 . . . . 0.0 114.356 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.86 -16.5 64.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.31 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 64.3 m -151.57 -175.58 5.25 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -137.2 152.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.6 t -77.26 120.65 22.6 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.481 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 58.7 mtp180 -80.6 169.85 17.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.758 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.76 -24.69 66.72 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.61 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 13.8 p-10 -82.09 13.64 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.04 0.42 . . . . 0.0 111.834 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.65 31.42 70.6 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 121.415 -0.421 . . . . 0.0 113.779 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -140.78 155.26 46.44 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.423 0.63 . . . . 0.0 110.332 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -68.18 142.08 55.81 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.197 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.481 ' HA3' ' HD2' ' A' ' 21' ' ' ARG . . . -151.6 131.16 3.36 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 117.208 0.504 . . . . 0.0 110.014 -179.249 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.227 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . 1.1 p -133.52 147.19 51.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.972 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.677 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -104.05 1.07 30.54 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -167.0 159.95 13.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.04 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 23.1 t0 -60.67 -37.78 82.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.293 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -57.22 -21.22 32.24 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.677 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 64.3 m-20 -67.82 -19.16 65.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 111.12 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.451 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 t -113.66 145.77 34.09 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.573 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 74.0 Cg_exo -53.83 149.89 31.8 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.367 2.711 . . . . 0.0 112.75 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.03 -22.67 13.41 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.022 -0.99 . . . . 0.0 114.871 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.79 81.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.242 0.521 . . . . 0.0 110.856 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.8 m -104.39 179.64 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.625 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.66 147.63 23.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.815 0.34 . . . . 0.0 110.616 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 43.3 t -77.62 120.55 22.73 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -80.22 170.29 16.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.16 0.505 . . . . 0.0 111.649 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.44 -26.2 61.64 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.704 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -74.08 -7.18 51.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.72 0.26 . . . . 0.0 111.344 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.49 35.24 14.45 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.554 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -141.94 154.44 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 0.0 110.337 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.6 m -63.22 137.73 58.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.674 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.64 126.78 3.54 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 C--N 1.322 -0.611 0 CA-C-O 120.682 0.277 . . . . 0.0 111.041 -179.48 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.7 tptt . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 25.9 p -154.21 150.14 27.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.571 0.7 . . . . 0.0 112.124 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.563 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -132.01 18.41 4.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.164 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.92 173.78 1.83 Allowed 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.22 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.86 -54.34 43.45 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m -58.9 -20.43 51.42 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.563 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 64.5 m-20 -61.52 -23.55 66.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.162 0.506 . . . . 0.0 111.326 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 t -124.81 142.27 40.43 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 35.8 Cg_endo -64.92 163.89 26.67 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.776 2.317 . . . . 0.0 112.366 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.21 -17.67 11.55 Favored Glycine 0 CA--C 1.521 0.411 0 O-C-N 123.583 0.552 . . . . 0.0 113.713 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.52 -10.2 57.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 110.946 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.7 m -149.99 -178.45 6.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.657 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.9 pt -140.88 148.27 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.748 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.5 t -75.22 122.1 23.14 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.357 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -81.44 171.25 14.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.774 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.09 -25.73 75.2 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.795 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -84.94 14.12 5.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.0 32.03 63.78 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 114.726 0.651 . . . . 0.0 114.726 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -135.98 158.53 44.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.949 0.404 . . . . 0.0 110.273 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.6 m -71.75 136.62 47.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.07 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.81 136.06 11.5 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.087 0.47 . . . . 0.0 111.999 -178.696 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 p -120.96 148.41 44.13 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.115 0.483 . . . . 0.0 111.067 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -101.3 -17.12 16.7 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.657 ' HG2' ' OD1' ' A' ' 13' ' ' ASP . 4.0 ptp85 -165.6 177.18 7.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.14 -1.845 . . . . 0.0 107.045 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 6.2 t0 -61.2 -37.64 83.7 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.074 0.464 . . . . 0.0 111.109 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -59.49 -29.03 67.55 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.657 ' OD1' ' HG2' ' A' ' 10' ' ' ARG . 1.0 OUTLIER -69.15 -13.32 62.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 111.02 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.657 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 4.2 t -103.34 143.14 26.02 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.408 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.657 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 37.9 Cg_endo -63.91 154.0 72.5 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.793 2.328 . . . . 0.0 111.961 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.62 -30.3 34.51 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.585 -0.734 . . . . 0.0 114.527 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.11 2.3 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.312 0.556 . . . . 0.0 112.193 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 62.3 m -148.79 -176.77 5.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.12 156.72 24.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.903 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 44.2 t -77.01 121.08 23.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.476 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -81.11 169.73 17.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.33 -27.58 72.61 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.529 -0.759 . . . . 0.0 113.353 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -84.18 19.31 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.888 0.344 . . . . 0.0 111.875 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.41 32.08 82.39 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 114.111 0.404 . . . . 0.0 114.111 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 15.3 m-85 -135.98 158.88 43.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.211 0.529 . . . . 0.0 110.352 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.463 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m -70.06 142.03 52.74 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.213 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -138.86 132.81 5.9 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 120.843 0.354 . . . . 0.0 110.957 -179.53 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.321 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 11.6 p -119.24 177.92 4.71 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.161 0.505 . . . . 0.0 111.489 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.674 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -131.13 9.66 4.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.132 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -175.04 172.71 2.78 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.676 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.51 -43.52 69.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.722 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -59.76 -13.97 12.54 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.674 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 69.3 m-20 -68.01 -21.04 65.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.008 0.432 . . . . 0.0 110.992 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -111.47 141.57 24.79 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.006 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 24.6 Cg_endo -61.82 165.66 13.59 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.893 2.396 . . . . 0.0 112.177 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.37 21.31 0.23 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 114.48 0.552 . . . . 0.0 114.48 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.57 -28.77 23.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.233 0.539 . . . . 0.0 109.749 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 82.8 m -156.19 -175.24 5.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.42 ' H ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -129.17 148.83 33.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.46 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 t -76.21 123.01 25.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.606 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 46.4 mtp85 -80.31 172.98 13.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.229 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.25 -23.72 48.76 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.08 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.606 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 15.7 p-10 -76.59 -1.08 25.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.028 0.414 . . . . 0.0 111.449 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 79.67 33.24 34.81 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.331 -0.461 . . . . 0.0 113.733 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -144.11 155.18 43.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 110.164 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.1 m -63.87 138.05 58.31 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.352 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -153.83 143.42 10.11 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.962 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.6 p . . . . . 0 C--N 1.323 -0.562 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.977 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.583 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 4.7 p -119.06 145.09 46.19 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.3 0.572 . . . . 0.0 112.423 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.12 -1.57 28.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.057 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.717 ' NH1' ' HB3' ' A' ' 12' ' ' SER . 26.1 ptt85 -171.75 179.64 2.73 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.806 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -62.84 -56.96 12.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.494 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.717 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 28.8 t -69.79 3.0 2.82 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 8' ' ' CYS . 7.7 t70 -73.24 -12.22 60.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.442 0.639 . . . . 0.0 109.808 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -126.57 145.54 53.54 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.231 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 30.9 Cg_endo -61.92 158.53 37.94 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.753 2.302 . . . . 0.0 112.443 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.0 -24.29 8.32 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.591 -0.731 . . . . 0.0 114.562 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.57 -23.35 67.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 110.913 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.7 m -134.5 -178.96 5.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.471 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 pt -143.19 150.82 17.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.873 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.2 t -73.73 120.32 19.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.044 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' HD3' ' HA3' ' A' ' 27' ' ' GLY . 21.8 mmm180 -81.62 168.73 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.724 0.297 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.64 -25.13 62.96 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 116.044 -0.525 . . . . 0.0 113.375 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.88 -7.24 56.43 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.92 31.7 19.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.666 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -138.3 156.45 47.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 0.0 110.03 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.4 m -66.07 135.76 55.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.178 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.612 ' HA3' ' HD3' ' A' ' 21' ' ' ARG . . . -134.36 138.84 10.36 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 117.067 0.433 . . . . 0.0 111.846 -178.351 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.757 0.313 . . . . 0.0 110.941 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.631 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 3.9 p -149.3 144.22 26.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.894 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.498 ' HD2' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -105.63 11.35 32.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.674 -179.07 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 13' ' ' ASP . 20.0 ptt-85 -171.75 172.46 4.89 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.965 0.412 . . . . 0.0 110.653 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -60.57 -55.32 34.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.769 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.8 m -80.23 21.6 0.59 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.895 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.631 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 6.7 t0 -86.63 -29.56 22.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.636 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.8 t -108.78 146.33 33.54 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.557 -1.202 . . . . 0.0 109.408 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.636 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.0 Cg_endo -60.47 159.79 26.24 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.738 2.292 . . . . 0.0 112.434 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.36 -8.25 3.47 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 115.684 -0.689 . . . . 0.0 114.552 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.0 -20.81 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.166 0.508 . . . . 0.0 110.704 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 55.8 m -152.11 178.12 9.79 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.46 143.69 40.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.532 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.9 t -75.24 121.47 22.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.56 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -82.13 171.17 14.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.68 -24.2 63.97 Favored Glycine 0 C--O 1.227 -0.293 0 CA-C-N 115.817 -0.628 . . . . 0.0 113.062 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -74.41 -11.3 60.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.473 0.178 . . . . 0.0 111.299 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.44 32.86 9.85 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.684 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -142.16 147.21 36.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.443 0.64 . . . . 0.0 110.625 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.6 m -65.62 136.3 56.15 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.97 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -124.44 125.71 5.85 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 C--N 1.327 -0.375 0 C-N-CA 122.701 0.4 . . . . 0.0 111.909 -178.56 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.231 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 18.6 p -148.91 143.18 26.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.027 0.441 . . . . 0.0 111.483 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.553 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -105.39 6.36 32.53 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 172.9 171.79 0.12 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.727 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.06 -30.37 68.0 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.4 0.438 . . . . 0.0 111.677 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -56.92 -26.74 59.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.553 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 1.7 m-20 -78.98 5.13 12.4 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.428 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 t -149.89 147.3 22.12 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.042 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 70.5 Cg_exo -55.13 150.41 39.59 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.125 2.55 . . . . 0.0 113.113 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.55 -24.03 16.11 Favored Glycine 0 N--CA 1.462 0.425 0 CA-C-N 114.951 -1.022 . . . . 0.0 114.197 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.89 -21.56 66.52 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.219 0.533 . . . . 0.0 110.963 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.9 m -128.7 -179.6 5.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.297 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.3 pt -142.11 159.51 20.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.607 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.6 t -79.61 120.35 23.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.942 0.401 . . . . 0.0 110.012 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.853 ' HD3' ' HA3' ' A' ' 27' ' ' GLY . 12.2 mmm180 -81.4 166.55 20.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.774 0.321 . . . . 0.0 110.466 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.41 58.96 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.362 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -77.6 -5.33 49.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.79 30.39 32.42 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.673 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -135.84 161.72 34.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.034 0.445 . . . . 0.0 110.125 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 99.3 m -68.62 136.15 52.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.968 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.853 ' HA3' ' HD3' ' A' ' 21' ' ' ARG . . . -140.06 137.64 8.55 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.325 -0.5 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.63 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.132 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 13' ' ' ASP . 1.8 p -135.56 144.83 46.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.819 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.526 ' HG3' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -104.13 13.19 32.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.471 0.653 . . . . 0.0 110.311 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 35.6 ptt180 -170.27 165.56 8.92 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.602 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 26.6 t70 -65.78 -52.22 52.65 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.405 0.441 . . . . 0.0 111.009 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.6 t -74.66 29.22 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.104 0.478 . . . . 0.0 111.609 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 11' ' ' ASP . 1.4 t70 -96.26 -27.05 15.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.785 0.802 . . . . 0.0 109.244 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.73 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -108.44 151.8 41.73 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.172 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.73 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.6 Cg_endo -60.43 156.55 40.71 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.472 2.115 . . . . 0.0 112.024 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.28 -19.25 5.64 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.446 -0.797 . . . . 0.0 115.054 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.33 69.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 0.0 111.169 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 39.7 m -134.49 179.03 6.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.38 149.13 33.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.191 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.602 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 11.0 t -76.86 113.17 14.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.502 ' NE ' ' HA3' ' A' ' 27' ' ' GLY . 98.7 mtt180 -81.92 173.3 12.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.167 0.508 . . . . 0.0 111.717 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.28 -25.94 55.39 Favored Glycine 0 C--O 1.229 -0.212 0 CA-C-N 115.228 -0.896 . . . . 0.0 114.509 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.442 HD21 ' HB2' ' A' ' 25' ' ' TYR . 16.2 p-10 -78.3 4.04 13.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.168 0.484 . . . . 0.0 111.754 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.18 31.2 59.77 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.281 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.442 ' HB2' HD21 ' A' ' 23' ' ' ASN . 27.5 m-85 -139.68 158.39 44.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.348 0.594 . . . . 0.0 110.327 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.8 m -68.15 133.06 48.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.65 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -129.85 132.26 6.97 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 C--N 1.324 -0.537 0 O-C-N 123.94 0.436 . . . . 0.0 111.825 -179.371 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.548 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 121.055 0.455 . . . . 0.0 111.72 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.7 p -143.74 146.29 33.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.963 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.652 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -104.88 -16.99 14.71 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 17.4 ptt180 -156.81 167.3 30.88 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.762 -2.017 . . . . 0.0 107.253 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.46 -24.0 67.06 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.065 0.459 . . . . 0.0 110.184 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 10' ' ' ARG . 4.1 m -63.27 -27.11 69.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.528 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.547 ' OD2' ' HG2' ' A' ' 10' ' ' ARG . 13.4 m-20 -81.13 15.65 1.82 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.065 0.459 . . . . 0.0 110.706 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.663 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -150.35 147.97 23.08 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.663 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 33.4 Cg_endo -62.73 156.18 54.8 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.448 2.099 . . . . 0.0 112.254 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.94 -8.47 5.91 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.582 -0.735 . . . . 0.0 114.223 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.21 -18.67 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.053 0.454 . . . . 0.0 110.545 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.2 m -143.84 179.83 6.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.119 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -131.35 167.53 25.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.563 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.0 t -87.82 123.47 32.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.987 0.422 . . . . 0.0 110.856 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -81.9 170.49 15.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.981 0.419 . . . . 0.0 110.86 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 -29.33 73.42 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.565 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -76.1 -4.6 42.38 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 37.05 11.16 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.925 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -142.88 153.73 43.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m -63.92 142.7 58.31 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.726 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -150.64 139.83 7.53 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 121.027 0.442 . . . . 0.0 111.375 -178.952 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -132.4 143.83 50.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.397 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.738 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -105.05 15.01 28.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.285 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.614 ' HG2' ' HB2' ' A' ' 13' ' ' ASP . 29.0 ptt85 -170.86 169.07 6.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.552 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -66.76 -56.5 10.21 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.249 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m -78.73 22.91 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.834 0.349 . . . . 0.0 111.808 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.738 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 7.9 t0 -79.79 -36.35 37.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.604 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -93.61 144.84 28.86 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.891 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.1 Cg_endo -61.27 161.51 23.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.886 2.391 . . . . 0.0 112.109 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.29 -19.21 2.68 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 114.849 0.7 . . . . 0.0 114.849 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.72 -20.3 66.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.063 0.432 . . . . 0.0 111.408 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.0 m -151.25 -179.25 7.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.049 0.452 . . . . 0.0 110.118 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.02 148.52 22.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -69.7 120.63 15.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -81.01 -175.07 5.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.15 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.96 -24.89 76.2 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.257 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 25' ' ' TYR . 16.2 p-10 -83.97 17.74 2.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.42 28.91 73.76 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.389 -0.434 . . . . 0.0 113.792 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.436 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 13.4 m-85 -136.81 157.35 46.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.415 0.626 . . . . 0.0 110.385 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.6 m -64.8 134.89 55.08 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.275 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.46 132.75 6.9 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.32 -0.684 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -179.535 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.586 0.231 . . . . 0.0 110.501 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 2.1 p -146.09 145.31 30.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.363 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.694 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -105.69 4.12 29.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -168.32 159.4 10.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.618 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.556 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 21.0 t0 -58.89 -40.53 84.72 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.914 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -59.26 -17.87 32.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.694 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 62.5 m-20 -67.78 -22.32 65.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.829 0.347 . . . . 0.0 111.045 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -113.01 143.73 29.71 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.241 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 73.8 Cg_exo -52.94 148.71 28.66 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.239 2.626 . . . . 0.0 112.853 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.31 -22.06 6.78 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 114.937 -1.029 . . . . 0.0 114.614 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.48 94.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.068 0.434 . . . . 0.0 110.752 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 29.1 m -112.14 -179.89 3.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.037 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.4 147.33 28.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.68 0.276 . . . . 0.0 110.705 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.556 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 49.6 t -76.04 123.9 26.51 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.101 0.477 . . . . 0.0 110.268 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.97 173.26 12.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.327 0.585 . . . . 0.0 111.512 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.07 -25.59 73.36 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.951 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -81.15 7.94 9.93 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 35.65 58.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.653 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 46.7 m-85 -139.31 158.31 44.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.037 0.446 . . . . 0.0 110.131 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 86.4 m -67.23 137.24 56.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.403 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -126.97 137.37 9.89 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.797 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.327 -0.39 0 O-C-N 124.081 0.518 . . . . 0.0 111.309 -179.554 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.044 0.449 . . . . 0.0 111.046 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -112.86 159.99 18.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.629 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.526 ' HD2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -117.02 17.33 14.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.253 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.667 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 2.3 ptm180 -177.53 153.49 0.9 Allowed 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.302 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.515 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -57.49 -50.74 72.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.718 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -78.39 24.07 0.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.972 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.667 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 1.1 t0 -81.56 -32.28 32.25 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -89.6 149.09 41.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.032 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.664 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 20.4 Cg_endo -59.05 155.28 40.08 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.487 2.125 . . . . 0.0 112.324 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.92 -26.53 2.91 Favored Glycine 0 N--CA 1.466 0.647 0 O-C-N 123.97 0.794 . . . . 0.0 115.076 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.86 -20.39 65.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.972 0.386 . . . . 0.0 111.535 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.9 m -143.93 -178.81 6.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.775 0.321 . . . . 0.0 110.293 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.403 ' N ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -142.11 156.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 8.1 t -80.82 128.39 33.61 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.061 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.45 175.11 10.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.947 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.56 -28.02 69.02 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.54 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -76.43 -4.55 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.86 33.01 22.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.13 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -137.41 154.54 49.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 50.8 m -61.38 142.03 57.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.531 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.63 128.18 3.15 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 111.168 -179.289 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 29.1 m . . . . . 0 C--O 1.238 0.493 0 CA-C-O 120.665 0.269 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 1' ' ' CYS . 31.9 Cg_exo -58.93 138.4 85.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.199 2.6 . . . . 0.0 112.131 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -97.45 -37.87 9.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.631 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 tp -98.24 129.64 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.266 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 26' ' ' CYS . 2.6 pt? -163.68 144.88 9.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.02 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 25' ' ' TYR . 17.0 pttp -150.08 166.87 28.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -59.47 135.14 57.57 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.575 0.547 . . . . 0.0 111.61 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 26.7 p -149.88 144.69 26.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.688 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.22 14.09 12.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 0.0 109.741 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.425 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 16.9 ptp180 177.14 177.64 0.3 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.811 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.03 -46.76 86.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.884 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -53.91 -25.44 20.21 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 22.8 m-20 -69.09 -10.02 55.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.54 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t -140.17 141.47 26.65 Favored Pre-proline 0 C--N 1.32 -0.684 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.651 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 33.6 Cg_endo -63.35 162.87 25.45 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.947 2.431 . . . . 0.0 112.273 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.27 8.57 0.44 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.67 -22.35 46.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.523 0.678 . . . . 0.0 109.553 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 28' ' ' SER . 68.1 m -152.17 -176.94 5.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.737 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.494 HG12 ' HE ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -133.97 144.61 35.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.758 0.313 . . . . 0.0 110.73 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.5 t -69.76 116.71 10.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.333 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HE ' HG12 ' A' ' 19' ' ' ILE . 24.5 mmt85 -83.02 176.37 9.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.445 . . . . 0.0 111.386 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.89 -22.48 70.34 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.65 -0.704 . . . . 0.0 114.026 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 17.4 p-10 -77.94 2.21 18.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.888 0.344 . . . . 0.0 111.901 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.28 28.53 55.65 Favored Glycine 0 C--O 1.237 0.306 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.446 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 6' ' ' LYS . 26.8 m-85 -138.44 159.03 43.1 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.023 0.439 . . . . 0.0 109.994 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 5' ' ' LEU . 77.0 m -69.95 135.76 49.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -127.47 126.75 5.64 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.468 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 20.0 m -65.78 147.0 54.08 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 122.188 0.195 . . . . 0.0 110.805 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.56 -36.23 88.66 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.845 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.5 m -93.09 37.16 1.03 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -69.59 -32.12 70.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.928 0.394 . . . . 0.0 109.997 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.29 50.08 2.35 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.833 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.18 -45.25 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.482 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 72.3 m . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.65 68.13 1.15 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.91 2.407 . . . . 0.0 112.097 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -138.94 -44.61 0.47 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.915 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -150.56 134.97 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.24 0.543 . . . . 0.0 110.403 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.436 HD13 HG11 ' A' ' 34' ' ' VAL . 66.8 tp -157.69 122.3 4.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.728 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -150.85 152.84 34.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.724 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 143.14 49.37 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.483 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 3.6 p -151.37 153.19 34.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.821 0.343 . . . . 0.0 111.731 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.686 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -118.77 11.96 12.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 36.7 ptt180 -168.47 178.46 4.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.567 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -74.9 -42.29 58.08 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.561 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -55.56 -24.15 30.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.686 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 55.2 m-20 -70.64 -14.75 62.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.401 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 5.0 t -123.75 142.23 38.74 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.755 0.312 . . . . 0.0 110.303 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.606 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 26.7 Cg_endo -61.74 164.42 16.18 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.904 2.403 . . . . 0.0 111.943 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.25 21.98 0.29 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 114.184 0.434 . . . . 0.0 114.184 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.63 -26.98 24.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.25 0.548 . . . . 0.0 110.018 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 64.4 m -152.19 -177.23 6.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.51 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -124.11 146.34 29.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.645 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.0 t -72.57 120.37 18.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.265 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -81.9 173.94 11.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.175 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.81 -24.16 66.24 Favored Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 113.155 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -73.86 -10.11 59.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.557 0.218 . . . . 0.0 111.517 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.53 35.22 10.68 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.749 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -145.55 156.53 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.012 0.434 . . . . 0.0 109.942 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -65.19 136.03 56.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.301 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.577 ' HA2' HG22 ' A' ' 34' ' ' VAL . . . -137.7 127.52 3.95 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 7.2 m -67.29 126.07 28.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 111.856 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.44 -51.69 25.27 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.122 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.1 m -80.23 51.39 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.031 0.443 . . . . 0.0 110.315 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 4.0 t70 -161.42 -49.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.549 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.39 -45.0 1.37 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.97 -118.17 4.14 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.577 HG22 ' HA2' ' A' ' 27' ' ' GLY . 43.4 t . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.654 ' HB2' HG12 ' A' ' 4' ' ' ILE . 68.8 Cg_endo -73.76 133.81 19.12 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.709 2.273 . . . . 0.0 112.203 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -78.24 56.3 1.67 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.119 0.485 . . . . 0.0 110.422 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 2' ' ' PRO . 48.3 mm -88.97 113.91 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.998 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.2 tp -80.86 63.51 5.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.32 0.581 . . . . 0.0 110.992 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HB2' HG22 ' A' ' 4' ' ' ILE . 2.8 mtpm? -139.85 119.42 13.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.288 0.566 . . . . 0.0 112.444 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.889 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -86.97 149.33 24.85 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 175.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 5.2 p -142.77 142.35 31.89 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.365 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.611 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -108.62 14.68 24.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.125 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -179.08 174.57 1.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.646 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.13 -53.65 50.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.592 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.91 -13.64 17.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.988 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.611 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 9.1 t0 -64.14 -25.83 68.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.631 0.729 . . . . 0.0 109.935 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 t -122.47 144.38 42.0 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.836 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 29.5 Cg_endo -61.75 160.3 29.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.796 2.331 . . . . 0.0 112.45 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.41 -9.02 4.14 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.466 -0.788 . . . . 0.0 114.308 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.74 -21.54 66.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.063 0.459 . . . . 0.0 110.511 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.1 m -150.63 -176.04 5.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.942 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.7 pt -130.69 152.0 36.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.113 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.0 t -80.49 125.74 30.33 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.18 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -76.67 169.31 18.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.894 0.378 . . . . 0.0 110.359 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.17 -23.06 71.28 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.053 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -80.48 -1.92 43.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.33 40.88 9.65 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.248 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -145.79 150.53 36.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.082 0.441 . . . . 0.0 110.181 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 76.5 m -66.69 134.59 52.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.081 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.68 137.65 6.88 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 28.3 m -71.77 165.49 23.95 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.855 0.327 . . . . 0.0 111.114 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.52 -43.35 85.57 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.275 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -93.62 41.71 1.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.904 0.383 . . . . 0.0 110.005 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 28' ' ' SER . 37.9 t70 -58.85 -39.74 82.2 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.204 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.21 -36.43 88.72 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.185 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.49 -47.56 6.77 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.643 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--N 1.329 -0.312 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.358 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 56.1 m . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.578 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 42.3 Cg_endo -68.31 79.79 0.58 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.067 2.511 . . . . 0.0 112.482 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -60.63 -31.52 70.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.672 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' A' ' 26' ' ' CYS . 1.4 pp -89.88 138.13 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.703 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.4 tp -143.65 54.25 1.32 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.589 0.709 . . . . 0.0 110.274 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 35.5 mmtp -89.49 137.68 32.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.561 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 144.85 56.71 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 p -150.87 143.75 24.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.348 0.595 . . . . 0.0 112.065 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.561 ' HG2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -110.77 -0.7 16.92 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.561 ' HG2' ' HG2' ' A' ' 9' ' ' ARG . 13.5 ptm180 -167.4 154.35 8.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.053 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -55.69 -33.9 64.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.453 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 m -55.61 -26.6 44.84 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.491 ' CG ' ' HE ' ' A' ' 9' ' ' ARG . 50.7 m-20 -69.05 -14.36 62.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.33 . . . . 0.0 111.406 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.731 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -125.11 150.54 67.13 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.731 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 23.9 Cg_endo -59.58 157.88 30.17 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.735 2.29 . . . . 0.0 112.984 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.82 -24.21 48.14 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.13 -0.941 . . . . 0.0 114.109 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.44 18.3 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.138 0.469 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.9 m -154.18 174.6 14.54 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.65 154.99 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.0 t -82.35 128.41 34.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.983 0.42 . . . . 0.0 110.331 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -80.13 170.04 16.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.065 0.46 . . . . 0.0 110.687 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.56 -25.83 73.8 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.658 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -81.32 -0.39 40.85 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.73 38.81 13.05 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.397 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -140.69 157.92 44.73 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.671 ' HB3' HD13 ' A' ' 4' ' ' ILE . 59.4 m -65.34 140.38 58.67 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.621 0.724 . . . . 0.0 112.647 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.38 136.04 9.08 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.578 ' HB2' ' HA ' ' A' ' 2' ' ' PRO . 28.6 t -57.86 133.84 55.79 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.804 0.302 . . . . 0.0 111.161 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.3 -35.79 91.48 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.409 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 15.7 m -85.14 58.3 4.95 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -69.15 56.1 0.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.831 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.89 37.59 0.34 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.645 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.25 -48.94 0.58 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.15 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 30' ' ' SER . 60.3 t . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.217 0.532 . . . . 0.0 110.372 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.04 125.16 15.49 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.875 2.383 . . . . 0.0 112.76 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -78.28 57.42 1.88 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.887 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.7 tt -150.23 147.58 15.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.658 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.636 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.0 pt? -60.46 130.16 45.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.086 0.469 . . . . 0.0 109.984 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 15.6 pttp -139.52 130.63 26.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.712 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.556 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -146.66 151.23 36.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.857 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.55 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 5.8 p -152.7 146.77 25.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.047 0.451 . . . . 0.0 111.984 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.474 ' HE ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -110.27 11.75 23.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 8' ' ' CYS . 12.8 ptp180 -179.79 160.92 0.95 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.486 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 8.0 t0 -60.09 -26.81 66.49 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.307 0.575 . . . . 0.0 111.246 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -58.96 -26.97 64.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.701 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 8' ' ' CYS . 20.9 m-20 -84.97 15.65 3.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.48 0.181 . . . . 0.0 110.9 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -126.46 141.95 41.56 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-O 121.004 0.43 . . . . 0.0 111.196 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 60.4 Cg_endo -70.86 156.08 61.14 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.929 2.419 . . . . 0.0 111.824 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.02 -29.41 43.53 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.207 -0.451 . . . . 0.0 113.996 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 30' ' ' SER . . . -78.43 8.32 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 111.91 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.4 m -152.29 179.74 8.27 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.61 HD12 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -143.54 149.17 18.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 41.0 t -78.88 120.34 23.36 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.087 0.47 . . . . 0.0 110.219 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 mmm-85 -81.53 169.54 16.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.719 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.43 -26.57 68.24 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.803 -0.635 . . . . 0.0 113.767 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -81.83 7.39 12.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.928 0.364 . . . . 0.0 111.83 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.08 31.34 55.58 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.299 -0.477 . . . . 0.0 114.276 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -134.18 154.17 51.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 109.979 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 10.7 m -79.26 135.79 36.86 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.555 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.454 ' O ' HD13 ' A' ' 19' ' ' ILE . . . -123.27 139.19 12.07 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 46.7 m -70.69 63.29 0.28 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.61 ' HA3' HD12 ' A' ' 19' ' ' ILE . . . -67.85 -49.24 50.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.705 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.521 ' HB2' ' HA ' ' A' ' 17' ' ' ALA . 3.1 m -85.83 46.79 1.35 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.973 0.416 . . . . 0.0 109.898 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 2.6 t70 -160.46 -62.64 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.119 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.66 33.87 88.38 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.666 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.64 -120.58 1.84 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.189 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 121.05 0.452 . . . . 0.0 110.882 -179.82 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 21.8 p . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.13 131.78 31.76 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.826 2.351 . . . . 0.0 111.496 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 12.3 mptt -81.44 -43.3 19.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.361 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.2 mm -88.93 66.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.409 0.623 . . . . 0.0 110.129 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.6 tp -65.71 133.39 50.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.933 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -150.94 140.13 21.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.182 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.837 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.52 147.77 26.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.546 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 2.5 p -146.92 143.43 28.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.174 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.678 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -105.58 13.82 29.4 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.799 0.809 . . . . 0.0 109.464 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -171.79 158.59 4.96 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.775 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.577 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 35.8 t70 -65.2 -39.91 93.48 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.643 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -57.71 -17.84 17.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.678 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 79.7 m-20 -70.4 -20.96 62.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.996 0.427 . . . . 0.0 110.537 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -106.63 141.58 23.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.319 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 50.5 Cg_endo -67.85 158.59 56.6 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.618 2.212 . . . . 0.0 111.408 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.89 -16.47 2.92 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.605 0.602 . . . . 0.0 114.605 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.76 -24.17 66.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.909 0.354 . . . . 0.0 111.39 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.9 m -143.99 -177.17 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.7 pt -132.76 150.9 33.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.505 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.577 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 38.8 t -82.45 122.87 28.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -80.26 164.78 22.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.023 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.77 -23.93 63.84 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.305 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -76.96 -3.17 37.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.84 36.29 13.91 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.459 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -145.71 153.09 40.6 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -68.09 145.81 54.06 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.298 0.57 . . . . 0.0 111.269 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.9 143.12 11.52 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.193 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.7 m -60.87 139.12 58.07 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.875 0.397 . . . . 0.0 111.345 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.48 -110.53 1.1 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.0 m -88.16 28.41 1.07 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.281 0.562 . . . . 0.0 109.928 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.04 -37.46 84.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.283 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.09 38.23 16.05 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.973 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.37 135.41 4.61 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.016 -0.612 . . . . 0.0 111.691 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 C--N 1.323 -0.577 0 CA-C-O 120.966 0.412 . . . . 0.0 111.191 -179.593 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 55.5 m . . . . . 0 C--O 1.234 0.258 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.444 ' HG3' ' H ' ' A' ' 28' ' ' SER . 32.5 Cg_exo -57.43 118.14 4.96 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.471 2.114 . . . . 0.0 111.987 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -75.22 -30.1 60.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.673 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 tp -112.28 130.03 66.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.922 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.1 tp -131.87 119.08 20.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.975 0.417 . . . . 0.0 110.225 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 6' ' ' LYS . 41.1 mtmt -149.75 145.76 26.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.422 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.57 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -71.39 136.78 47.91 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.3 p -142.98 150.57 39.83 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.081 0.467 . . . . 0.0 111.735 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.663 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -113.68 8.03 17.42 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.181 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -169.51 164.88 10.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.024 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -66.84 -36.28 81.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -54.96 -24.55 24.47 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.663 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 52.8 m-20 -71.8 -13.08 61.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.758 0.313 . . . . 0.0 111.098 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 t -127.54 148.46 66.7 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.668 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 31.6 Cg_endo -62.12 159.03 36.36 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.301 2.001 . . . . 0.0 111.84 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.1 17.64 0.27 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 114.503 0.561 . . . . 0.0 114.503 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.432 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.23 -21.14 27.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.27 0.557 . . . . 0.0 109.942 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 56.8 m -149.93 -179.37 7.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.457 ' H ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -129.18 157.75 41.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.473 179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.0 t -77.41 117.35 18.81 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.668 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 17.4 mtp85 -80.77 169.59 17.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.57 -24.98 49.29 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.615 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -74.79 -8.46 56.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.704 0.252 . . . . 0.0 111.456 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.83 35.64 15.54 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.693 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -144.95 158.59 43.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.941 0.4 . . . . 0.0 109.997 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.7 m -65.0 138.01 58.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.754 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.668 ' HA3' ' HD2' ' A' ' 21' ' ' ARG . . . -147.51 150.92 23.22 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.157 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.444 ' H ' ' HG3' ' A' ' 2' ' ' PRO . 3.3 m -48.26 139.98 8.0 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.505 0.722 . . . . 0.0 112.052 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.82 -111.74 1.19 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.661 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -86.45 28.74 0.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.155 0.502 . . . . 0.0 110.587 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.623 ' HB3' HG22 ' A' ' 34' ' ' VAL . 32.0 m-20 -75.84 -54.28 7.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.291 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.53 39.43 93.13 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.55 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.62 -55.27 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.846 -1.169 . . . . 0.0 113.321 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.623 HG22 ' HB3' ' A' ' 31' ' ' ASP . 31.3 m . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.72 0.771 . . . . 0.0 111.132 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 65.5 m . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 120.74 0.305 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -62.7 135.98 55.46 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.676 2.251 . . . . 0.0 111.838 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -83.94 45.96 1.14 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.962 0.41 . . . . 0.0 111.068 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.3 tp -151.22 136.01 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.845 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.58 41.86 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.452 0.644 . . . . 0.0 111.627 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -89.5 119.5 29.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.482 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.539 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -73.35 143.45 46.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.841 0.353 . . . . 0.0 110.876 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 p -146.06 147.86 32.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.6 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.511 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -113.16 19.9 16.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.261 0.553 . . . . 0.0 109.767 178.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -178.6 179.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.325 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -71.77 -50.45 29.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.166 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -54.87 -26.17 33.68 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.511 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 73.5 m-20 -63.48 -19.34 64.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.305 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.597 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.9 t -115.43 141.28 27.01 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.976 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.597 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 47.9 Cg_endo -67.67 159.96 50.28 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.995 2.463 . . . . 0.0 112.005 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.85 -16.31 7.56 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.958 -0.565 . . . . 0.0 114.356 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.86 -16.5 64.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.31 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 64.3 m -151.57 -175.58 5.25 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -137.2 152.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.6 t -77.26 120.65 22.6 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.481 ' HD2' ' HA3' ' A' ' 27' ' ' GLY . 58.7 mtp180 -80.6 169.85 17.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.758 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.76 -24.69 66.72 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.61 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.41 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 13.8 p-10 -82.09 13.64 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.04 0.42 . . . . 0.0 111.834 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.65 31.42 70.6 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 121.415 -0.421 . . . . 0.0 113.779 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -140.78 155.26 46.44 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 121.423 0.63 . . . . 0.0 110.332 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -68.18 142.08 55.81 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.197 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.481 ' HA3' ' HD2' ' A' ' 21' ' ' ARG . . . -151.6 131.16 3.36 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.5 t -72.79 -178.28 2.66 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 117.208 0.504 . . . . 0.0 110.014 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -50.71 -40.03 40.03 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.059 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 m -94.48 56.46 2.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HB2' ' NE ' ' A' ' 21' ' ' ARG . 1.5 p-10 -58.58 -37.15 75.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.332 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.37 20.03 2.81 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.997 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.77 145.53 30.14 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 120.74 0.305 . . . . 0.0 110.574 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 42.2 t . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.934 0.397 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 1' ' ' CYS . 17.1 Cg_exo -67.33 134.39 33.37 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.997 2.465 . . . . 0.0 111.891 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -68.04 -27.98 66.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.519 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.5 tp -150.12 134.26 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.988 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -89.97 151.39 21.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.158 0.504 . . . . 0.0 111.02 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.04 127.01 35.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.053 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.814 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -76.94 137.1 38.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.148 179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' ASP . 1.1 p -133.52 147.19 51.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.972 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.677 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -104.05 1.07 30.54 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -167.0 159.95 13.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.04 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 23.1 t0 -60.67 -37.78 82.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.293 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -57.22 -21.22 32.24 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.677 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 64.3 m-20 -67.82 -19.16 65.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 111.12 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.451 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 t -113.66 145.77 34.09 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.573 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.451 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 74.0 Cg_exo -53.83 149.89 31.8 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.367 2.711 . . . . 0.0 112.75 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.03 -22.67 13.41 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.022 -0.99 . . . . 0.0 114.871 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.79 81.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.242 0.521 . . . . 0.0 110.856 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.8 m -104.39 179.64 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.625 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.66 147.63 23.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.815 0.34 . . . . 0.0 110.616 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 43.3 t -77.62 120.55 22.73 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -80.22 170.29 16.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.16 0.505 . . . . 0.0 111.649 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.44 -26.2 61.64 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.704 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -74.08 -7.18 51.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.72 0.26 . . . . 0.0 111.344 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.49 35.24 14.45 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.554 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -141.94 154.44 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.165 0.507 . . . . 0.0 110.337 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.6 m -63.22 137.73 58.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.674 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.64 126.78 3.54 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 m -63.64 138.37 58.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.682 0.277 . . . . 0.0 111.041 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.76 -55.89 2.2 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.6 p -147.68 21.93 1.15 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -125.4 43.9 2.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.151 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.41 -56.57 23.7 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.854 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.39 -122.92 30.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.169 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.445 -0.707 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.539 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 30' ' ' SER . 73.7 m . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.724 0.297 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.64 132.13 26.21 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.779 2.319 . . . . 0.0 112.561 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -89.4 66.88 7.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.38 0.61 . . . . 0.0 110.224 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.3 tp -87.11 126.28 40.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.99 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.418 HD11 ' HB3' ' A' ' 25' ' ' TYR . 43.8 tp -90.36 130.23 36.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.713 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 36.2 mtmt -148.37 168.72 21.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.978 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -83.96 140.28 32.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 25.9 p -154.21 150.14 27.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.571 0.7 . . . . 0.0 112.124 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.563 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -132.01 18.41 4.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.164 178.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.92 173.78 1.83 Allowed 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.22 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.86 -54.34 43.45 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m -58.9 -20.43 51.42 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.563 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 64.5 m-20 -61.52 -23.55 66.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.162 0.506 . . . . 0.0 111.326 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 t -124.81 142.27 40.43 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 35.8 Cg_endo -64.92 163.89 26.67 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.776 2.317 . . . . 0.0 112.366 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.21 -17.67 11.55 Favored Glycine 0 CA--C 1.521 0.411 0 O-C-N 123.583 0.552 . . . . 0.0 113.713 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' A' ' 1' ' ' CYS . . . -69.52 -10.2 57.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 110.946 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.7 m -149.99 -178.45 6.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.657 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.9 pt -140.88 148.27 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.748 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.5 t -75.22 122.1 23.14 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.357 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -81.44 171.25 14.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.774 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.09 -25.73 75.2 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.795 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -84.94 14.12 5.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.0 32.03 63.78 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 114.726 0.651 . . . . 0.0 114.726 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.418 ' HB3' HD11 ' A' ' 5' ' ' LEU . 16.0 m-85 -135.98 158.53 44.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.949 0.404 . . . . 0.0 110.273 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 6' ' ' LYS . 61.6 m -71.75 136.62 47.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.07 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.81 136.06 11.5 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -50.6 129.44 22.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.087 0.47 . . . . 0.0 111.999 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.24 63.25 0.55 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 1' ' ' CYS . 12.5 m -73.47 48.78 0.26 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.858 0.463 . . . . 0.0 111.774 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -67.87 -50.88 53.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.552 0.691 . . . . 0.0 109.553 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.27 46.77 3.06 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.662 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.31 -125.44 8.76 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.352 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 121.593 0.711 . . . . 0.0 110.523 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.36 111.45 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.453 2.102 . . . . 0.0 111.833 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -83.57 40.07 0.71 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.35 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.9 tp -151.94 133.6 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.084 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mp -62.79 135.93 57.6 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.081 0.467 . . . . 0.0 111.295 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -146.16 123.87 11.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.163 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -101.04 144.62 29.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.993 179.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.5 p -120.96 148.41 44.13 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.115 0.483 . . . . 0.0 111.067 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -101.3 -17.12 16.7 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.657 ' HG2' ' OD1' ' A' ' 13' ' ' ASP . 4.0 ptp85 -165.6 177.18 7.53 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.14 -1.845 . . . . 0.0 107.045 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 6.2 t0 -61.2 -37.64 83.7 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.074 0.464 . . . . 0.0 111.109 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -59.49 -29.03 67.55 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.657 ' OD1' ' HG2' ' A' ' 10' ' ' ARG . 1.0 OUTLIER -69.15 -13.32 62.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 111.02 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.657 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 4.2 t -103.34 143.14 26.02 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.408 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.657 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 37.9 Cg_endo -63.91 154.0 72.5 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.793 2.328 . . . . 0.0 111.961 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.62 -30.3 34.51 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.585 -0.734 . . . . 0.0 114.527 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.11 2.3 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.312 0.556 . . . . 0.0 112.193 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 62.3 m -148.79 -176.77 5.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.12 156.72 24.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.903 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.524 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 44.2 t -77.01 121.08 23.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.476 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -81.11 169.73 17.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.128 0.49 . . . . 0.0 110.907 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.33 -27.58 72.61 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.529 -0.759 . . . . 0.0 113.353 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -84.18 19.31 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.888 0.344 . . . . 0.0 111.875 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.41 32.08 82.39 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 114.111 0.404 . . . . 0.0 114.111 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 15.3 m-85 -135.98 158.88 43.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.211 0.529 . . . . 0.0 110.352 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.463 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 m -70.06 142.03 52.74 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.213 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -138.86 132.81 5.9 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 m -64.69 139.55 58.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.843 0.354 . . . . 0.0 110.957 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.32 -51.49 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.546 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -81.8 46.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.996 0.427 . . . . 0.0 110.484 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -172.68 -105.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.375 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.56 -25.23 11.27 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.68 -46.66 60.46 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.619 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.627 0.727 . . . . 0.0 111.634 -179.801 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 45.1 m . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 1' ' ' CYS . 10.4 Cg_exo -71.54 119.2 6.08 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.618 2.212 . . . . 0.0 111.992 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.92 43.32 0.59 Allowed 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.289 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.605 HG23 ' HG3' ' A' ' 6' ' ' LYS . 7.4 tp -152.32 144.12 15.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.91 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.417 ' HG ' ' HD2' ' A' ' 7' ' ' LYS . 17.2 tp -69.81 74.16 0.43 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.041 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.605 ' HG3' HG23 ' A' ' 4' ' ' ILE . 44.5 mttm -88.65 62.18 6.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.695 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -74.04 130.82 40.58 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 13' ' ' ASP . 11.6 p -119.24 177.92 4.71 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.161 0.505 . . . . 0.0 111.489 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.674 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -131.13 9.66 4.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.132 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -175.04 172.71 2.78 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.676 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.51 -43.52 69.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.722 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -59.76 -13.97 12.54 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.674 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 69.3 m-20 -68.01 -21.04 65.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.008 0.432 . . . . 0.0 110.992 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -111.47 141.57 24.79 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.006 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 24.6 Cg_endo -61.82 165.66 13.59 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.893 2.396 . . . . 0.0 112.177 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.37 21.31 0.23 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 114.48 0.552 . . . . 0.0 114.48 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 15' ' ' PRO . . . -86.57 -28.77 23.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.233 0.539 . . . . 0.0 109.749 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 82.8 m -156.19 -175.24 5.33 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.42 ' H ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -129.17 148.83 33.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.46 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 t -76.21 123.01 25.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.606 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 46.4 mtp85 -80.31 172.98 13.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.229 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.25 -23.72 48.76 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.08 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.606 ' OD1' ' HB2' ' A' ' 21' ' ' ARG . 15.7 p-10 -76.59 -1.08 25.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.028 0.414 . . . . 0.0 111.449 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 79.67 33.24 34.81 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.331 -0.461 . . . . 0.0 113.733 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -144.11 155.18 43.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 110.164 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.484 ' SG ' ' HD3' ' A' ' 6' ' ' LYS . 72.1 m -63.87 138.05 58.31 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.352 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -153.83 143.42 10.11 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.962 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.6 p -69.64 147.02 51.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.87 -58.27 5.85 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -155.82 23.76 0.39 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.49 51.99 1.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.99 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.96 -51.84 3.21 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.381 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 134.56 43.84 0.12 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.029 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 121.764 0.792 . . . . 0.0 110.696 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 44.7 t . . . . . 0 C--O 1.236 0.352 0 CA-C-O 120.908 0.385 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.871 ' HB2' HD12 ' A' ' 5' ' ' LEU . 15.9 Cg_exo -67.02 132.33 27.81 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.463 2.108 . . . . 0.0 111.095 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -79.19 -35.66 41.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.88 0.371 . . . . 0.0 110.944 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.493 ' O ' HD12 ' A' ' 4' ' ' ILE . 1.6 pp -139.7 136.07 39.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.841 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.871 HD12 ' HB2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -163.02 165.18 25.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.336 0.589 . . . . 0.0 111.34 -178.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.06 136.19 36.84 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.247 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.749 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.2 OUTLIER -73.48 137.83 44.74 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 176.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.583 ' HA ' ' OD2' ' A' ' 13' ' ' ASP . 4.7 p -119.06 145.09 46.19 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.3 0.572 . . . . 0.0 112.423 -177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.12 -1.57 28.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.057 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.717 ' NH1' ' HB3' ' A' ' 12' ' ' SER . 26.1 ptt85 -171.75 179.64 2.73 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.806 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -62.84 -56.96 12.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.494 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.717 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 28.8 t -69.79 3.0 2.82 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 8' ' ' CYS . 7.7 t70 -73.24 -12.22 60.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.442 0.639 . . . . 0.0 109.808 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -126.57 145.54 53.54 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.231 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 30.9 Cg_endo -61.92 158.53 37.94 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.753 2.302 . . . . 0.0 112.443 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.0 -24.29 8.32 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.591 -0.731 . . . . 0.0 114.562 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.57 -23.35 67.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 110.913 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.443 ' HA ' ' N ' ' A' ' 29' ' ' GLY . 57.7 m -134.5 -178.96 5.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.471 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 pt -143.19 150.82 17.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.873 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.2 t -73.73 120.32 19.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.044 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' HD3' ' HA3' ' A' ' 27' ' ' GLY . 21.8 mmm180 -81.62 168.73 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.724 0.297 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.64 -25.13 62.96 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 116.044 -0.525 . . . . 0.0 113.375 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -77.88 -7.24 56.43 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.92 31.7 19.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.666 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.523 ' HB3' HD23 ' A' ' 5' ' ' LEU . 84.2 m-85 -138.3 156.45 47.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 0.0 110.03 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 83.4 m -66.07 135.76 55.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.178 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.612 ' HA3' ' HD3' ' A' ' 21' ' ' ARG . . . -134.36 138.84 10.36 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.887 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 1.2 m -45.78 126.16 6.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.067 0.433 . . . . 0.0 111.846 -178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -71.02 -53.98 9.98 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.178 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.7 m -84.99 45.37 1.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.123 0.487 . . . . 0.0 110.071 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.887 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 21.7 t70 -164.96 -120.25 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' H ' ' CG ' ' A' ' 31' ' ' ASP . . . -178.79 21.75 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.601 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.92 52.78 10.69 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.316 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.345 0.593 . . . . 0.0 112.422 -179.623 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 57.0 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.55 132.77 50.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.679 2.253 . . . . 0.0 112.093 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HG3' HG22 ' A' ' 4' ' ' ILE . 53.3 pttt -157.89 -49.07 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.659 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.431 HG22 ' HG3' ' A' ' 3' ' ' LYS . 9.4 tp -151.15 52.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 122.678 1.227 . . . . 0.0 109.549 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.785 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.9 pt? -72.73 128.82 36.68 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.35 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.705 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 12.5 mmmm -118.56 128.8 54.91 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.616 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -67.97 139.17 56.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.757 0.313 . . . . 0.0 110.941 -179.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.631 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 3.9 p -149.3 144.22 26.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.894 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.498 ' HD2' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -105.63 11.35 32.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.674 -179.07 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 13' ' ' ASP . 20.0 ptt-85 -171.75 172.46 4.89 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.965 0.412 . . . . 0.0 110.653 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -60.57 -55.32 34.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.769 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.8 m -80.23 21.6 0.59 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.895 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.631 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 6.7 t0 -86.63 -29.56 22.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.636 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.8 t -108.78 146.33 33.54 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.557 -1.202 . . . . 0.0 109.408 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.636 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.0 Cg_endo -60.47 159.79 26.24 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.738 2.292 . . . . 0.0 112.434 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.36 -8.25 3.47 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 115.684 -0.689 . . . . 0.0 114.552 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.0 -20.81 65.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.166 0.508 . . . . 0.0 110.704 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 55.8 m -152.11 178.12 9.79 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.46 143.69 40.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.532 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.9 t -75.24 121.47 22.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.56 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -82.13 171.17 14.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.68 -24.2 63.97 Favored Glycine 0 C--O 1.227 -0.293 0 CA-C-N 115.817 -0.628 . . . . 0.0 113.062 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -74.41 -11.3 60.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.473 0.178 . . . . 0.0 111.299 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.44 32.86 9.85 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.684 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -142.16 147.21 36.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.443 0.64 . . . . 0.0 110.625 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' A' ' 6' ' ' LYS . 37.6 m -65.62 136.3 56.15 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.97 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -124.44 125.71 5.85 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -75.2 69.96 2.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.701 0.4 . . . . 0.0 111.909 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.34 26.02 63.49 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.085 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.517 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 4.7 m -99.88 61.73 1.13 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.231 0.538 . . . . 0.0 109.679 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.61 59.88 1.19 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.065 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.97 -47.09 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.587 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.44 147.08 8.63 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.517 ' HB ' ' CB ' ' A' ' 30' ' ' SER . 8.1 p . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.169 0.509 . . . . 0.0 111.096 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 86.3 m . . . . . 0 C--O 1.239 0.501 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' O ' ' HE3' ' A' ' 3' ' ' LYS . 78.5 Cg_exo -49.97 137.75 35.84 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.117 2.544 . . . . 0.0 111.749 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -132.74 55.12 1.91 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.902 0.382 . . . . 0.0 111.255 -177.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.7 mm -89.11 121.56 39.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 33.7 tp -76.21 65.85 2.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.302 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -148.18 123.25 10.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.539 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.67 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -84.05 150.1 25.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.536 179.211 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.473 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 18.6 p -148.91 143.18 26.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.027 0.441 . . . . 0.0 111.483 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.553 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -105.39 6.36 32.53 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 172.9 171.79 0.12 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.727 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.06 -30.37 68.0 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.4 0.438 . . . . 0.0 111.677 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -56.92 -26.74 59.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.553 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 1.7 m-20 -78.98 5.13 12.4 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.428 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 t -149.89 147.3 22.12 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.042 -178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 70.5 Cg_exo -55.13 150.41 39.59 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.125 2.55 . . . . 0.0 113.113 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.55 -24.03 16.11 Favored Glycine 0 N--CA 1.462 0.425 0 CA-C-N 114.951 -1.022 . . . . 0.0 114.197 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.89 -21.56 66.52 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.219 0.533 . . . . 0.0 110.963 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.422 ' HA ' ' N ' ' A' ' 29' ' ' GLY . 51.9 m -128.7 -179.6 5.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.297 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.3 pt -142.11 159.51 20.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.607 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.6 t -79.61 120.35 23.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.942 0.401 . . . . 0.0 110.012 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.853 ' HD3' ' HA3' ' A' ' 27' ' ' GLY . 12.2 mmm180 -81.4 166.55 20.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.774 0.321 . . . . 0.0 110.466 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.41 58.96 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.362 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -77.6 -5.33 49.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.79 30.39 32.42 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.673 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -135.84 161.72 34.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.034 0.445 . . . . 0.0 110.125 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 99.3 m -68.62 136.15 52.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.968 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.853 ' HA3' ' HD3' ' A' ' 21' ' ' ARG . . . -140.06 137.64 8.55 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.44 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 17.6 m -45.9 129.33 9.46 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' N ' ' HA ' ' A' ' 18' ' ' CYS . . . -106.19 -56.01 0.67 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.8 m -93.53 45.61 1.17 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 1.9 t70 -171.28 121.51 0.53 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.19 44.08 3.23 Favored Glycine 0 C--N 1.31 -0.882 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.096 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.79 127.93 41.99 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.333 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.679 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.684 0.278 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.439 ' HB2' HG12 ' A' ' 4' ' ' ILE . 35.0 Cg_endo -65.4 158.11 54.42 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.707 2.272 . . . . 0.0 112.247 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -76.06 49.84 0.57 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.377 0.608 . . . . 0.0 110.624 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 2' ' ' PRO . 48.9 mm -112.09 146.35 17.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.45 87.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.136 0.493 . . . . 0.0 109.755 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.871 ' HD2' ' HB2' ' A' ' 26' ' ' CYS . 16.8 pttm -88.58 73.53 8.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.96 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.774 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -92.44 143.95 25.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.311 179.211 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 13' ' ' ASP . 1.8 p -135.56 144.83 46.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.819 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.526 ' HG3' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -104.13 13.19 32.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.471 0.653 . . . . 0.0 110.311 -179.492 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 35.6 ptt180 -170.27 165.56 8.92 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.602 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 26.6 t70 -65.78 -52.22 52.65 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.405 0.441 . . . . 0.0 111.009 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.6 t -74.66 29.22 0.09 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.104 0.478 . . . . 0.0 111.609 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 11' ' ' ASP . 1.4 t70 -96.26 -27.05 15.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.785 0.802 . . . . 0.0 109.244 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.73 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -108.44 151.8 41.73 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.172 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.73 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.6 Cg_endo -60.43 156.55 40.71 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.472 2.115 . . . . 0.0 112.024 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.28 -19.25 5.64 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.446 -0.797 . . . . 0.0 115.054 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.33 69.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 0.0 111.169 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 39.7 m -134.49 179.03 6.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.38 149.13 33.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.191 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.602 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 11.0 t -76.86 113.17 14.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.502 ' NE ' ' HA3' ' A' ' 27' ' ' GLY . 98.7 mtt180 -81.92 173.3 12.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.167 0.508 . . . . 0.0 111.717 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.28 -25.94 55.39 Favored Glycine 0 C--O 1.229 -0.212 0 CA-C-N 115.228 -0.896 . . . . 0.0 114.509 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.442 HD21 ' HB2' ' A' ' 25' ' ' TYR . 16.2 p-10 -78.3 4.04 13.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.168 0.484 . . . . 0.0 111.754 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.18 31.2 59.77 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.281 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.442 ' HB2' HD21 ' A' ' 23' ' ' ASN . 27.5 m-85 -139.68 158.39 44.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.348 0.594 . . . . 0.0 110.327 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.871 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 63.8 m -68.15 133.06 48.29 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.65 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -129.85 132.26 6.97 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -55.96 146.71 21.52 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.94 0.436 . . . . 0.0 111.825 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.93 -52.6 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.421 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 m -97.98 33.7 2.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.443 0.64 . . . . 0.0 109.303 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -148.31 -42.04 0.16 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.072 -178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.86 -47.49 1.03 Allowed Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.15 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.12 49.3 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.287 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.351 0.596 . . . . 0.0 110.684 179.771 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 55.9 m . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.769 0.319 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.631 ' HB2' HG22 ' A' ' 4' ' ' ILE . 17.3 Cg_exo -66.68 158.04 57.97 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.054 2.503 . . . . 0.0 111.936 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 mmmp? -74.12 51.09 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.811 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -145.17 146.43 19.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.553 HD12 ' HE2' ' A' ' 25' ' ' TYR . 31.1 tp -67.95 64.64 0.09 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.602 ' HG3' HG23 ' A' ' 4' ' ' ILE . 53.1 mttm -90.45 56.15 3.25 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.013 0.435 . . . . 0.0 110.039 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.652 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.4 OUTLIER -64.77 135.75 56.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.72 -179.109 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.7 p -143.74 146.29 33.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.963 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.652 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -104.88 -16.99 14.71 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HG2' ' OD2' ' A' ' 13' ' ' ASP . 17.4 ptt180 -156.81 167.3 30.88 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.762 -2.017 . . . . 0.0 107.253 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.46 -24.0 67.06 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.065 0.459 . . . . 0.0 110.184 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 10' ' ' ARG . 4.1 m -63.27 -27.11 69.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.528 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.547 ' OD2' ' HG2' ' A' ' 10' ' ' ARG . 13.4 m-20 -81.13 15.65 1.82 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.065 0.459 . . . . 0.0 110.706 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.663 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -150.35 147.97 23.08 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.663 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 33.4 Cg_endo -62.73 156.18 54.8 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.448 2.099 . . . . 0.0 112.254 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.94 -8.47 5.91 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.582 -0.735 . . . . 0.0 114.223 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.21 -18.67 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.053 0.454 . . . . 0.0 110.545 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.2 m -143.84 179.83 6.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.119 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.4 pp -131.35 167.53 25.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.563 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.0 t -87.82 123.47 32.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.987 0.422 . . . . 0.0 110.856 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -81.9 170.49 15.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.981 0.419 . . . . 0.0 110.86 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 -29.33 73.42 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.565 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -76.1 -4.6 42.38 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 37.05 11.16 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.925 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.553 ' HE2' HD12 ' A' ' 5' ' ' LEU . 77.7 m-85 -142.88 153.73 43.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 6' ' ' LYS . 61.3 m -63.92 142.7 58.31 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.726 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -150.64 139.83 7.53 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 15.9 m -60.24 137.8 58.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.027 0.442 . . . . 0.0 111.375 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.95 -96.81 0.18 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.162 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.3 m -78.68 50.63 1.0 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 110.593 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 1.1 t70 -148.48 -52.08 0.17 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.368 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.91 108.18 0.22 Allowed Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.61 49.08 1.03 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.528 -0.368 . . . . 0.0 113.625 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.4 t . . . . . 0 C--N 1.324 -0.525 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.161 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 C--O 1.233 0.211 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.16 129.8 26.81 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.643 2.228 . . . . 0.0 111.639 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.562 ' HA ' ' HB3' ' A' ' 28' ' ' SER . 53.3 tttm -86.38 63.36 7.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.108 0.48 . . . . 0.0 111.212 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 tt -87.49 138.61 18.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.282 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 31.1 tp -103.59 124.33 48.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.008 0.432 . . . . 0.0 111.629 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 33.2 mmtp -150.94 143.22 24.18 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.703 ' HD2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -82.32 137.83 34.69 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.308 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -132.4 143.83 50.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.397 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.738 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -105.05 15.01 28.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.285 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.614 ' HG2' ' HB2' ' A' ' 13' ' ' ASP . 29.0 ptt85 -170.86 169.07 6.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.552 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -66.76 -56.5 10.21 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.249 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m -78.73 22.91 0.35 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.834 0.349 . . . . 0.0 111.808 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.738 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 7.9 t0 -79.79 -36.35 37.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.604 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -93.61 144.84 28.86 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 114.473 -1.239 . . . . 0.0 109.891 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 28.1 Cg_endo -61.27 161.51 23.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.886 2.391 . . . . 0.0 112.109 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.29 -19.21 2.68 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 114.849 0.7 . . . . 0.0 114.849 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.72 -20.3 66.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.063 0.432 . . . . 0.0 111.408 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.0 m -151.25 -179.25 7.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.049 0.452 . . . . 0.0 110.118 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.02 148.52 22.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -69.7 120.63 15.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -81.01 -175.07 5.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.15 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.96 -24.89 76.2 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.257 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 25' ' ' TYR . 16.2 p-10 -83.97 17.74 2.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.42 28.91 73.76 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.389 -0.434 . . . . 0.0 113.792 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.436 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 13.4 m-85 -136.81 157.35 46.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.415 0.626 . . . . 0.0 110.385 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 6' ' ' LYS . 84.6 m -64.8 134.89 55.08 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.275 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.46 132.75 6.9 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.562 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 11.9 p -61.76 146.07 50.55 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.13 45.99 1.19 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.029 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 m -82.03 16.79 1.78 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.251 0.548 . . . . 0.0 110.72 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -72.36 -27.75 62.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.64 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.97 41.55 0.17 Allowed Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.573 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.82 175.57 45.98 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.313 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 121.147 0.498 . . . . 0.0 110.487 179.604 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 C--O 1.24 0.586 0 CA-C-O 120.614 0.245 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -80.74 147.71 17.38 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.641 2.894 . . . . 0.0 112.481 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 3' ' ' LYS . 37.3 ttmt -178.75 -54.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.38 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.3 pt -147.7 161.65 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.157 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 5' ' ' LEU . 1.1 mm? -71.82 130.7 41.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.221 0.534 . . . . 0.0 110.689 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -103.71 113.97 27.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.288 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.772 ' HD2' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -108.64 153.04 23.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.501 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 2.1 p -146.09 145.31 30.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.363 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.694 ' HD2' ' OD2' ' A' ' 13' ' ' ASP . 0.6 OUTLIER -105.69 4.12 29.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -168.32 159.4 10.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.618 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.556 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 21.0 t0 -58.89 -40.53 84.72 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.914 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -59.26 -17.87 32.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.694 ' OD2' ' HD2' ' A' ' 9' ' ' ARG . 62.5 m-20 -67.78 -22.32 65.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.829 0.347 . . . . 0.0 111.045 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 t -113.01 143.73 29.71 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.241 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 73.8 Cg_exo -52.94 148.71 28.66 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.239 2.626 . . . . 0.0 112.853 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.31 -22.06 6.78 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 114.937 -1.029 . . . . 0.0 114.614 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.621 ' HB1' ' HB3' ' A' ' 31' ' ' ASP . . . -63.17 -39.48 94.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.068 0.434 . . . . 0.0 110.752 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 29.1 m -112.14 -179.89 3.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.037 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.4 147.33 28.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.68 0.276 . . . . 0.0 110.705 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.556 ' CB ' ' HA ' ' A' ' 11' ' ' ASP . 49.6 t -76.04 123.9 26.51 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.101 0.477 . . . . 0.0 110.268 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.97 173.26 12.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.327 0.585 . . . . 0.0 111.512 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.07 -25.59 73.36 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.951 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -81.15 7.94 9.93 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 35.65 58.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.653 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 46.7 m-85 -139.31 158.31 44.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.037 0.446 . . . . 0.0 110.131 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 86.4 m -67.23 137.24 56.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.403 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 18' ' ' CYS . . . -126.97 137.37 9.89 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.797 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m -57.85 139.77 53.38 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 124.081 0.518 . . . . 0.0 111.309 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.79 -109.99 0.48 Allowed Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -78.46 47.49 0.71 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.14 0.495 . . . . 0.0 111.02 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.621 ' HB3' ' HB1' ' A' ' 17' ' ' ALA . 8.0 p-10 -144.45 -50.87 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.256 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.65 33.66 83.15 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.654 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.56 51.5 0.17 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.848 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.946 0.403 . . . . 0.0 110.207 179.8 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 70.0 m . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.91 151.1 86.98 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.562 2.175 . . . . 0.0 112.182 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -57.21 -31.98 66.03 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.145 0.498 . . . . 0.0 110.6 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.75 119.32 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.321 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 8.2 mp -80.56 118.76 22.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -102.82 130.58 49.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.952 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.828 ' H ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -71.83 130.76 41.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.046 -179.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -112.86 159.99 18.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.629 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.526 ' HD2' ' HG2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -117.02 17.33 14.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.253 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.667 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 2.3 ptm180 -177.53 153.49 0.9 Allowed 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.302 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.515 ' HA ' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -57.49 -50.74 72.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.718 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -78.39 24.07 0.28 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.972 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.667 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 1.1 t0 -81.56 -32.28 32.25 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 t -89.6 149.09 41.65 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.032 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.664 ' HD2' ' SG ' ' A' ' 14' ' ' CYS . 20.4 Cg_endo -59.05 155.28 40.08 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.487 2.125 . . . . 0.0 112.324 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.92 -26.53 2.91 Favored Glycine 0 N--CA 1.466 0.647 0 O-C-N 123.97 0.794 . . . . 0.0 115.076 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.86 -20.39 65.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.972 0.386 . . . . 0.0 111.535 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.9 m -143.93 -178.81 6.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.775 0.321 . . . . 0.0 110.293 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.617 HD11 ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -142.11 156.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 8.1 t -80.82 128.39 33.61 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.061 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.45 175.11 10.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.947 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.56 -28.02 69.02 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.54 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -76.43 -4.55 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.86 33.01 22.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.13 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.401 ' CD2' ' HB3' ' A' ' 5' ' ' LEU . 82.1 m-85 -137.41 154.54 49.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 50.8 m -61.38 142.03 57.21 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.531 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.63 128.18 3.15 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 15.6 m -76.41 58.87 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.74 0.305 . . . . 0.0 111.168 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.617 ' HA3' HD11 ' A' ' 19' ' ' ILE . . . -60.38 -41.52 98.53 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.56 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -82.03 34.0 0.4 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.934 0.397 . . . . 0.0 110.411 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 33.9 t70 -162.85 57.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.858 0.837 . . . . 0.0 109.373 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.16 -33.98 1.51 Allowed Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.59 -0.732 . . . . 0.0 113.443 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.77 23.05 6.99 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.445 -0.716 0 CA-C-O 121.591 0.71 . . . . 0.0 110.902 -179.992 . . . . . . . . 0 0 . 1 stop_ save_